image_name
stringlengths 68
68
| type
stringclasses 2
values | gt_table
stringlengths 116
12.6k
|
|---|---|---|
5d535e087c83fc7531eb8e1ab64bcf9db17e4fab229d2ca0cf5b3234f12438ae.png | simple | <table><tr><td>Number of region</td><td>Color</td><td>Maximum number of correctly sequenced syllables</td><td>Minimum number of correctly sequenced syllables</td></tr><tr><td>1</td><td>dark red</td><td>90</td><td>75</td></tr><tr><td>2</td><td>red</td><td>74</td><td>61</td></tr><tr><td>3</td><td>light red</td><td>60</td><td>45</td></tr><tr><td>4</td><td>light blue</td><td>44</td><td>31</td></tr><tr><td>5</td><td>blue</td><td>30</td><td>15</td></tr><tr><td>6</td><td>dark blue</td><td>14</td><td>0</td></tr></table> |
493e80ab9b90bdb9f5d63c29fbdc0e45c45abf544eec18c79e5fee4e5fe43931.png | simple | <table><tr><td>EZ Metric Endpoint</td><td>Weighting factor</td></tr><tr><td>24 hpf mortality</td><td>1.0</td></tr><tr><td>120 hpf mortality</td><td>0.95</td></tr><tr><td>Heart malformation</td><td>0.12</td></tr><tr><td>Brain malformation</td><td>0.12</td></tr><tr><td>Yolk sac edema</td><td>0.1</td></tr><tr><td>Notochord malformation</td><td>0.08</td></tr><tr><td>Curved axis</td><td>0.08</td></tr><tr><td>Trunk malformation</td><td>0.06</td></tr><tr><td>Delayed developmental progression</td><td>0.06</td></tr><tr><td>Occluded circulation</td><td>0.04</td></tr><tr><td>Eye malformation</td><td>0.04</td></tr><tr><td>Jaw malformation</td><td>0.04</td></tr><tr><td>Lack of spontaneous movement</td><td>0.04</td></tr><tr><td>Somite malformation</td><td>0.02</td></tr><tr><td>Motility</td><td>0.02</td></tr><tr><td>Lack of touch response</td><td>0.02</td></tr><tr><td>Snout malformation</td><td>0.02</td></tr><tr><td>Otic malformation</td><td>0.02</td></tr><tr><td>Caudal/pectoral fin malformation</td><td>0.02</td></tr><tr><td>Atypical pigmentation</td><td>0.02</td></tr><tr><td>Atypical swim bladder inflation</td><td>0.02</td></tr></table> |
5212d9b691490ceef38b3a454dc02ed7e54593455da2347c7fd01deb5c11a6ff.png | complex | <table><tr><td></td><td>Total</td><td>RCRC</td><td>LCRC</td><td></td></tr><tr><td></td><td>N (%)</td><td>N (%)</td><td>N (%)</td><td><i>P</i> value</td></tr><tr><td>Patient Number</td><td>901 (100.0)</td><td>136 (100.0)</td><td>765 (100.0)</td><td></td></tr><tr><td colspan="5">Gender</td></tr><tr><td> Male</td><td>557 (61.8)</td><td>74 (54.4)</td><td>483 (63.1)</td><td>.0536</td></tr><tr><td> Female</td><td>344 (38.2)</td><td>62 (45.6)</td><td>282 (36.9)</td><td></td></tr><tr><td colspan="5">Mean age at treatment (years)</td></tr><tr><td> Mean (SD)</td><td>59.95 (12.02)</td><td>61.39 (11.91)</td><td>59.70 (12.02)</td><td>.0992</td></tr><tr><td> Median (min, max)</td><td>60 (22, 96)</td><td>61 (22, 96)</td><td>60 (26, 90)</td><td></td></tr><tr><td colspan="5">Age group (years)</td></tr><tr><td><50</td><td>163 (18.1)</td><td>18 (13.2)</td><td>145 (19.0)</td><td>.2256</td></tr><tr><td>50-64</td><td>420 (46.6)</td><td>64 (47.1)</td><td>356 (46.5)</td><td></td></tr><tr><td>65+</td><td>318 (35.3)</td><td>54 (39.7)</td><td>264 (34.5)</td><td></td></tr><tr><td colspan="5">Histology</td></tr><tr><td> Mucinous adenocarcinoma</td><td>36 (4.0)</td><td>15 (11.0)</td><td>21 (2.7)</td><td>< .0001</td></tr><tr><td> Non-mucinous adenocarcinoma</td><td>836 (92.8)</td><td>115 (84.6)</td><td>721 (94.2)</td><td></td></tr><tr><td> Others</td><td>29 (3.2)</td><td>6 (4.4)</td><td>23 (3.0)</td><td></td></tr><tr><td colspan="5">Grade</td></tr><tr><td> 1</td><td>43 (4.8)</td><td>5 (3.7)</td><td>38 (5.0)</td><td>.0002</td></tr><tr><td> 2</td><td>689 (76.5)</td><td>90 (66.2)</td><td>599 (78.3)</td><td></td></tr><tr><td> 3</td><td>93 (10.3)</td><td>28 (20.6)</td><td>65 (8.5)</td><td></td></tr><tr><td>Undifferentiated or Unknown</td><td>76 (8.4)</td><td>13 (9.6)</td><td>63 (8.2)</td><td></td></tr><tr><td colspan="5">Stage at diagnosis<sup>a</sup></td></tr><tr><td> I-III</td><td>396 (44.0)</td><td>64 (47.1)</td><td>332 (43.4)</td><td>.4281</td></tr><tr><td> IV</td><td>505 (56.0)</td><td>72 (52.9)</td><td>433 (56.6)</td><td></td></tr><tr><td>Cetuximab combination with chemotherapy</td><td>893 (99.1)</td><td>135 (99.3)</td><td>758 (99.1)</td><td></td></tr><tr><td>Chemotherapy after end of cetuximab</td><td>495 (54.9)</td><td>61 (44.9)</td><td>434 (56.7)</td><td></td></tr><tr><td>Death</td><td>747 (82.9)</td><td>121 (89.0)</td><td>626 (81.8)</td><td></td></tr><tr><td colspan="5">Follow-up (months)</td></tr><tr><td> Mean (SD)</td><td>13.0 (8.6)</td><td>10.1 (8.0)</td><td>13.5 (8.6)</td><td></td></tr><tr><td> Median (min, max)</td><td>11.5 (0.1, 39.4)</td><td>8.1 (1.2, 34.8)</td><td>12.5 (0.1, 39.4)</td><td></td></tr></table> |
954295b1977478316acbdcbb525ed25f4b9f41f7ae563c0e9bf31611404f6a03.png | simple | <table><tr><td>Parameter</td><td>Symbol</td><td>Nominal value</td></tr><tr><td>Maximal firing rate</td><td><i>Q</i><sub>max</sub></td><td>250 s<sup>−1</sup></td></tr><tr><td>Average spike-threshold</td><td>θ</td><td>15 mV</td></tr><tr><td>Spike-threshold deviation</td><td>σ</td><td>3.3 mV</td></tr><tr><td>Synaptic decay rate</td><td>α</td><td>50 s<sup>−1</sup></td></tr><tr><td>Synaptic rise rate</td><td>β</td><td>200 s<sup>−1</sup></td></tr><tr><td>Synaptic strength from e to e neurons</td><td>ν<sub><i>ee</i></sub></td><td>1 mV s</td></tr><tr><td>Synaptic strength from i to e neurons</td><td>ν<sub><i>ei</i></sub></td><td>−1.8 mV s</td></tr><tr><td>Synaptic strength from s to e neurons</td><td>ν<sub><i>es</i></sub></td><td>3.2 mV s</td></tr><tr><td>Synaptic strength from i to i neurons</td><td>ν<sub><i>ii</i></sub></td><td>−1.8 mV s</td></tr><tr><td>Synaptic strength from e to i neurons</td><td>ν<sub><i>ie</i></sub></td><td>1 mV s</td></tr><tr><td>Synaptic strength from s to i neurons</td><td>ν<sub><i>is</i></sub></td><td>3.2 mV s</td></tr><tr><td>Synaptic strength from r to s neurons</td><td>ν<sub><i>sr</i></sub></td><td>−0.8 mV s</td></tr><tr><td>Synaptic strength from e to s neurons</td><td>ν<sub><i>se</i></sub></td><td>2.2 mV s</td></tr><tr><td>Synaptic strength from s to r neurons</td><td>ν<sub><i>rs</i></sub></td><td>0.6 mV s</td></tr><tr><td>Synaptic strength from e to r neurons</td><td>ν<sub><i>re</i></sub></td><td>1.6 mV s</td></tr><tr><td>Average noise level</td><td>ν<sub><i>sn</i></sub>φ<sub><i>n</i></sub></td><td>2.0 mV</td></tr><tr><td>Noise standard deviation</td><td>σ<sub><i>n</i></sub></td><td>0.2 mV</td></tr><tr><td>Cortico-thalamic delay</td><td>τ</td><td>0.04 s</td></tr><tr><td>Cortical damping rate</td><td>γ</td><td>100 s<sup>−1</sup></td></tr></table> |
4a545027f4bc47bfe93087fc2c84cc9ffcbb91d8467ec7e50344db7f9593223d.png | complex | <table><tr><td></td><td colspan="9">Han</td><td colspan="9">Uygur</td></tr><tr><td></td><td colspan="3">Total</td><td colspan="3">Men</td><td colspan="3">Women</td><td colspan="3">Total</td><td colspan="3">Men</td><td colspan="3">Women</td></tr><tr><td></td><td>CAD</td><td>Control</td><td>P value</td><td>CAD</td><td>Control</td><td>P value</td><td>CAD</td><td>Control</td><td>P value</td><td>CAD</td><td>Control</td><td>P value</td><td>CAD</td><td>Control</td><td>P value</td><td>CAD</td><td>Control</td><td>P value</td></tr><tr><td>Number (n)</td><td>389</td><td>411</td><td></td><td>294</td><td>224</td><td></td><td>95</td><td>187</td><td></td><td>293</td><td>408</td><td></td><td>210</td><td>205</td><td></td><td>83</td><td>203</td><td></td></tr><tr><td>Age (years)</td><td>58.73 ± 7.32</td><td>57.82 ± 8.53</td><td>0.502</td><td>59.82 ± 8.24</td><td>58.52 ± 8.43</td><td>0.332</td><td>58.21 ± 6.37</td><td>59.76 ± 6.76</td><td>0.052</td><td>56.97 ± 5.58</td><td>55.93 ± 5.59</td><td>0.086</td><td>56.57 ± 8.33</td><td>54.96 ± 9.06</td><td>0.09</td><td>54.20 ± 3.89</td><td>52.30 ± 4.83</td><td>0.076</td></tr><tr><td>BMI (kg/m2)</td><td>27.62 ± 3.71</td><td>28.23 ± 2.74</td><td>0.428</td><td>26.63 ± 1.72</td><td>26.34 ± 1.75</td><td>0.201</td><td>30.63 ± 1.78</td><td>30.17 ± 2.23</td><td>0.069</td><td>32.34 ± 7.20</td><td>28.11 ± 4.37</td><td><0.001<sup>*</sup></td><td>31.45 ± 6.84</td><td>28.48 ± 3.98</td><td><0.001<sup>*</sup></td><td>32.97 ± 7.40</td><td>26.73 ± 5.41</td><td><0.001<sup>*</sup></td></tr><tr><td>Pulse(beats/min)</td><td>73.82 ± 10.23</td><td>73.13 ± 10.01</td><td>0.673</td><td>74.24 ± 10.52</td><td>73.76 ± 10.23</td><td>0.324</td><td>73.13 ± 9.24</td><td>72.45 ± 8.53</td><td>0.802</td><td>74.59 ± 10.92</td><td>76.56 ± 7.93</td><td>0.38</td><td>73.49 ± 11.20</td><td>74.76 ± 8.45</td><td>0.732</td><td>76.91 ± 9.74</td><td>80.38 ± 5.17</td><td>0.339</td></tr><tr><td>Glu (mmol/L)</td><td>6.12 ± 2.34</td><td>5.28 ± 1.67</td><td><0.001<sup>*</sup></td><td>5.63 ± 1.68</td><td>5.42 ± 1.45</td><td>0.036<sup>*</sup></td><td>6.48 ± 3.12</td><td>5.42 ± 1.59</td><td><0.001<sup>*</sup></td><td>6.60 ± 2.78</td><td>5.24 ± 2.38</td><td><0.001<sup>*</sup></td><td>6.21 ± 2.64</td><td>5.20 ± 2.55</td><td><0.001<sup>*</sup></td><td>7.31 ± 3.25</td><td>5.37 ± 2.41</td><td><0.001<sup>*</sup></td></tr><tr><td>TG (mmol/L)</td><td>1.97 ± 1.22</td><td>1.82 ± 1.76</td><td>0.978</td><td>1.74 ± 0.87</td><td>1.58 ± 0.69</td><td>0.284</td><td>2.23 ± 1.64</td><td>1.62 ± 1.18</td><td>0.254</td><td>1.83 ± 1.25</td><td>1.76 ± 1.35</td><td>0.435</td><td>1.77 ± 0.99</td><td>1.83 ± 1.50</td><td>0.638</td><td>2.10 ± 2.07</td><td>1.70 ± 1.24</td><td>0.061</td></tr><tr><td>TC (mmol/L)</td><td>4.35 ± 1.08</td><td>4.12 ± 0.74</td><td>0.262</td><td>4.35 ± 1.17</td><td>4.26 ± 0.82</td><td>0.431</td><td>4.62 ± 1.23</td><td>4.52 ± 0.85</td><td>0.873</td><td>4.24 ± 1.08</td><td>4.15 ± 0.98</td><td>0.34</td><td>4.18 ± 1.06</td><td>4.13 ± 0.97</td><td>0.565</td><td>4.50 ± 1.15</td><td>4.17 ± 0.97</td><td>0.037<sup>*</sup></td></tr><tr><td>HDL (mmol/L)</td><td>1.14 ± 0.23</td><td>1.26 ± 0.31</td><td>0.054</td><td>1.12 ± 0.26</td><td>1.19 ± 0.47</td><td>0.672</td><td>1.15 ± 0.36</td><td>1.33 ± 0.24</td><td>0.528</td><td>0.98 ± 0.13</td><td>1.01 ± 0.12</td><td>0.142</td><td>0.97 ± 0.31</td><td>0.98 ± 0.25</td><td>0.738</td><td>1.044 ± 0.20</td><td>1.04 ± 0.10</td><td>0.702</td></tr><tr><td>LDL (mmol/L)</td><td>2.53 ± 0.79</td><td>2.16 ± 0.85</td><td><0.001<sup>*</sup></td><td>2.62 ± 0.84</td><td>2.56 ± 0.68</td><td>0.005<sup>*</sup></td><td>2.58 ± 1.02</td><td>2.24 ± 0.58</td><td><0.001<sup>*</sup></td><td>2.86 ± 0.86</td><td>2.59 ± 0.97</td><td><0.001<sup>*</sup></td><td>2.90 ± 0.84</td><td>2.56 ± 0.99</td><td><0.001<sup>*</sup></td><td>2.84 ± 0.87</td><td>2.72 ± 0.89</td><td>0.356</td></tr><tr><td>EH (%)</td><td>59.32</td><td>47.63</td><td>0.023<sup>*</sup></td><td>62.31</td><td>43.34</td><td><0.001<sup>*</sup></td><td>57.27</td><td>51.22</td><td>0.031<sup>*</sup></td><td>42.68</td><td>18.42</td><td><0.001<sup>*</sup></td><td>34.35</td><td>20.01</td><td><0.001<sup>*</sup></td><td>51</td><td>16.53</td><td><0.001<sup>*</sup></td></tr><tr><td>DM (%)</td><td>27.23</td><td>13.56</td><td><0.001<sup>*</sup></td><td>22.74</td><td>15.03</td><td><0.001<sup>*</sup></td><td>31.18</td><td>12.26</td><td><0.001<sup>*</sup></td><td>26.71</td><td>12.84</td><td><0.001<sup>*</sup></td><td>21.53</td><td>7.73</td><td><0.001<sup>*</sup></td><td>30.69</td><td>17.95</td><td><0.001<sup>*</sup></td></tr><tr><td>Smoke (%)</td><td>58.48</td><td>31.43</td><td><0.001<sup>*</sup></td><td>87.59</td><td>56.38</td><td><0.001<sup>*</sup></td><td>12.13</td><td>3.62</td><td>0.002<sup>*</sup></td><td>33.15</td><td>17.97</td><td><0.001<sup>*</sup></td><td>63.73</td><td>34.9</td><td><0.001<sup>*</sup></td><td>5.63</td><td>1.23</td><td>0.023<sup>*</sup></td></tr></table> |
7881e68a88e56b6ba459b65e037c6154426a2d40717a2c27d5ee7f44984f73f7.png | complex | <table><tr><td></td><td colspan="3"><i>Type 1 (n=641)</i></td><td colspan="3"><i>Type 2 (n=10039)</i></td></tr><tr><td></td><td><i>Without retinopathy</i><i>n=540 </i></td><td><i>With Retinopathy</i><i>n=101 </i></td><td><i>p-value</i></td><td><i>Without retinopathy</i><i>n=7484 </i></td><td><i>With Retinopathy</i><i>n=2555</i></td><td><i>p-value</i></td></tr><tr><td>Age(years)</td><td>24.59±11.68</td><td>31.14±13.28</td><td>0.000</td><td>52.16±10.55</td><td>54.06±9.61</td><td>0.000</td></tr><tr><td>Sex (M/F)</td><td>232 / 308(43.0% / 57.0%)</td><td>45 / 56(44.6% / 55.4%)</td><td>0.767</td><td>2322 / 5162(31.0% / 69.0%)</td><td>947 / 1608(37.1% / 62.9%)</td><td>0.000</td></tr><tr><td>BMI</td><td>22.16±6.48</td><td>24.96±7.20</td><td>0.000</td><td>27.98±5.67</td><td>28.22±5.94</td><td>0.066</td></tr><tr><td>W.C(cm)</td><td>88.32±15.21</td><td>84.74±16.47</td><td>0.035</td><td>93.11±11.99</td><td>91.52±11.61</td><td>0.000</td></tr><tr><td>SBP(mmHg)</td><td>128.48±15.04</td><td>141.53±26.74</td><td>0.000</td><td>125.40±14.99</td><td>137.29±22.94</td><td>0.000</td></tr><tr><td>DBP(mmHg)</td><td>76.94±8.57</td><td>79.50±7.98</td><td>0.006</td><td>83.11±9.88</td><td>83.88±10.12</td><td>0.001</td></tr><tr><td>RBS(mg/dl)</td><td>240.39±85.50</td><td>302.33±122.52</td><td>0.000</td><td>221.85±84.88</td><td>283.90±115.40</td><td>0.000</td></tr></table> |
b8aa2df37d96fe28b75db84186da4d8354ace8b3454047c6fa0cc4384f579f7e.png | complex | <table><tr><td> </td><td>All homes</td><td>Box-shaped, Metal-roofed</td><td>Round-shaped, Thatch-roofed</td><td> </td></tr><tr><td>ACH</td><td>Mean (SD)</td><td>Mean (SD)</td><td>Mean (SD)</td><td>p-value</td></tr><tr><td>Closed</td><td>3 (2.9)</td><td>3 (2.7)</td><td>3 (3.3)</td><td>0.50</td></tr><tr><td>Windows Open</td><td>9 (7.1)</td><td>13 (8.1)</td><td>5 (2.9)</td><td>0.01</td></tr><tr><td>Windows & Door</td><td rowspan="2">20 (13.1)</td><td rowspan="2">27 (9.7)</td><td rowspan="2">13 (12.8)</td><td rowspan="2">0.01</td></tr><tr><td>Open</td></tr><tr><td>*TB Risk (10h exposure)</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Closed</td><td>55.4 (27.8)</td><td>58.3 (24.7)</td><td>52.5 (31.5)</td><td>0.62</td></tr><tr><td>Windows Open</td><td>21.5 (14.1)</td><td>24.7 (18.1)</td><td>18 (8.4)</td><td>0.32</td></tr><tr><td>Windows & Door</td><td rowspan="2">9.6 (4.7)</td><td rowspan="2">8.9 (3.6)</td><td rowspan="2">10 (5.6)</td><td rowspan="2">0.44</td></tr><tr><td>Open</td></tr></table> |
96f8acdad324011f269017009a236759a8b87ecb1b323c8fc340c0b373cc75b7.png | simple | <table><tr><td>Gene set/pathway</td><td>NT<sub>k </sub><i>q </i>value</td><td>NE<sub>k </sub><i>q </i>value</td></tr><tr><td>Regulation of cell growth (GO:0001558)</td><td>0.0</td><td>0.0</td></tr><tr><td>Nuclear pore complex (GO:0046930)</td><td>0.0</td><td>0.03</td></tr><tr><td>Negative regulation of cellular metabolism (GO:0031324)</td><td>0.0</td><td>0.04</td></tr><tr><td>Chromatin remodeling (GO:0016568)</td><td>0.0</td><td>0.055</td></tr><tr><td>PI3K-AKT signaling pathway (humanpaths)</td><td>0.0</td><td>0.1</td></tr><tr><td>Histone acetyltransferase binding (GO:0035035)</td><td>0.0</td><td>0.2</td></tr><tr><td>cAMP/Ca<sup>2+ </sup>signaling (humanpaths)</td><td>0.0</td><td>0.3</td></tr><tr><td>Spliceosome complex (GO:0005681)</td><td>0.0</td><td>0.9</td></tr></table> |
1e5771631eb936f938bd4e8a4abbecd38a69216b17efd6c957338157f400ce52.png | simple | <table><tr><td></td><td>Rainy season 2009</td><td>Dry season 2010</td><td>P-values</td><td>Total</td></tr><tr><td>Sensitivity%</td><td>56.4</td><td>20.7</td><td>< 0.001</td><td>52.9</td></tr><tr><td>Specificity%</td><td>72.4</td><td>97.3</td><td>< 0.001</td><td>85.5</td></tr><tr><td>PPV%</td><td>67.5</td><td>43.3</td><td>< 0.001</td><td>66.1</td></tr><tr><td>NPV%</td><td>62</td><td>92.5</td><td>< 0.001</td><td>77.2</td></tr><tr><td>P-values</td><td>< 0.001</td><td>< 0.001</td><td></td><td>< 0.001</td></tr></table> |
7e4f49510aa90a4230d3f471b45a05974c16732a8c7d44e434cc11852b882142.png | complex | <table><tr><td></td><td></td><td></td><td colspan="3">No. of individuals with genotype (%)</td><td></td></tr><tr><td>Population and disease</td><td>No.</td><td>VariantAllele Frequency (%)</td><td>Ser/Ser</td><td>Ser/Leu</td><td>Leu/Leu</td><td><i>P </i>value<sup>a</sup></td></tr><tr><td>Ghana, delivering women</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> <i>P. falciparum </i>positive</td><td>541</td><td>0.1</td><td>540 (99.8)</td><td>1 (0.2)</td><td>0 (0)</td><td>0.49</td></tr><tr><td> <i>P. falciparum </i>negative</td><td>554</td><td>0</td><td>554 (100)</td><td>0 (0)</td><td>0 (0)</td><td></td></tr><tr><td>Germany</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Sepsis patients</td><td>223</td><td>18.1</td><td>170 (76.2)</td><td>43 (19.3)</td><td>10 (4.5)</td><td>0.19</td></tr><tr><td> Controls</td><td>188</td><td>19.2</td><td>138 (74.4)</td><td>48 (25.5)</td><td>2 (1.1)<sup>b</sup></td><td></td></tr><tr><td>Bangladesh</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Leprosy patients</td><td>263</td><td>16.3</td><td>186 (70.7)</td><td>68 (25.9)</td><td>9 (3.4)</td><td>0.22</td></tr><tr><td> Controls</td><td>280</td><td>17.2</td><td>188 (67.1)</td><td>88 (31.5)</td><td>4 (1.4)</td><td></td></tr><tr><td>Turkey</td><td></td><td></td><td></td><td></td><td></td><td>0.11</td></tr><tr><td> Leprosy patients</td><td>60</td><td>10.8</td><td>47 (78)</td><td>13 (21)</td><td>0 (0)</td><td></td></tr><tr><td> Controls</td><td>100</td><td>6.5</td><td>88 (88)</td><td>11 (11)</td><td>1 (1)</td><td></td></tr></table> |
dcf058e0b6c2c061970fd3a2a6dc93613bad7fe12068621fac2ab8db2c232abb.png | simple | <table><tr><td></td><td>Healthy</td><td>Milder fibrosis</td><td>Significant fibrosis</td><td>Early Cirrhosis</td></tr><tr><td>Number</td><td>42</td><td>24</td><td>32</td><td>12</td></tr><tr><td>Age (Mean ± SD)</td><td>32.9 ± 9.2</td><td>37.4 ± 12.4</td><td>34.4 ± 11.7</td><td>38.5 ± 14.4</td></tr><tr><td>Gender (Male/Female)</td><td>42/0</td><td>22/2</td><td>28/4</td><td>10/2</td></tr></table> |
69e937c38cbed1d495c4131b30b2eff75115644a52db277b467b4648c476c442.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">14–16 weeks</td><td colspan="2">22–24 weeks<sup>c</sup></td><td colspan="2">30–32 weeks</td><td colspan="2">36–38 weeks<sup>c</sup></td><td colspan="2">5 year. follow-up</td></tr><tr><td>Uni</td><td>Multi</td><td>Uni</td><td>Multi</td><td>Uni</td><td>Multi</td><td>Uni</td><td>Multi</td><td>Uni</td><td>Multi</td></tr><tr><td>Age</td><td>−0.02</td><td></td><td>−0.01</td><td></td><td>−0.03</td><td></td><td><i>−0.13*</i></td><td>−0.12*</td><td>−0.01</td><td></td></tr><tr><td>BMI</td><td><i>0.70***</i></td><td>0.53***</td><td><i>0.68***</i></td><td>0.50***</td><td><i>0.61***</i></td><td>0.38***</td><td><i>0.61***</i></td><td>0.50***</td><td><i>0.73***</i></td><td>0.56***</td></tr><tr><td>Parity<sup>a</sup></td><td>0.05</td><td></td><td>0.02</td><td></td><td>−0.01</td><td></td><td><i>−0.08</i></td><td>−0.14**</td><td>0.04</td><td></td></tr><tr><td>Smoking<sup>b</sup></td><td><i>0.16*</i></td><td></td><td><i>0.15*</i></td><td></td><td><i>0.09</i></td><td></td><td><i>0.18**</i></td><td></td><td>0.01</td><td></td></tr><tr><td>Systolic BP</td><td><i>0.26***</i></td><td></td><td><i>0.20**</i></td><td></td><td><i>0.22***</i></td><td></td><td><i>0.25***</i></td><td></td><td><i>0.28***</i></td><td></td></tr><tr><td>CRP</td><td><i>0.25***</i></td><td></td><td><i>0.32***</i></td><td></td><td><i>0.28***</i></td><td></td><td><i>0.20***</i></td><td></td><td><i>0.32***</i></td><td></td></tr><tr><td>Insulin sensitivity</td><td><i>−0.60***</i></td><td>−0.32***</td><td><i>−0.61**</i></td><td>−0.35***</td><td><i>−0.61***</i></td><td>−0.24*</td><td><i>−0.50***</i></td><td>−0.37***</td><td><i>−0.61***</i></td><td>−0.29***</td></tr><tr><td>Insulin resistance</td><td><i>0.56***</i></td><td></td><td><i>0.53***</i></td><td></td><td><i>0.59***</i></td><td>0.28*</td><td><i>0.48***</i></td><td></td><td><i>0.56***</i></td><td></td></tr><tr><td>Β-cell function</td><td><i>−0.39***</i></td><td></td><td><i>−0.38***</i></td><td></td><td><i>−0.33***</i></td><td>0.20**</td><td><i>−0.18***</i></td><td>0.17**</td><td><i>−0.45***</i></td><td></td></tr><tr><td>R-square</td><td></td><td>0.56</td><td></td><td>0.55</td><td></td><td></td><td></td><td>0.49</td><td></td><td></td></tr></table> |
172a11a5c9230459a9ac69d6b630e0e12750c7eec88015c0adc27e8216ae8e07.png | complex | <table><tr><td>GEO ID</td><td>Description</td></tr><tr><td colspan="2">GSE43559 (gene expression)</td></tr><tr><td>GSM1065332</td><td>PGC E13 F3-Control biological rep1</td></tr><tr><td>GSM1065333</td><td>PGC E13 F3-Control biological rep2</td></tr><tr><td>GSM1065334</td><td>PGC E13 F3-Vinclozolin biological rep1</td></tr><tr><td>GSM1065335</td><td>PGC E13 F3-Vinclozolin biological rep2</td></tr><tr><td>GSM1065336</td><td>PGC E16 F3-Control biological rep1</td></tr><tr><td>GSM1065337</td><td>PGC E16 F3-Control biological rep2</td></tr><tr><td>GSM1065338</td><td>PGC E16 F3-Vinclozolin biological rep1</td></tr><tr><td>GSM1065339</td><td>PGC E16 F3-Vinclozolin biological rep2</td></tr><tr><td colspan="2">GSE59510 (promoter methylation)</td></tr><tr><td>GSM1438556</td><td>E16-Vip2/Cip2</td></tr><tr><td>GSM1438557</td><td>E13-Vip2/Cip1</td></tr><tr><td>GSM1438558</td><td>E13-Vip1/Cip1</td></tr><tr><td>GSM1438559</td><td>E16-Vip1/Cip1</td></tr><tr><td>GSM1438560</td><td>E16-Vip2/Cip1</td></tr><tr><td>GSM1438561</td><td>E13-Vip2/Cip2</td></tr></table> |
f0aec64f28d0d77487228e7b91d32c86776efc59f4d59419e8c9e2a9ecf50969.png | simple | <table><tr><td>Variables</td><td>Total cholesterol<150 mg/dL(n = 68)</td><td>Total cholesterol>150 mg/dL(n = 97)</td></tr><tr><td>Age in years</td><td>39.8 ± 7.9</td><td>41.1 ± 7.2</td></tr><tr><td>Men</td><td>72%</td><td>68%</td></tr><tr><td>Women</td><td>28%</td><td>32%</td></tr><tr><td>Black</td><td>65%</td><td>55%</td></tr><tr><td>Hispanic</td><td>33%</td><td>29%</td></tr><tr><td>White</td><td>0%</td><td>16%</td></tr><tr><td>Annual income</td><td></td><td></td></tr><tr><td>Less than $10,000</td><td>89%</td><td>88%</td></tr><tr><td>$11,000-$20,000</td><td>9%</td><td>10%</td></tr><tr><td>More than $20,000</td><td>2%</td><td>2%</td></tr><tr><td>Cigarette smoker</td><td>81%</td><td>80%</td></tr><tr><td>Hazardous alcohol use</td><td>64%</td><td>48%</td></tr><tr><td>Drug use</td><td>42%</td><td>39%</td></tr><tr><td>Albumin in mg/dl</td><td>4.0 ± 0.4</td><td>4.1 ± 0.5</td></tr><tr><td>Body mass index in kg/m<sup>2</sup></td><td>26.2 ± 6.2</td><td>27.4 ± 6.7</td></tr><tr><td>Number of years diagnosed with HIV</td><td>9.7 ± 6.6</td><td>8.7 ± 5.6</td></tr></table> |
05557b75bbb922b298c885f3266d8def17511eda4ea75913334f0d409ebf195a.png | simple | <table><tr><td> </td><td>Class 1 (n = 16)</td><td>Class 2 (n = 30)</td><td>P-value</td></tr><tr><td>Age (years), mean ± SD</td><td>64.38 ± 11.32</td><td>61.50 ± 6.26</td><td>0.186</td></tr><tr><td>Men, n (%)</td><td>16 (100%)</td><td>27 (90%)</td><td>0.542</td></tr><tr><td>Neurological symptoms*, n (%)</td><td>6 (37.5%)</td><td>18 (60%)</td><td>0.217</td></tr><tr><td>Hypertension, n (%)</td><td>9 (56.3%)</td><td>13 (43.3%)</td><td>0.538</td></tr><tr><td>Diabetes mellitus, n (%)</td><td>3 (18.8%)</td><td>9 (30.0%)</td><td>0.498</td></tr><tr><td>Hypercholesterolemia, n (%)</td><td>9 (56.3%)</td><td>18 (60.0%)</td><td>1.000</td></tr><tr><td>Current smoker, n (%)</td><td>8 (50.5%)</td><td>19 (63.3%)</td><td>0.531</td></tr></table> |
9e29fbf5bf96cb66ffa4dd81491d8cb4a15a13705da8f791a35469fd4261dfcf.png | complex | <table><tr><td></td><td>EG mean (SD)</td><td>CG mean (SD)</td></tr><tr><td colspan="3">H1: General self-care management<sup>a</sup></td></tr><tr><td> Baseline</td><td>46.19 (13.13)</td><td>46.31 (8.97)</td></tr><tr><td> 1 month</td><td>50.57 (4.89)</td><td>50.76 (6.73)</td></tr><tr><td>H2: Self-care specific to HF<sup>a</sup></td><td></td><td></td></tr><tr><td> Baseline</td><td>49.37 (20.37)</td><td>46.25 (14.50)</td></tr><tr><td> 1 month</td><td>75.23 (10.60)</td><td>69.48 (16.66)</td></tr><tr><td colspan="3">H3: Perceived competence to manage HF<sup>a</sup></td></tr><tr><td> Baseline</td><td>20.13 (4.08)</td><td>19.06 (5.30)</td></tr><tr><td> 1 month</td><td>23.29 (3.27)</td><td>23.85 (4.02)</td></tr><tr><td colspan="3">H4: Behavioral Questionnaire of the Elderly-Health activities</td></tr><tr><td> H4a A-motivation<sup>b</sup></td><td></td><td></td></tr><tr><td> Baseline</td><td>7.88 (3.98)</td><td>5.87 (3.46)</td></tr><tr><td> 1 month</td><td>4.14 (2.18)</td><td>6.08 (3.64)</td></tr><tr><td>H4b: External extrinsic motivation<sup>b</sup></td><td></td><td></td></tr><tr><td> Baseline</td><td>13.00 (4.77)</td><td>15.13 (4.73)</td></tr><tr><td> 1 month</td><td>16.29 (6.40)</td><td>13.85 (5.32)</td></tr><tr><td>H4c: Internal extrinsic motivation<sup>a</sup></td><td></td><td></td></tr><tr><td> Baseline</td><td>16.65 (2.93)</td><td>16.38 (3.16)</td></tr><tr><td> 1 month</td><td>19.29 (1.77)</td><td>17.54 (3.23)</td></tr><tr><td>H4d: Intrinsic motivation<sup>a</sup></td><td></td><td></td></tr><tr><td> Baseline</td><td>11.13 (5.58)</td><td>9.63 (4.26)</td></tr><tr><td> 1 month</td><td>10.86 (7.55)</td><td>9.77 (5.48)</td></tr><tr><td colspan="3">H5: Family Care Climate Questionnaire-Patient version<sup>a</sup></td></tr><tr><td> Baseline</td><td>57.56 (7.97)</td><td>60.19 (5.24)</td></tr><tr><td> 1 month</td><td>61.86 (6.63)</td><td>62.46 (6.57)</td></tr><tr><td colspan="3">H6: Family Care Climate Questionnaire-Family version<sup>a</sup></td></tr><tr><td> Baseline</td><td>58.13 (4.94)</td><td>57.94 (6.69)</td></tr><tr><td> 1 month</td><td>60.21 (4.93)</td><td>57.85 (6.45)</td></tr></table> |
db6fdd4998bbf5b2577bb9382f20c1c59b96921ee13f11e883a2fd9c2e9c12bc.png | complex | <table><tr><td>Characteristic</td><td>Notifying hospitals</td><td>Cardiac arrests/eligible for donation</td><td><i>p</i> value</td><td>OR (95 % CI)</td></tr><tr><td>Total, <i>n</i> (%)</td><td>27 (100)</td><td>141/465 (30.3)</td><td></td><td></td></tr><tr><td colspan="5">Hospital beds, <i>n</i> (%)</td></tr><tr><td>< 150 beds</td><td>10 (37.0)</td><td>29/62 (46.7)</td><td>0.002</td><td>2.28 (1.32; 3.93)</td></tr><tr><td> 150–250 beds</td><td>10 (37.0)</td><td>65/217 (29.9)</td><td>0.87</td><td></td></tr><tr><td>> 250 beds</td><td>7 (25.9)</td><td>47/186 (25.2)</td><td>0.053</td><td>0.66 (0.44; 1.0)</td></tr><tr><td colspan="5">ICU beds, <i>n</i> (%)</td></tr><tr><td>< 5 %</td><td>5 (18.5)</td><td>44/131 (33.5)</td><td>0.33</td><td></td></tr><tr><td> 5–10 %</td><td>15 (55.6)</td><td>89/294 (30.3)</td><td>0.97</td><td></td></tr><tr><td>> 10 %</td><td>7 (25.9)</td><td>14/39 (35.8)</td><td>0.43</td><td></td></tr><tr><td colspan="5">Teaching, <i>n</i> (%)</td></tr><tr><td> Yes</td><td>15 (55.6)</td><td>101/329 (30.7)</td><td>0.78</td><td></td></tr><tr><td> No</td><td>12 (44.4)</td><td>40/136 (29.4)</td><td></td><td></td></tr><tr><td colspan="5">Trauma referral center, <i>n</i> (%)</td></tr><tr><td> Yes</td><td>15 (55.6)</td><td>112/354 (31.6)</td><td>0.27</td><td></td></tr><tr><td> No</td><td>12 (44.4)</td><td>29/111 (26.1)</td><td></td><td></td></tr><tr><td colspan="5">Transplant center, <i>n</i> (%)</td></tr><tr><td> Yes</td><td>6 (22.2)</td><td>44/211 (20.8)</td><td><0.001</td><td>0.42 (0.28; 0.65)</td></tr><tr><td> No</td><td>21 (78.8)</td><td>97/254 (38.1)</td><td></td><td></td></tr><tr><td colspan="5">Onsite training, <i>n</i> (%)</td></tr><tr><td> Yes</td><td>8 (29.7)</td><td>69/238 (28.9)</td><td>0.52</td><td></td></tr><tr><td> No</td><td>19 (70.3)</td><td>72/227 (31.7)</td><td></td><td></td></tr><tr><td colspan="5">Transplant coordination unit connected to the ICU, <i>n</i> (%)</td></tr><tr><td> Yes</td><td>17 (63.0)</td><td>113/394 (18.2)</td><td>0.07</td><td>0.61 (0.36; 1.04)</td></tr><tr><td> No</td><td>10 (37.0)</td><td>28/70 (25.9)</td><td></td><td></td></tr><tr><td colspan="5">Public administration, <i>n</i> (%)</td></tr><tr><td> Yes</td><td>22 (81.5)</td><td>137/433 (31.6)</td><td>0.02</td><td>3.23 (1.11; 9.41)</td></tr><tr><td> No</td><td>5 (18.5)</td><td>4/31 (12.3)</td><td></td><td></td></tr></table> |
39886a3776721f63f7ac426384d3cb7954581d4cc8d2e08c81bfd0fdb9fe5458.png | simple | <table><tr><td>Factors</td><td>Odds ratio</td><td>95% confidence interval</td></tr><tr><td>Nicardipine vs. labetalol</td><td>2.73</td><td>1.113-6.698</td></tr><tr><td>Female</td><td>3.311</td><td>1.36-8.064</td></tr><tr><td>No history of stroke</td><td>5.38</td><td>1.565-18.468</td></tr></table> |
ceb3cfe95ad15367694aeb2a0c6122c78f8b1d047be9f46428a47d6e16eba0ca.png | complex | <table><tr><td>Strains</td><td>Clinical signs first evident</td><td>No. leisions/total</td><td>Mortality<sup>e</sup></td><td>Main clinical signs</td><td>Salient gross lesions</td></tr><tr><td> </td><td> </td><td> </td><td> </td><td>SPF chickens</td><td> </td></tr><tr><td>Herts/33</td><td>2 dpi</td><td>12/12</td><td>8/8</td><td>severe depression, lethargy, ruffled feathers, eyelid edema, diarrhea, open-mouth breathing</td><td>Spleen, Atr; Intestene, Hem; Proventriculus, Hem; Pancreas, Nec; Thymus, Hem; Larynx and trachea, Hem;</td></tr><tr><td>ZJ1</td><td>2 dpi</td><td>12/12</td><td>8/8</td><td rowspan="4">severe depression, lethargy, ruffled feathers, eyelid edema, diarrhea, open-mouth breathing</td><td rowspan="4">Spleen, Nec; Intestene, Hem + Nec; Proventriculus, Hem; Pancreas, Nec; Thymus, Hem; Larynx and trachea, Hem;</td></tr><tr><td>JS-5-05-Go</td><td>2 dpi</td><td>12/12</td><td>8/8</td></tr><tr><td>XJ-2/97</td><td>2 dpi</td><td>12/12</td><td>8/8</td></tr><tr><td>JS-3-05-Ch</td><td>2 dpi</td><td>12/12</td><td>8/8</td></tr><tr><td> </td><td> </td><td> </td><td> </td><td>Geese</td><td> </td></tr><tr><td>Herts/33</td><td>4 dpi</td><td>12/12</td><td>4/8</td><td>morderate depression, diarrhea, crouch, nasal discharge, eyelid edema</td><td>Spleen, Atr; Intestene, Hem, Proventriculus, Ed + Hem; Pancreas, Nec;Thymus, Hem; Larynx and trachea, Hem;</td></tr><tr><td>ZJ1</td><td>3 dpi</td><td>12/12</td><td>5/8</td><td rowspan="3">morderate to severe depression, diarrhea, crouch, nasal discharge, eyelid edema</td><td rowspan="3">Spleen, Nec; Intestene, Hem + Nec; Proventriculus, Ed + Hem; Pancreas, Nec; Thymus, Hem; Larynx and trachea, Hem;</td></tr><tr><td>JS-5-05-Go</td><td>3 dpi</td><td>12/12</td><td>6/8</td></tr><tr><td>XJ-2/97</td><td>3 dpi</td><td>12/12</td><td>5/8</td></tr><tr><td>JS-3-05-Ch</td><td>3 dpi</td><td>12/12</td><td>6/8</td><td> </td><td> </td></tr></table> |
484409397d2c591d04972367d51dc530428cc8481c9bc76ca3aba1abe193828d.png | simple | <table><tr><td>Source</td><td>Sum of squares</td><td>Degree of freedom</td><td>Mean<sup>2</sup></td><td>F value</td><td>P > F</td><td>Coefficient estimate</td></tr><tr><td>Block</td><td>46.37</td><td>2</td><td>23.19</td><td> </td><td> </td><td> </td></tr><tr><td>Model</td><td>2905.88</td><td>14</td><td>207.56</td><td>8.47</td><td>0.0002</td><td> </td></tr><tr><td>A</td><td>37.50</td><td>1</td><td>37.50</td><td>1.53</td><td>0.2379</td><td>1.25</td></tr><tr><td>B</td><td>2.30</td><td>1</td><td>2.30</td><td>0.094</td><td>0.7643</td><td>−0.31</td></tr><tr><td>C</td><td>153.30</td><td>1</td><td>153.30</td><td>6.26</td><td>0.0265</td><td>2.53</td></tr><tr><td>D</td><td>1053.35</td><td>1</td><td>1053.35</td><td>42.99</td><td><0.0001</td><td>−6.62</td></tr><tr><td>A<sup>2</sup></td><td>0.15</td><td>1</td><td>0.15</td><td>6.258E-3</td><td>0.9381</td><td>0.08</td></tr><tr><td>B<sup>2</sup></td><td>181.64</td><td>1</td><td>181.64</td><td>7.41</td><td>0.0174</td><td>2.57</td></tr><tr><td>C<sup>2</sup></td><td>634.40</td><td>1</td><td>634.40</td><td>25.89</td><td>0.0002</td><td>4.81</td></tr><tr><td>D<sup>2</sup></td><td>624.94</td><td>1</td><td>624.94</td><td>25.51</td><td>0.0002</td><td>4.77</td></tr><tr><td>AB</td><td>2.81</td><td>1</td><td>2.81</td><td>0.11</td><td>0.7405</td><td>−0.42</td></tr><tr><td>AC</td><td>32.23</td><td>1</td><td>32.23</td><td>1.32</td><td>0.2721</td><td>−1.42</td></tr><tr><td>AD</td><td>1.72</td><td>1</td><td>1.72</td><td>0.070</td><td>0.7951</td><td>−0.33</td></tr><tr><td>BC</td><td>0.020</td><td>1</td><td>0.020</td><td>8.178E-4</td><td>0.9776</td><td>0.04</td></tr><tr><td>BD</td><td>359.40</td><td>1</td><td>359.40</td><td>14.67</td><td>0.0021</td><td>−4.74</td></tr><tr><td>CD</td><td>60.63</td><td>1</td><td>60.63</td><td>2.47</td><td>0.1397</td><td>−1.95</td></tr><tr><td>Residuals</td><td>318.51</td><td>13</td><td>24.50</td><td> </td><td> </td><td> </td></tr><tr><td>Lack of Fit</td><td>299.05</td><td>10</td><td>29.91</td><td>4.61</td><td>0.1175</td><td> </td></tr><tr><td>Pure error</td><td>19.46</td><td>3</td><td>6.49</td><td> </td><td> </td><td> </td></tr><tr><td>Cor total</td><td>3270.76</td><td>29</td><td> </td><td> </td><td> </td><td> </td></tr></table> |
91fc75ad2be323e54fdcaee6638d338af8cd9ce7ef425bef420acf8048624076.png | simple | <table><tr><td></td><td>PKS/NRPS</td><td>LuxRI</td><td>Bacteriocin</td><td>Siderophore</td><td>Terpene</td><td>Ectoine</td></tr><tr><td><i>Leisingera</i> sp. ANG-Vp</td><td>1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>1</td></tr><tr><td><i>Leisingera</i> sp. ANG-M1</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>1</td></tr><tr><td><i>Leisingera</i> sp. ANG1</td><td>1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td><i>Leisingera</i> sp. ANG-DT</td><td>1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td><i>Leisingera</i> sp. ANG-S</td><td>1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td><i>Leisingera</i> sp. ANG-S3</td><td>1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td><i>Leisingera</i> sp. ANG-M6</td><td>1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td><i>Leisingera</i> sp. ANG-S5</td><td>1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td><i>Leisingera</i> sp. ANG-M7</td><td>1</td><td>1</td><td>0</td><td>1</td><td>0</td><td>0</td></tr><tr><td><i>Ruegeria</i> sp. ANG-R</td><td>1</td><td>2</td><td>3</td><td>0</td><td>0</td><td>1</td></tr><tr><td><i>Ruegeria</i> sp. ANG-S4</td><td>2</td><td>2</td><td>3</td><td>0</td><td>0</td><td>0</td></tr><tr><td><i>Tateyamaria</i> sp. ANG-S1</td><td>0</td><td>1</td><td>2</td><td>1</td><td>1</td><td>0</td></tr></table> |
690826cf4a14b545ab3cddfb1e6f00c0aec01f1c259cdad947576e6f6c9951f5.png | complex | <table><tr><td>A</td><td></td><td colspan="3">Fixed effect</td><td colspan="4">Random effect</td><td colspan="6">% variances</td></tr><tr><td></td><td></td><td>M</td><td>D</td><td>Y</td><td>G</td><td>G×M</td><td>G×D</td><td>G×Y</td><td>G</td><td>G×M</td><td>G×D</td><td>G×Y</td><td>Res</td><td><i>h</i><sup><i>2</i></sup><sub><i>b</i></sub></td></tr><tr><td></td><td><i>NDVI</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>-</td><td>-</td><td>35</td><td>19</td><td>-</td><td>-</td><td>46</td><td>0.62</td></tr><tr><td></td><td><i>sdNDVI</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>-</td><td>-</td><td>21</td><td>8</td><td>-</td><td>-</td><td>71</td><td>0.50</td></tr><tr><td></td><td><i>VARI</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>23</td><td>6</td><td>9</td><td>-</td><td>61</td><td>0.77</td></tr><tr><td></td><td><i>sdVARI</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>9</td><td>5</td><td>10</td><td>-</td><td>76</td><td>0.56</td></tr><tr><td></td><td><i>SRPI</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>19</td><td>18</td><td>4</td><td>-</td><td>59</td><td>0.60</td></tr><tr><td></td><td><i>sdSRPI</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>17</td><td>8</td><td>5</td><td>-</td><td>70</td><td>0.69</td></tr><tr><td></td><td><i>TsTa</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>15</td><td>18</td><td>5</td><td>-</td><td>62</td><td>0.55</td></tr><tr><td></td><td><i>sdTsTa</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>7</td><td>9</td><td>4</td><td>-</td><td>79</td><td>0.49</td></tr><tr><td></td><td><i>WDI</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>11</td><td>7</td><td>5</td><td>-</td><td>76</td><td>0.59</td></tr><tr><td></td><td><i>sdWDI</i></td><td>x</td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>3</td><td>6</td><td>6</td><td>-</td><td>85</td><td>0.31</td></tr><tr><td></td><td><i>TCSA</i></td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>-</td><td>51</td><td>15</td><td>-</td><td>-</td><td>34</td><td>0.76</td></tr><tr><td></td><td><i>NbFr</i></td><td>x</td><td>-</td><td>x</td><td>x</td><td>-</td><td>-</td><td>x</td><td>25</td><td>-</td><td>-</td><td>37</td><td>37</td><td>0.52</td></tr><tr><td></td><td><i>BmFr</i></td><td>x</td><td>-</td><td>x</td><td>x</td><td>x</td><td>-</td><td>x</td><td>12</td><td>8</td><td>-</td><td>32</td><td>49</td><td>0.31</td></tr><tr><td>B</td><td></td><td colspan="3">Fixed effect</td><td colspan="4">Random effect</td><td colspan="6">% variances`</td></tr><tr><td></td><td></td><td>M</td><td>D</td><td>Y</td><td>G</td><td>G×M</td><td>G×D</td><td>G×Y</td><td>G</td><td>G×M</td><td>G×D</td><td>G×Y</td><td>Res</td><td><i>h</i><sup><i>2</i></sup><i><sub>b</sub></i></td></tr><tr><td></td><td><i>NDVI_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>-</td><td>-</td><td>44</td><td>-</td><td>-</td><td>-</td><td>56</td><td>0.61</td></tr><tr><td></td><td><i>sdNDVI_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>-</td><td>-</td><td>19</td><td>-</td><td>-</td><td>-</td><td>81</td><td>0.32</td></tr><tr><td></td><td><i>VARI_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>-</td><td>-</td><td>19</td><td>-</td><td>-</td><td>-</td><td>81</td><td>0.33</td></tr><tr><td></td><td><i>sdVARI_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>13</td><td>-</td><td>8</td><td>-</td><td>79</td><td>0.62</td></tr><tr><td></td><td><i>SRPI_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>-</td><td>-</td><td>35</td><td>-</td><td>-</td><td>-</td><td>65</td><td>0.52</td></tr><tr><td></td><td><i>sdSRPI_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>17</td><td>-</td><td>7</td><td>-</td><td>75</td><td>0.70</td></tr><tr><td></td><td><i>TsTa_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>-</td><td>-</td><td>34</td><td>-</td><td>-</td><td>-</td><td>66</td><td>0.50</td></tr><tr><td></td><td><i>sdTsTa_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>19</td><td>-</td><td>14</td><td>-</td><td>67</td><td>0.70</td></tr><tr><td></td><td><i>WDI_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>-</td><td>-</td><td>17</td><td>-</td><td>-</td><td>-</td><td>83</td><td>0.29</td></tr><tr><td></td><td><i>sdWDI_DI</i></td><td>-</td><td>x</td><td>-</td><td>x</td><td>-</td><td>-</td><td>-</td><td>9</td><td>-</td><td>-</td><td>-</td><td>91</td><td>0.17</td></tr><tr><td></td><td><i>TCSA_DI</i></td><td>-</td><td>-</td><td>x</td><td>x</td><td>-</td><td>-</td><td>-</td><td>35</td><td>-</td><td>-</td><td>-</td><td>65</td><td>0.52</td></tr><tr><td></td><td><i>NbFr_DI</i></td><td>-</td><td>-</td><td>x</td><td>x</td><td>-</td><td>-</td><td>x</td><td>13</td><td>-</td><td>-</td><td>1</td><td>86</td><td>0.38</td></tr><tr><td></td><td><i>BmFr_DI</i></td><td>-</td><td>-</td><td>x</td><td>x</td><td>-</td><td>-</td><td>-</td><td>17</td><td>-</td><td>-</td><td>-</td><td>83</td><td>0.29</td></tr></table> |
7ff3652048ef9055ca81a456fceeedc7ae2c724a0a6216142ea6a9b651ea7119.png | complex | <table><tr><td> </td><td colspan="5">Veterinary rating of pet owner compliance in endemic regions</td><td> </td></tr><tr><td> </td><td colspan="5">Number clinics responding (% responding)</td><td> </td></tr><tr><td> </td><td>Excellent</td><td>Good</td><td>Reasonable</td><td>Poor</td><td>Non-compliant</td><td>Responders</td></tr><tr><td>France</td><td>10 (21)</td><td>7 (15)</td><td>19 (40)</td><td>4 (9)</td><td>7 (15)</td><td>47</td></tr><tr><td>Spain</td><td>0 (0)</td><td>21 (51)</td><td>17 (41)</td><td>3 (7)</td><td>0 (0)</td><td>41</td></tr><tr><td>Italy</td><td>26 (24)</td><td>76 (71)</td><td>2 (2)</td><td>3 (3)</td><td>0 (0)</td><td>107</td></tr><tr><td>Total</td><td>36 (18)</td><td>104 (53)</td><td>38 (19)</td><td>10 (5)</td><td>7 (4)</td><td>195</td></tr></table> |
6f51ff10766ec91abade48701d057e19bd4d81c9ac678b439f2d3e7c960904e8.png | simple | <table><tr><td></td><td>Gene features</td><td>Clinical covariates</td><td>Samples</td></tr><tr><td>UPP</td><td>44,928</td><td>21</td><td>251</td></tr><tr><td>MAINZ</td><td>22,283</td><td>21</td><td>200</td></tr><tr><td>TransBig</td><td>22,283</td><td>21</td><td>198</td></tr><tr><td>VDX</td><td>22,283</td><td>21</td><td>344</td></tr><tr><td>TCGA</td><td>19,420</td><td>5</td><td>3096</td></tr></table> |
cd01c435b7aa02efbc65a1cbdf91beb9d111d0fb91c5258874121ac4ea6ac1fd.png | simple | <table><tr><td>Valuables (<i>n</i>)</td><td>AR positive (<i>n</i>, %)</td><td>B</td><td>SE</td><td><i>p</i>-value</td><td>OR (95% CI)</td></tr><tr><td><i>Gender</i></td><td></td><td>−1.627</td><td>0.680</td><td>0.017*</td><td>0.197(0.052–0.745)</td></tr><tr><td> Male (70)</td><td>42 (60)</td><td></td><td></td><td></td><td></td></tr><tr><td> Female (19)</td><td>7 (36.8)</td><td></td><td></td><td></td><td></td></tr><tr><td><i>Fuhrman Grade</i><sup>a</sup></td><td></td><td></td><td></td><td>0.003*</td><td></td></tr><tr><td> 1 (17)</td><td>14 (82.4)</td><td></td><td></td><td></td><td></td></tr><tr><td> 2 (42)</td><td>26 (61.9)</td><td>−1.789</td><td>0.884</td><td>0.043</td><td>0.167 (0.030–0.945)</td></tr><tr><td> 3 (23)</td><td>7 (30.4)</td><td>−3.615</td><td>1.080</td><td>0.001</td><td>0.027 (0.003–0.224)</td></tr><tr><td> 4 (7)</td><td>2 (28.8)</td><td>−4.559</td><td>1.428</td><td>0.001</td><td>0.010 (0.001–0.172)</td></tr><tr><td><i>pT stage</i><sup><i>b</i></sup></td><td></td><td></td><td></td><td>0.123</td><td></td></tr><tr><td> T1 (54)</td><td>31 (57.4)</td><td></td><td></td><td></td><td></td></tr><tr><td> T2 (9)</td><td>4 (44.4)</td><td>−1.350</td><td>0.878</td><td>0.124</td><td>0.259 (0.046–1.449)</td></tr><tr><td> T3 (23)</td><td>12 (52.2)</td><td>1.296</td><td>0.745</td><td>0.082</td><td>3.655 (0.848–15.754)</td></tr><tr><td> T4 (3)</td><td>2 (62.7)</td><td>22.420</td><td>15921.320</td><td>0.999</td><td>5.459E9 (0.000)</td></tr><tr><td><i>Pulmonary metastasis</i></td><td></td><td>1.904</td><td>0.842</td><td>0.024*</td><td>6.711 (1.289–34.929)</td></tr><tr><td> No (76)</td><td>39 (51.3)</td><td></td><td></td><td></td><td></td></tr><tr><td> Yes (13)</td><td>10 (76.9)</td><td></td><td></td><td></td><td></td></tr><tr><td><i>Lymphatic metastasis</i></td><td></td><td>−21.410</td><td>15921.320</td><td>0.999</td><td>0.000 (0.000)</td></tr><tr><td> No (80)</td><td>47 (58.8)</td><td></td><td></td><td></td><td></td></tr><tr><td> Yes (9)</td><td>2 (22.2)</td><td></td><td></td><td></td><td></td></tr><tr><td><i>Constant</i></td><td></td><td>7.174</td><td>3980.330</td><td>0.999</td><td>1304.430</td></tr></table> |
6536bed2c8d39d0b90086285f481e0722965332ec23dfc481ad857b891a2541d.png | simple | <table><tr><td>PDB ID</td><td>Ligand</td><td>Proc. Snap. (%)</td><td>TOP10 (%)</td><td>TOP20 (%)</td><td>TOP30 (%)</td><td>TOP100 (%)</td><td>TOP200 (%)</td></tr><tr><td>1P44</td><td>GEQ</td><td>48.92</td><td>100.00</td><td>95.00</td><td>93.00</td><td>86.00</td><td>86.00</td></tr><tr><td>2B35</td><td>TCL</td><td>50.67</td><td>80.00</td><td>55.00</td><td>60.00</td><td>75.00</td><td>80.00</td></tr><tr><td>2B36</td><td>5PP</td><td>50.97</td><td>60.00</td><td>70.00</td><td>66.00</td><td>67.00</td><td>73.00</td></tr><tr><td>2B37</td><td>8PS</td><td>49.72</td><td>60.00</td><td>60.00</td><td>60.00</td><td>78.00</td><td>79.50</td></tr><tr><td>2H7I</td><td>566</td><td>52.33</td><td>80.00</td><td>90.00</td><td>83.00</td><td>79.00</td><td>78.00</td></tr><tr><td>2H7L</td><td>665</td><td>50.62</td><td>100.00</td><td>100.00</td><td>100.00</td><td>98.00</td><td>98.00</td></tr><tr><td>2H7M</td><td>641</td><td>47.75</td><td>100.00</td><td>100.00</td><td>100.00</td><td>100.00</td><td>100.00</td></tr><tr><td>2H7N</td><td>744</td><td>50.65</td><td>100.00</td><td>100.00</td><td>100.00</td><td>97.00</td><td>97.00</td></tr><tr><td>2H7P</td><td>468</td><td>49.84</td><td>90.00</td><td>95.00</td><td>83.00</td><td>82.00</td><td>82.00</td></tr><tr><td>3FNE</td><td>8PC</td><td>52.46</td><td>90.00</td><td>90.00</td><td>93.00</td><td>90.00</td><td>88.00</td></tr><tr><td>3FNH</td><td>JPJ</td><td>47.89</td><td>100.00</td><td>100.00</td><td>100.00</td><td>96.00</td><td>93.00</td></tr><tr><td>2NSD</td><td>4PI</td><td>53.61</td><td>100.00</td><td>95.00</td><td>96.00</td><td>97.00</td><td>96.00</td></tr><tr><td>Average</td><td>-</td><td>50.45</td><td>88.83</td><td>87.50</td><td>86.17</td><td>87.08</td><td>87.54</td></tr></table> |
2b55a7b6ba0f409ec91e73268d9c8189d599d968d110443686e87ac18d3522b7.png | simple | <table><tr><td> </td><td>Patients with NTG (n = 24)</td><td>Controls (n = 24)</td></tr><tr><td>Age (years)</td><td>66.7 ± 10.2</td><td>67.2 ± 11.6</td></tr><tr><td>Male</td><td>9 (37.5%)</td><td>9 (37.5%)</td></tr><tr><td>Female</td><td>15 (62.5%)</td><td>15 (62.5%)</td></tr><tr><td>Smoking</td><td>13 (54.2%)</td><td>11 (45.8%)</td></tr><tr><td>Body-mass index (kg/m<sup>2</sup>)</td><td>26.8 ± 2.3</td><td>25.9 ± 2.4</td></tr><tr><td>Neck circumference (cm)</td><td>34.61 ± 2.43</td><td>33.26 ± 3.78</td></tr></table> |
5baba8f8acbfc512bf7ccdd6f6252e8de7f26149415d1bbf82cfa1b9336a8205.png | complex | <table><tr><td></td><td colspan="3">Carriers of the class S allele</td><td colspan="3">Non-carriers of the class S allele</td></tr><tr><td>Arsenic exposure, μg/L</td><td>Controls n (%)</td><td>Patients n (%)</td><td>Multivariate-adjusted OR (95% CI)</td><td>Controls n (%)</td><td>Patients n (%)</td><td>Multivariate-adjusted OR (95% CI)</td></tr><tr><td><i>Lanyang cohort</i><sup><i>a</i></sup></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> ≤ 10</td><td>13 (6.8)</td><td>7 (3.9)</td><td>1.0 (referent)</td><td>5 (7.7)</td><td>2 (2.8)</td><td>1.0 (referent)</td></tr><tr><td> 10.1-50</td><td>7 (3.7)</td><td>5 (2.8)</td><td>1.57 (0.33-7.38)</td><td>3 (4.6)</td><td>4 (5.6)</td><td>8.64 (0.70-106.82)</td></tr><tr><td> 50.1-100</td><td>66 (34.6)</td><td>64 (36.0)</td><td>2.90 (1.02-8.27)*</td><td>21 (32.3)</td><td>24 (33.3)</td><td>4.04 (0.64-25.76)</td></tr><tr><td> 100.1-300</td><td>60 (31.4)</td><td>61 (34.3)</td><td>2.90 (1.00-8.35)*</td><td>19 (29.2)</td><td>20 (27.8)</td><td>4.47 (0.69-29.19)</td></tr><tr><td> > 300</td><td>45 (23.6)</td><td>41 (23.0)</td><td>2.39 (0.81-7.05)</td><td>17 (26.2)</td><td>22 (30.6)</td><td>3.97 (0.62-25.57)</td></tr><tr><td> Trend test</td><td></td><td></td><td>1.12 (0.91-1.38)</td><td></td><td></td><td>1.13 (0.81-1.57)</td></tr><tr><td><i>LMN cohort</i><sup><i>b</i></sup></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> ≤ 300</td><td>39 (32.8)</td><td>10 (12.4)</td><td>1.0 (referent)</td><td>13 (28.9)</td><td>2 (5.6)</td><td>1.0 (referent)</td></tr><tr><td> 300-750</td><td>43 (36.1)</td><td>36 (44.4)</td><td>2.04 (0.75-5.57)</td><td>22 (48.9)</td><td>20 (55.6)</td><td>1.13 (0.16-7.95)</td></tr><tr><td> > 750</td><td>37 (31.1)</td><td>35 (43.2)</td><td>2.20 (0.79-6.10)</td><td>10 (22.2)</td><td>14 (38.9)</td><td>4.65 (0.66-32.94)</td></tr><tr><td> Trend test</td><td></td><td></td><td>1.39 (0.86-2.25)</td><td></td><td></td><td>2.65 (1.03-6.82)*</td></tr></table> |
7371ac34cca13ffbfa368cdd59199ce712b1b3c963704f984685b035a5dfd3ae.png | complex | <table><tr><td>Outcome</td><td>Model A</td><td>Model B</td><td>Model C</td></tr><tr><td>BMI z-score increment</td></tr><tr><td>LMW metabolites</td><td>0.07 (0.02, 0.13)*</td><td>0.03 (–0.03, 0.09)</td><td>0.03 (–0.03, 0.09)</td></tr><tr><td>HMW metabolites</td><td>–0.003 (–0.05, 0.05)</td><td>–0.01 (–0.06, 0.04)</td><td>–0.01 (–0.06, 0.04)</td></tr><tr><td>DEHP metabolites</td><td>–0.01 (–0.06, 0.04)</td><td>–0.02 (–0.07, 0.03)</td><td>–0.01 (–0.06, 0.03)</td></tr><tr><td>Overweight OR</td></tr><tr><td>LMW metabolites</td><td>1.08 (0.97, 1.19)</td><td>1.01 (0.90, 1.14)</td><td>1.01 (0.90, 1.13)</td></tr><tr><td>HMW metabolites</td><td>0.97 (0.86, 1.10)</td><td>0.96 (0.85, 1.08)</td><td>0.96 (0.86, 1.09)</td></tr><tr><td>DEHP metabolites</td><td>0.95 (0.84, 1.08)</td><td>0.95 (0.84, 1.06)</td><td>0.95 (0.85, 1.07)</td></tr><tr><td>Obesity OR</td></tr><tr><td>LMW metabolites</td><td>1.12 (0.99, 1.25)</td><td>1.02 (0.89, 1.16)</td><td>1.02 (0.90, 1.17)</td></tr><tr><td>HMW metabolites</td><td>1.02 (0.89, 1.17)</td><td>1.03 (0.88, 1.20)</td><td>1.04 (0.89, 1.22)</td></tr><tr><td>DEHP metabolites</td><td>1.01 (0.88, 1.16)</td><td>1.02 (0.88, 1.19)</td><td>1.04 (0.89, 1.20)</td></tr><tr><td colspan="4">Model A adjusts only for urinary creatinine; model B alsoincludes sex, poverty–income ratio, parental education, serum cotinine,age, and race/ethnicity category; model C includes model B covariatesplus caloric intake and television watching. All associations are withthe natural log of the phthalate metabolite concentration. Resultsrepresent increase in odds of BMI z-score per unit log increase inphthalate metabolite. *p < 0.05.</td></tr></table> |
a5dd66ed1d38380971fd3d316310ec8cacc763176f7f5cdc2d4f288ec2f89542.png | simple | <table><tr><td></td><td>RT-PCR negative</td><td>RT-PCR positive</td><td><i>p</i>-value<sup>a</sup></td><td>Single ARI</td><td>Multiple ARI</td><td><i>p</i>-value</td></tr><tr><td>DSS, mean</td><td>8.83</td><td>13.83</td><td>0.000</td><td>13.57</td><td>14.51</td><td>0.243</td></tr><tr><td>Fever n/total (%)</td><td>37/103 (35.9)</td><td>243/457 (53.2)</td><td>0.002</td><td>173/331 (52.3)</td><td>70/126 (55.6)</td><td>0.529</td></tr><tr><td>Admission n/total, (%)</td><td>74/103 (71.8)</td><td>342/457 (74.8)</td><td>0.530</td><td>252/331 (76.1)</td><td>90/126 (71.4)</td><td>0.300</td></tr><tr><td>LOS (days)</td><td>2.99</td><td>3.95</td><td>0.003</td><td>4.02</td><td>3.76</td><td>0.432</td></tr><tr><td>Oxygen supply (days)</td><td>0.85</td><td>1.98</td><td>0.000</td><td>1.99</td><td>1.96</td><td>0.912</td></tr><tr><td>Nebulizer therapy (days)</td><td>1.03</td><td>1.19</td><td>0.227</td><td>1.10</td><td>1.46</td><td>0.140</td></tr><tr><td>Antibiotics (days)</td><td>1.56</td><td>2.32</td><td>0.041</td><td>2.19</td><td>2.67</td><td>0.190</td></tr></table> |
3cfc566b83fbc72454744429cc0de6f20405c5ebe6158d4d34fea53713a3206a.png | complex | <table><tr><td>Gene</td><td colspan="3">Exon</td><td colspan="3">Tag-seq</td></tr><tr><td> </td><td>Log2 FC</td><td>Adj. P-val.</td><td>MDL</td><td>Log2 FC</td><td>Adj. P-val.</td><td>MDL</td></tr><tr><td>TCL1A</td><td>6.976</td><td><0.001</td><td>4.5%</td><td>10.069</td><td><0.001</td><td>1.9%</td></tr><tr><td>HLA-DRA</td><td>6.135</td><td><0.001</td><td>12.6%</td><td>9.541</td><td><0.001</td><td>4.0%</td></tr><tr><td>CD74</td><td>5.891</td><td>0.001</td><td>5.0%</td><td>10.077</td><td><0.001</td><td>2.0%</td></tr><tr><td>C13orf18</td><td>6.801</td><td><0.001</td><td>6.1%</td><td>7.401</td><td>0.008</td><td>7.9%</td></tr><tr><td>ARHGDIB</td><td>6.188</td><td><0.001</td><td>9.7%</td><td>7.349</td><td>0.008</td><td>15.4%</td></tr><tr><td>CKB</td><td>−5.573</td><td>0.002</td><td>NA</td><td>−9.526</td><td><0.001</td><td>NA</td></tr><tr><td>LCP1</td><td>7.108</td><td><0.001</td><td>7.4%</td><td>6.087</td><td>0.029</td><td>27.4%</td></tr><tr><td>CD52</td><td>5.63</td><td>0.002</td><td>9.1%</td><td>7.209</td><td>0.010</td><td>16.9%</td></tr><tr><td>FHL1</td><td>−5.736</td><td>0.001</td><td>NA</td><td>−6.229</td><td>0.028</td><td>NA</td></tr><tr><td>UCHL1</td><td>−5.212</td><td>0.006</td><td>NA</td><td>−7.714</td><td>0.005</td><td>NA</td></tr><tr><td>APBB1IP</td><td>5.408</td><td>0.003</td><td>18.4%</td><td>6.267</td><td>0.028</td><td>25.5%</td></tr><tr><td>GLUL</td><td>−5.323</td><td>0.004</td><td>NA</td><td>−6.592</td><td>0.012</td><td>NA</td></tr><tr><td>CD79A</td><td>6.132</td><td><0.001</td><td>4.8%</td><td>5.858</td><td>0.033</td><td>33.1%</td></tr><tr><td>GCET2</td><td>5.347</td><td>0.004</td><td>14.8%</td><td>6.129</td><td>0.029</td><td>45.2%</td></tr><tr><td>CD79B</td><td>4.682</td><td>0.020</td><td>7.3%</td><td>8.077</td><td>0.003</td><td>7.7%</td></tr><tr><td>ELF1</td><td>5.07</td><td>0.008</td><td>6.9%</td><td>6.977</td><td>0.012</td><td>12.7%</td></tr><tr><td>CPNE3</td><td>−5.036</td><td>0.009</td><td>NA</td><td>−6.304</td><td>0.028</td><td>NA</td></tr><tr><td>CD53</td><td>6.122</td><td><0.001</td><td>9.0%</td><td>5.392</td><td>0.049</td><td>47.4%</td></tr><tr><td>AMOT</td><td>−5.189</td><td>0.006</td><td>NA</td><td>−6.044</td><td>0.029</td><td>NA</td></tr><tr><td>ST6GAL1</td><td>5.254</td><td>0.005</td><td>5.8%</td><td>5.858</td><td>0.028</td><td>18.8%</td></tr><tr><td>ETS1</td><td>5.299</td><td>0.005</td><td>18.8%</td><td>5.781</td><td>0.036</td><td>26.6%</td></tr><tr><td>CNN3</td><td>−4.618</td><td>0.023</td><td>NA</td><td>−6.066</td><td>0.029</td><td>NA</td></tr><tr><td>MS4A1</td><td>4.435</td><td>0.037</td><td>13.9%</td><td>5.977</td><td>0.029</td><td>37.9%</td></tr><tr><td>MYB</td><td>5.117</td><td>0.007</td><td>14.5%</td><td>5.392</td><td>0.049</td><td>31.8%</td></tr><tr><td>APP</td><td>−4.419</td><td>0.039</td><td>NA</td><td>−5.858</td><td>0.033</td><td>NA</td></tr><tr><td>PTPRC</td><td>4.799</td><td>0.015</td><td>66.4%</td><td>5.392</td><td>0.049</td><td>67.7%</td></tr><tr><td>BANK1</td><td>4.677</td><td>0.020</td><td>35.5%</td><td>5.426</td><td>0.049</td><td>42.6%</td></tr><tr><td>ACSL5</td><td>4.685</td><td>0.020</td><td>29.3%</td><td>5.392</td><td>0.049</td><td>64.8%</td></tr><tr><td>BCL6</td><td>4.366</td><td>0.044</td><td>21.2%</td><td>5.524</td><td>0.046</td><td>50.2%</td></tr><tr><td>EBF1</td><td>4.34</td><td>0.046</td><td>15.1%</td><td>5.392</td><td>0.049</td><td>77.7%</td></tr></table> |
e54fae407726b219882a59ce8f85e69869fc46c068ae9f0c1ad96e4da52f49de.png | simple | <table><tr><td>Features for Event Detection</td><td>Results</td><td>Ref</td></tr><tr><td>Spatio-temporal of Markov Random Field (MRF) for motion vectors and object tracking</td><td>Overall success rate is 94.6% for horizontal and vertical traffic</td><td>[110]</td></tr><tr><td>Discrete Cosine Transform (DCT) coefficient feature vector with traffic detections using Gaussian mixture HMM</td><td>HMM classifier correctly detected 91% to 94% under different illumination situations</td><td>[107]</td></tr><tr><td>Spatio-temporal motion trajectories using MRF</td><td>Able to detect accidents at a very high recall rate, which is more than 90%</td><td>[114]</td></tr><tr><td>Blob tracker using Kalman filter</td><td>Results reported that the percentage of falsely classified vehicle modes was about 3%</td><td>[100]</td></tr><tr><td>Extracted features: shape, position, motion and track object using Kalman filter</td><td>Correctly classify five types of vehicle behavior and pedestrians with 86% to 96% accuracy</td><td>[105]</td></tr><tr><td>Motion trajectories and hierarchical clustering</td><td>Half total error rate (HTER) = 11% and area under the curve (AUC) > 0.8</td><td>[109]</td></tr><tr><td>Motion trajectories; velocities of motion vector</td><td>The accuracy increases up to 95%, tested on two video clips (277 frame sequences)</td><td>[116]</td></tr><tr><td>Target trajectories with context free grammar (CFG) representations</td><td>Results reported using (1) stochastic CFG, TP = 86%, TN = 14%; (2) HMM, TP = 55%, TN = 45%</td><td>[117]</td></tr><tr><td>Optical flow and K-means clustering</td><td>Only visual sample results; no empirical analysis</td><td>[102]</td></tr><tr><td>Local motion patterns to initialize the Gaussian mixture model (GMM)</td><td>Accuracy of detection measured = 83.23%, and the error rate is 16.77%</td><td>[113]</td></tr><tr><td>Motion trajectories and C-means clustering</td><td>Results reported that the false rejection rate (FRR) = 6%, and the false acceptance rate (FAR) = 8.3%</td><td>[111]</td></tr><tr><td>Track target trajectories and learn rules using grammar representations</td><td>The accuracy increased from 73% to 98.6% when tested on five traffic sub-events with different parsing parameters, <i>θ</i> and <i>ω</i></td><td>[94]</td></tr><tr><td>Lane tracking using particle swarm optimization (PSO) particle filters (PF)</td><td>Results indicated that particle filter output is smoother than the PSO-PF algorithm</td><td>[103]</td></tr></table> |
d221940ba965867737951e6efb2e8f1cc6ee502a25a8c8c3d95f72584d9ae35b.png | simple | <table><tr><td>The pair of parameters</td><td>R Spearman</td><td>p</td></tr><tr><td>Number of metastases & WBC</td><td>0.795611</td><td>0.000000</td></tr><tr><td>Number of metastases & LYM</td><td>0.785315</td><td>0.000000</td></tr><tr><td>Number of metastases & MON</td><td>0.788080</td><td>0.000000</td></tr><tr><td>Number of metastases & GRA</td><td>0.755175</td><td>0.000001</td></tr><tr><td>Number of metastases & MCV</td><td>0.632756</td><td>0.000102</td></tr><tr><td>Number of metastases & MCH</td><td>0.515611</td><td>0.002525</td></tr></table> |
3908292a08ca62aae1ea57a97439723ac3a33eadeccb88c7734d6bad05259603.png | complex | <table><tr><td rowspan="2">Cell Category</td><td colspan="3">All Features (<i>k</i> = 5)</td><td colspan="3">P-Fuzzy (<i>k</i> = 4)</td><td colspan="3">Q-Fuzzy (<i>k</i> = 4)</td></tr><tr><td>Precision</td><td>Recall</td><td>F1 Score</td><td>Precision</td><td>Recall</td><td>F1 Score</td><td>Precision</td><td>Recall</td><td>F1 Score</td></tr><tr><td>Normal superficial</td><td>0.83</td><td>0.86</td><td>0.84</td><td>0.95</td><td>0.91</td><td>0.93</td><td>0.95</td><td>0.95</td><td>0.95</td></tr><tr><td>Normal intermediate</td><td>0.82</td><td>0.74</td><td>0.78</td><td>0.89</td><td>0.84</td><td>0.86</td><td>0.89</td><td>0.89</td><td>0.89</td></tr><tr><td>Normal columnar</td><td>0.63</td><td>0.67</td><td>0.65</td><td>0.65</td><td>0.72</td><td>0.68</td><td>0.61</td><td>0.74</td><td>0.67</td></tr><tr><td>Carcinoma in situ</td><td>0.74</td><td>0.83</td><td>0.78</td><td>0.81</td><td>0.87</td><td>0.84</td><td>0.84</td><td>0.90</td><td>0.87</td></tr><tr><td>Light dysplastic</td><td>0.83</td><td>0.78</td><td>0.81</td><td>0.88</td><td>0.94</td><td>0.91</td><td>0.89</td><td>0.97</td><td>0.93</td></tr><tr><td>Moderate dysplastic</td><td>0.69</td><td>0.85</td><td>0.76</td><td>0.83</td><td>0.96</td><td>0.89</td><td>0.89</td><td>0.96</td><td>0.93</td></tr><tr><td>Severe dysplastic</td><td>0.79</td><td>0.62</td><td>0.70</td><td>0.86</td><td>0.65</td><td>0.74</td><td>0.88</td><td>0.61</td><td>0.72</td></tr></table> |
0fd6529cbdaa97fec3f6ab5926934bfcb7f64b7bcb298eb97bf2940cac595891.png | complex | <table><tr><td>Branch</td><td colspan="2">Free-ratio</td><td colspan="3">2-ratio</td></tr><tr><td></td><td><i>d</i><sub><i>N</i></sub>/<i>d</i><sub><i>S</i></sub></td><td>Bootstrap</td><td><i>d</i><sub><i>N</i></sub>/<i>d</i><sub><i>S</i></sub></td><td>2Δ<i>L</i></td><td><i>P</i></td></tr><tr><td>A</td><td>0.024</td><td>91</td><td>0.021</td><td>3.167</td><td>0.0751</td></tr><tr><td>B</td><td>0.057</td><td>80</td><td>0.056</td><td>1.064</td><td>0.3024</td></tr><tr><td>C</td><td>0.080</td><td>96</td><td>0.049</td><td>1.550</td><td>0.2131</td></tr><tr><td>D</td><td>0.129</td><td>68</td><td>0.023</td><td>2.224</td><td>0.1359</td></tr><tr><td>E</td><td>0.365</td><td>61</td><td>0.002</td><td>1.746</td><td>0.1864</td></tr><tr><td>F</td><td>0.049</td><td>100</td><td>0.051</td><td>0.726</td><td>0.3942</td></tr><tr><td>G</td><td>0.013</td><td>100</td><td>< 0.001</td><td>7.951</td><td>0.0048<sup>#</sup></td></tr><tr><td>H</td><td>0.022</td><td>100</td><td>0.018</td><td>3.961</td><td>0.0466</td></tr><tr><td>I</td><td>0.085</td><td>73</td><td>0.019</td><td>0.342</td><td>0.5588</td></tr><tr><td>J</td><td>0.853</td><td>41</td><td>> 999</td><td>11.627</td><td>0.0006**<sup>,##</sup></td></tr><tr><td>K</td><td>0.094</td><td>100</td><td>0.116</td><td>0.087</td><td>0.7680</td></tr><tr><td>L</td><td>0.131</td><td>100</td><td>0.141</td><td>0.399</td><td>0.5278</td></tr><tr><td>M</td><td>0.112</td><td>100</td><td>0.172</td><td>0.412</td><td>0.5212</td></tr><tr><td>N</td><td>0.613</td><td>62</td><td>> 999</td><td>4.752</td><td>0.0293</td></tr><tr><td>O</td><td>> 999</td><td>97</td><td>> 999</td><td>6.263</td><td>0.0123</td></tr><tr><td>P</td><td>0.303</td><td>77</td><td>> 999</td><td>5.772</td><td>0.0163</td></tr><tr><td>Q</td><td>0.177</td><td>100</td><td>0.237</td><td>2.696</td><td>0.1006</td></tr><tr><td>R</td><td>0.017</td><td>99</td><td>0.027</td><td>1.360</td><td>0.2435</td></tr><tr><td>S</td><td>0.087</td><td>100</td><td>0.077</td><td>0.146</td><td>0.7022</td></tr><tr><td>T</td><td>0.173</td><td>97</td><td>0.180</td><td>0.280</td><td>0.5964</td></tr><tr><td>U</td><td>0.177</td><td>90</td><td>0.214</td><td>0.447</td><td>0.5039</td></tr><tr><td>V</td><td>0.029</td><td>100</td><td>0.029</td><td>3.183</td><td>0.0744</td></tr><tr><td>W</td><td>0.171</td><td>85</td><td>0.073</td><td>0.100</td><td>0.7524</td></tr><tr><td>X</td><td>3.860</td><td>59</td><td>> 999</td><td>3.589</td><td>0.0582</td></tr><tr><td>Y</td><td>0.740</td><td>58</td><td>> 999</td><td>8.385</td><td>0.0038<sup>#</sup></td></tr><tr><td>Z</td><td>2.148</td><td>47</td><td>17.722</td><td>1.898</td><td>0.1683</td></tr><tr><td>AA</td><td>0.016</td><td>93</td><td>0.027</td><td>0.665</td><td>0.4148</td></tr><tr><td>AB</td><td>0.451</td><td>54</td><td>8.852</td><td>1.815</td><td>0.1779</td></tr><tr><td>AC</td><td>0.072</td><td>98</td><td>0.137</td><td>0.050</td><td>0.8228</td></tr><tr><td>AD</td><td>0.074</td><td>100</td><td>0.056</td><td>0.836</td><td>0.3605</td></tr><tr><td>AE</td><td>0.027</td><td>100</td><td>0.025</td><td>2.859</td><td>0.0909</td></tr><tr><td>AF</td><td>0.091</td><td>95</td><td>0.102</td><td>0.000</td><td>0.9929</td></tr><tr><td>AG</td><td>0.073</td><td>100</td><td>0.106</td><td>0.005</td><td>0.9447</td></tr><tr><td>AH</td><td>0.046</td><td>100</td><td>0.055</td><td>1.221</td><td>0.2691</td></tr><tr><td>AI</td><td>0.039</td><td>100</td><td>0.024</td><td>2.779</td><td>0.0955</td></tr><tr><td>AJ</td><td>< 0.001</td><td>99</td><td>< 0.001</td><td>10.084</td><td>0.0015*<sup>,##</sup></td></tr><tr><td>AK</td><td>0.236</td><td>95</td><td>0.287</td><td>1.944</td><td>0.1632</td></tr><tr><td>AL</td><td>> 999</td><td>90</td><td>> 999</td><td>4.708</td><td>0.0300</td></tr><tr><td>AM</td><td>0.366</td><td>70</td><td>0.581</td><td>2.098</td><td>0.1475</td></tr><tr><td>AN</td><td>0.266</td><td>94</td><td>0.361</td><td>3.621</td><td>0.0570</td></tr><tr><td>AO</td><td>0.382</td><td>71</td><td>0.982</td><td>1.682</td><td>0.1947</td></tr><tr><td>AP</td><td>0.188</td><td>81</td><td>0.080</td><td>0.241</td><td>0.6235</td></tr><tr><td>AQ</td><td>0.713</td><td>53</td><td>> 999</td><td>3.275</td><td>0.0703</td></tr></table> |
544977720214825a47bc4f2ed3bd7640fe8c81045333c324bb0daa1cc2e73957.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>Private health facilities</td><td>Public health facilities</td><td rowspan="2">p value</td></tr><tr><td>Frequency (%)</td><td>Frequency (%)</td></tr><tr><td colspan="4">Location</td></tr><tr><td> Urban</td><td>194/241 (81)</td><td>25/52 (48)</td><td><0.01*</td></tr><tr><td> Rural</td><td>47/241 (19)</td><td>27/52 (52)</td><td>0.02*</td></tr><tr><td colspan="4">Level of facility</td></tr><tr><td> Health centre II</td><td></td><td>31/52 (59.6)</td><td></td></tr><tr><td> Health centre III</td><td>–</td><td>16/52 (30.8)</td><td>–</td></tr><tr><td> Health centre IV</td><td></td><td>3/52 (5.8)</td><td></td></tr><tr><td> Hospital</td><td></td><td>2/52 (3.8)</td><td></td></tr><tr><td>Type of facility</td><td></td><td>Ownership</td><td></td></tr><tr><td> Drug shop</td><td>170/241 (71)</td><td>Government 39/52 (75)</td><td></td></tr><tr><td> Private clinic</td><td>59/241 (24)</td><td>Private for profit 6/52 (12)</td><td>–</td></tr><tr><td> Pharmacy</td><td>12/241 (5)</td><td>Private not for profit 7/52 (13)</td><td></td></tr><tr><td>Drug shop/private clinic registered</td><td></td><td></td><td>–</td></tr><tr><td> Yes</td><td>191/241 (79)</td><td>–</td><td></td></tr><tr><td> No</td><td>50/241 (21)</td><td></td><td></td></tr><tr><td colspan="4">Days when facility is open</td></tr><tr><td> Monday to friday</td><td>241/241 (100)</td><td>53/53 (100)</td><td>–</td></tr><tr><td> Saturdays</td><td>232/241 (96)</td><td>49/53 (92.4)</td><td></td></tr><tr><td> Sundays</td><td>191/241 (79)</td><td>39/53 (74)</td><td></td></tr><tr><td>Number of Children with fever seen on atypical day</td><td>Median 4 (IQR 3)</td><td>Median 8 (IQR 6)</td><td></td></tr><tr><td>Children with cough seen on atypical day</td><td>Median 5 (IQR 7)</td><td>Median 10 (IQR 11)</td><td></td></tr><tr><td>Children with diarrhoea seen on atypical day</td><td>Median 2 (IQR 2)</td><td>Median 3 (IQR 3)</td><td></td></tr><tr><td colspan="4">Patients’ register present</td></tr><tr><td> Yes</td><td>93/241 (39)</td><td>53/53 (100)</td><td><0.01*</td></tr><tr><td> No</td><td>148/241 (61)</td><td>–</td><td></td></tr></table> |
bbadb260d035f6e47614e55b24c3819043e640ec540eb299e1a80add1a3ea74c.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">OS</td><td colspan="2">PFS</td><td colspan="2">LRRFS</td></tr><tr><td>Overall, mo (95% CI)</td><td>1-year, %</td><td>Overall, mo (95% CI)</td><td>1-year, %</td><td>Overall, mo (95% CI)</td><td>1-year, %</td></tr><tr><td>TRT</td><td>17.7 (14.1-18.8)</td><td>57.9</td><td>9.8 (8.4–11.3)</td><td>45.9</td><td>16.2 (13.5–24.9)</td><td>72.6</td></tr><tr><td>Non-TRT</td><td>11.3 (9.8–12.7)</td><td>27.3</td><td>6.3 (5.0–7.0)</td><td>9.3</td><td>6.3 (5.6–7.0)</td><td>10.2</td></tr><tr><td><i>P</i></td><td><0.001</td><td>–</td><td><0.001</td><td>–</td><td><0.001</td><td>–</td></tr><tr><td>ERT</td><td>16.4 (13.4–18.4)</td><td>66.2</td><td>8.0 (7.0–9.0)</td><td>34.2</td><td>25.3 (21.5–27.9)</td><td>69.8</td></tr><tr><td>LRT</td><td>14.5 (12.2–17.0)</td><td>60.5</td><td>11.7 (9.1–13.4)</td><td>44.1</td><td>19.2 (13.1–23.1)</td><td>63.8</td></tr><tr><td><i>P</i></td><td>0.272</td><td>–</td><td>0.226</td><td>–</td><td>0.498</td><td>–</td></tr></table> |
e5c083b2563d48687bb1350891119734435cc29ff3dd5ef4df4fc9391f7b586a.png | simple | <table><tr><td>Outcome</td><td>LMWH (D or E) vs. Control</td><td>SE</td><td>P-Value</td><td>Impact on Risk</td></tr><tr><td><underline>VTE Risk in Placebo Trials</underline></td><td><underline>Relative Risk</underline></td><td></td><td></td><td></td></tr><tr><td>Both drugs vs. placebo</td><td>0.50 (0.40 - 0.61)</td><td></td><td><0.001</td><td>↓by 50%</td></tr><tr><td>RR difference between drugs (E vs. D)</td><td>0.23 (i.e. 12%)</td><td>0.25</td><td>0.36</td><td>NS</td></tr><tr><td><underline>Region (vs. North American)</underline></td><td></td><td></td><td></td><td></td></tr><tr><td>European trial</td><td>0.33</td><td>0.49</td><td>0.50</td><td>NS</td></tr><tr><td>Global trial</td><td>0.20</td><td>0.58</td><td>0.73</td><td>NS</td></tr><tr><td>LMWH dosing<sup>1</sup></td><td>-0.09</td><td>0.53</td><td>0.87</td><td>NS</td></tr><tr><td>LMWH treatment duration<sup>2</sup></td><td>-0.21</td><td>0.31</td><td>0.51</td><td>NS</td></tr><tr><td>Year of publication</td><td>0.04</td><td>0.04</td><td>0.34</td><td>NS</td></tr><tr><td><underline>Risk of Major Bleeds</underline></td><td></td><td></td><td></td><td></td></tr><tr><td>Both drugs vs. placebo</td><td>1.19(0.39 - 3.55)</td><td></td><td>0.76</td><td>NS</td></tr><tr><td>Risk difference between Drugs (E vs. D)</td><td>-0.94</td><td>1.25</td><td>0.45</td><td>NS</td></tr><tr><td><underline>Risk of HIT</underline></td><td></td><td></td><td></td><td></td></tr><tr><td>Both drugs vs. placebo</td><td>1.13 (0.36 - 3.53)</td><td></td><td>0.83</td><td>NS</td></tr><tr><td>RR difference between Drugs (E vs. D)</td><td>-0.85</td><td>2.0</td><td>0.48</td><td>NS</td></tr><tr><td><underline>Risk of Death</underline></td><td></td><td></td><td></td><td></td></tr><tr><td>Both drugs vs. placebo</td><td>0.72 (0.22-2.34)</td><td></td><td>0.59</td><td>NS</td></tr><tr><td>RR difference between Drugs (E vs. D)</td><td>0.22</td><td>1.28</td><td>0.86</td><td>NS</td></tr><tr><td><underline>VTE Risk in UH Trials</underline></td><td></td><td></td><td></td><td></td></tr><tr><td>Both drugs vs. UH</td><td>0.83 (0.66-1.05)</td><td></td><td>0.12</td><td>NS</td></tr><tr><td>RR difference between drugs (E vs. D)</td><td>-0.24 (i.e. - 22%)</td><td>0.61</td><td>0.66</td><td>NS</td></tr><tr><td><underline>Risk of Major Bleeds</underline></td><td></td><td></td><td></td><td></td></tr><tr><td>Both drugs vs. UH</td><td>0.70 (0.35-1.38)</td><td></td><td>0.30</td><td>NS</td></tr><tr><td>RR difference between Drugs (E vs. D)</td><td>NA</td><td></td><td></td><td></td></tr><tr><td><underline>Risk of HIT</underline></td><td></td><td></td><td></td><td></td></tr><tr><td>Both drugs vs. UH</td><td>0.61 (0.21-1.77)</td><td></td><td>0.36</td><td>NS</td></tr><tr><td>RR difference between Drugs (E vs. D)</td><td>0.56</td><td>1.53</td><td>0.71</td><td>NS</td></tr><tr><td><underline>Risk of Death</underline></td><td></td><td></td><td></td><td></td></tr><tr><td>Both drugs vs. UH</td><td>0.59 (0.12-3.1)</td><td></td><td>0.53</td><td>NS</td></tr><tr><td>RR difference between Drugs (E vs. D)</td><td>NA</td><td></td><td></td><td></td></tr></table> |
1733de61795e350003d5167cc29f49ae3501cd4fb05329024fd9b3968a5b74da.png | simple | <table><tr><td>Quality indicators of colonoscopy</td><td>Patients included in primary analysis<sup>1</sup></td><td>Patients included in secondary analysis<sup>2</sup></td><td>Recommended</td><td>Provincial endoscopist performance, 2015</td></tr><tr><td>Cecal intubation rate, %</td><td>98</td><td>97</td><td>≥ 95</td><td>97 - 99</td></tr><tr><td>PR, screening, men %</td><td>36</td><td>45</td><td>-</td><td>34 - 50</td></tr><tr><td>PR, screening, women %</td><td>34</td><td>34</td><td>-</td><td>34 - 50</td></tr><tr><td>ADR, screening, men, %</td><td>25</td><td>40</td><td>≥ 25</td><td>-</td></tr><tr><td>ADR, screening, women, %</td><td>19</td><td>30</td><td>≥ 15</td><td>-</td></tr><tr><td>Inadequate bowel preparation, %</td><td>7</td><td>6</td><td>≤ 10</td><td>3 - 7</td></tr><tr><td>Withdrawal time<sup>3</sup> (SD)</td><td>6 (5)</td><td>6 (5)</td><td>6-7</td><td>-</td></tr><tr><td>Complications</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td> Bleeding rate, %</td><td>0.0</td><td>0.0</td><td>≤ 0.1</td><td>0.1 - 0.5</td></tr><tr><td> Bowel perforation rate, %</td><td>0.0</td><td>0.0</td><td>≤ 0.1</td><td>0.1 - 0.8</td></tr><tr><td> Other rate, %</td><td>0.0</td><td>0.0</td><td>-</td><td>-</td></tr></table> |
66e153af2f86d2a6ebe9db78da37b59eb6eca5ec02fbf3dcf522a3b3221db13c.png | simple | <table><tr><td>Risk Factor</td><td>Wald χ<sup>2</sup></td><td>P</td><td>OR</td><td>95% C.I</td></tr><tr><td>BMI</td><td>30.73</td><td><0.01</td><td>0.80</td><td>0.74-0.87</td></tr><tr><td>C602A</td><td>5.69</td><td><0.01</td><td>7.58</td><td>1.53-11.97</td></tr><tr><td>T1559C</td><td>6.12</td><td><0.05</td><td>6.77</td><td>1.07-1.83</td></tr><tr><td>Height</td><td>9.51</td><td><0.01</td><td>1.07</td><td>1.02-1.11</td></tr><tr><td>Weight</td><td>27.93</td><td><0.01</td><td>0.92</td><td>0.90-0.95</td></tr></table> |
0f495d9a1d3567677418fbd294c00434a2eac757cf8dcc850306b696338810aa.png | complex | <table><tr><td colspan="2">Respondent profile (%)</td><td colspan="2">Child profile (%)</td></tr><tr><td colspan="2">Relationship to child</td><td colspan="2">Sex</td></tr><tr><td>Mother</td><td>67.3</td><td>Male</td><td>53.8</td></tr><tr><td>Father</td><td>15.7</td><td>Female</td><td>46.2</td></tr><tr><td>Grandmother</td><td>15.7</td><td colspan="2">Age group (years)</td></tr><tr><td>Grandfather</td><td>1.2</td><td>1-2</td><td>32.7</td></tr><tr><td colspan="2">Occupation</td><td>3-5</td><td>32.9</td></tr><tr><td>PMEB</td><td>28.7</td><td>6-10</td><td>34.4</td></tr><tr><td>Other white collar</td><td>19.7</td><td colspan="2">Race</td></tr><tr><td>Blue collar</td><td>7.4</td><td>Chinese</td><td>64.4</td></tr><tr><td>Housewife</td><td>37.6</td><td>Malay</td><td>16.7</td></tr><tr><td>Unemployed</td><td>2.9</td><td>Indian/other</td><td>18.9</td></tr><tr><td>Other</td><td>3.7</td><td colspan="2"> </td></tr><tr><td colspan="2">Education</td><td> </td><td> </td></tr><tr><td>None</td><td>2.0</td><td> </td><td> </td></tr><tr><td>Primary</td><td>13.3</td><td> </td><td> </td></tr><tr><td>Secondary</td><td>37.3</td><td> </td><td> </td></tr><tr><td>Tertiary (polytechnic)</td><td>19.7</td><td> </td><td> </td></tr><tr><td>Tertiary (university)</td><td>27.8</td><td> </td><td> </td></tr></table> |
a4debd1cc38cd0392389185b78df13fdd65dae65d43b3e6da41695763a29d1b0.png | complex | <table><tr><td> </td><td colspan="2">ZOI (mm)<sup>a</sup></td><td colspan="2">MIC (μg/mL)</td><td colspan="2">MBC (μg/mL)</td></tr><tr><td>Microorganisms</td><td>Eugenol</td><td>Isoeugenol</td><td>Eugenol</td><td>Isoeugenol</td><td>Eugenol</td><td>Isoeugenol</td></tr><tr><td>Gram-positive</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>S. aureus</i></td><td>12.7 ± 0.6 cB</td><td>20.8 ± 0.6 bA</td><td>625.0</td><td>312.5</td><td>625.0</td><td>312.5</td></tr><tr><td><i>B. subtilis</i></td><td>15.3 ± 0.7 bcB</td><td>21.3 ± 2.1 bA</td><td>625.0</td><td>312.5</td><td>625.0</td><td>312.5</td></tr><tr><td><i>L. monocytogenes</i></td><td>22.3 ± 1.4 aB</td><td>26.0 ± 1.5 aA</td><td>625.0</td><td>312.5</td><td>625.0</td><td>312.5</td></tr><tr><td>Gram-negative</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><i>E. coli</i></td><td>17.1 ± 1.2 bA</td><td>18.0 ± 1.8 bA</td><td>312.5</td><td>312.5</td><td>312.5</td><td>312.5</td></tr><tr><td><i>S. typhimurium</i></td><td>20.1 ± 1.0 aA</td><td>21.2 ± 1.2 bA</td><td>625.0</td><td>312.5</td><td>625.0</td><td>312.5</td></tr><tr><td><i>S. dysenteriae</i></td><td>17.0 ± 1.0 bA</td><td>18.3 ± 1.2 bA</td><td>312.5</td><td>312.5</td><td>312.5</td><td>312.5</td></tr></table> |
f453419f79e82e86b7cc67d872ab84d04efc070e5c40fd42602f9cdac014e536.png | complex | <table><tr><td></td><td colspan="2">Item 1</td><td colspan="2">Item 2</td><td colspan="2">Item 3</td><td colspan="2">Proprioceptive drift</td></tr><tr><td></td><td>Block 1</td><td>Block 2</td><td>Block 1</td><td>Block 2</td><td>Block 1</td><td>Block 2</td><td>Block 1</td><td>Block 2</td></tr><tr><td>Periodic</td><td>1.68 (0.36)</td><td>1.59 (0.39)</td><td>1.86 (0.25)</td><td>2.05 (0.26)</td><td>1.86 (0.27)</td><td>1.81 (0.18)</td><td>1.81 (0.87)</td><td>3.02 (0.79)</td></tr><tr><td>Non-Periodic</td><td>1.59 (0.35)</td><td>0.95 (0.86)</td><td>2.14 (0.23)</td><td>1.64 (0.31)</td><td>1.95 (0.25)</td><td>1.55 (0.28)</td><td>1.73 (0.81)</td><td>3.41 (0.92)</td></tr><tr><td>Asynchronous</td><td>−0.77 (0.47)</td><td>−0.73 (0.49)</td><td>−0.82 (0.39)</td><td>−0.82 (0.39)</td><td>−0.55 (0.45)</td><td>−0.5 (0.31)</td><td>0.11 (0.88)</td><td>1.41 (0.51)</td></tr></table> |
791e290e685b8c7dee465e6b90c08a1d3d3baa2d411cf6e1cbc424bbfe6bd02e.png | complex | <table><tr><td>Promoter</td><td>Line name</td><td>Replica</td><td>Total plant #</td><td>Total GUS+</td><td>Total GUS−</td><td>%GUS+</td></tr><tr><td rowspan="3"><i>pLeExt1</i></td><td><underline>LIG29-2</underline></td><td>3</td><td>18</td><td>18</td><td>0</td><td>100</td></tr><tr><td>LIG31A-19</td><td>2</td><td>11</td><td>11</td><td>0</td><td>100</td></tr><tr><td>LIG26-7</td><td>2</td><td>11</td><td>9</td><td>2</td><td>81.82</td></tr><tr><td rowspan="3"><i>pAtCortex</i></td><td><underline>CoG11-6</underline></td><td>3</td><td>13</td><td>13</td><td>0</td><td>100</td></tr><tr><td>CoG29-1</td><td>2</td><td>10</td><td>10</td><td>0</td><td>100</td></tr><tr><td>CoG5b-23</td><td>2</td><td>10</td><td>0</td><td>10</td><td>0</td></tr><tr><td rowspan="2"><i>pAtE29</i></td><td><underline>29G4b-5</underline></td><td>3</td><td>15</td><td>15</td><td>0</td><td>100</td></tr><tr><td>29G7-32</td><td>2</td><td>15</td><td>15</td><td>0</td><td>100</td></tr><tr><td rowspan="2"><i>pAtS13</i></td><td><underline>13G26b-28</underline></td><td>3</td><td>14</td><td>14</td><td>0</td><td>100</td></tr><tr><td>13G3b-100</td><td>2</td><td>11</td><td>11</td><td>0</td><td>100</td></tr><tr><td rowspan="2"><i>pAtS18</i></td><td><underline>XG5A-5</underline></td><td>3</td><td>19</td><td>19</td><td>0</td><td>100</td></tr><tr><td>XG2C-7</td><td>2</td><td>10</td><td>0</td><td>10</td><td>0</td></tr><tr><td rowspan="2"><i>pCaMV35S</i></td><td><underline>SG15A-2</underline></td><td>2</td><td>11</td><td>11</td><td>0</td><td>100</td></tr><tr><td>SG19b-5</td><td>2</td><td>10</td><td>0</td><td>10</td><td>0</td></tr><tr><td>Control vector</td><td>NEG15B-5</td><td>3</td><td>18</td><td>0</td><td>18</td><td>0</td></tr></table> |
2af605f3961b3f65a30d4f0ed047c15c643ed300be4c5c8ec760feadae56df34.png | simple | <table><tr><td>Model</td><td>Odds ratio</td><td> </td><td>95% CI</td><td>p-value</td></tr><tr><td>1 Sex (male vs female)</td><td>1.9</td><td> </td><td>0.9 - 4.2</td><td>0.10</td></tr><tr><td> Age (yrs)</td><td>1.06</td><td> </td><td>1.01 - 1.12</td><td>0.03</td></tr><tr><td>2 Sex (male vs female)</td><td>1.8</td><td> </td><td>0.8 - 4.1</td><td>0.13</td></tr><tr><td> Age (yrs)</td><td>1.07</td><td> </td><td>1.01 - 1.14</td><td>0.02</td></tr><tr><td> Prophylaxis (yes/no)</td><td>0.5</td><td> </td><td>0.2 - 1.0</td><td>0.06</td></tr><tr><td>3 Sex (male vs female)</td><td>4.1</td><td> </td><td>1.2 - 14.4</td><td>0.03</td></tr><tr><td> Age (yrs)</td><td>1.03</td><td> </td><td>0.94 - 1.12</td><td>0.54</td></tr><tr><td> Prophylaxis (yes/no)</td><td>0.3</td><td> </td><td>0.1 - 1.1</td><td>0.07</td></tr><tr><td> LET</td><td>101</td><td> </td><td>18 - 583</td><td><0.0001</td></tr><tr><td>4 Sex (male vs female)</td><td>3.8</td><td> </td><td>1.07 - 13.4</td><td>0.04</td></tr><tr><td> Age (yrs)</td><td>1.03</td><td> </td><td>0.95 - 1.13</td><td>0.46</td></tr><tr><td> Prophylaxis (yes/no)</td><td>0.3</td><td> </td><td>0.1 - 1.1</td><td>0.07</td></tr><tr><td> LET</td><td>75</td><td> </td><td>11 - 495</td><td><0.0001</td></tr><tr><td> Dipslide</td><td>1.6</td><td> </td><td>0.5 - 5.4</td><td>0.46</td></tr></table> |
2a2d703c6fe636da2b48f7ac56324bee093da8c2db771e2608723d3bed8f7978.png | complex | <table><tr><td>Personal</td><td>Community–related</td><td>Service-related</td></tr><tr><td>• Age</td><td>• Presence of and links to NHCs</td><td>• Training</td></tr><tr><td>• Gender</td><td>• Distance between CHW and TBA families</td><td>• Experience</td></tr><tr><td>• Education</td><td rowspan="6">• Distances among , CHW and rural health center</td><td>• Supervision and support by relevant community and health system structures</td></tr><tr><td>• Socio-economic status</td><td>• Payment or in-kind compensation</td></tr><tr><td>• Language</td><td>• Motivation</td></tr><tr><td>• Tribal affiliation</td><td>• Availability of means of transport (e.g. bicycle)</td></tr><tr><td>• Religion</td><td>• Possession of a cell phone</td></tr><tr><td> •Employment</td><td>• Availability of various supplies and drugs that the CHW and TBA might need to provide the defined services</td></tr><tr><td>• Membership in an association</td><td> </td><td> </td></tr></table> |
ed95c97c9972426c060b2419418321c7051c41432bd6355ab12ad115d8e0e954.png | complex | <table><tr><td></td><td colspan="5">Physiotherapist</td><td>Patient</td></tr><tr><td>Timing of data collection</td><td>Before training</td><td colspan="5">At follow-up</td></tr><tr><td>Measurements</td><td>Questionnaire</td><td>Questionnaire</td><td>Observation video/audio</td><td>Assessing patient files</td><td>Reflection report</td><td>Questionnaire</td></tr><tr><td colspan="7">1a. To what extent is the PSG performed as intended?</td></tr><tr><td> Performance and recording of the PSG steps</td><td></td><td></td><td>X</td><td>X</td><td></td><td></td></tr><tr><td> Patients’ involvement in the PSG</td><td></td><td></td><td></td><td></td><td></td><td>X</td></tr><tr><td colspan="7">1b. How satisfied are patients about the PSG?</td></tr><tr><td> Patients’ satisfaction with the PSG</td><td></td><td></td><td></td><td></td><td></td><td>X</td></tr><tr><td colspan="7">1c. What are physiotherapists’ experiences with the PSG?</td></tr><tr><td> Physiotherapists’ experiences with the PSG</td><td></td><td></td><td></td><td></td><td>X</td><td></td></tr><tr><td colspan="7">2. Did the physiotherapists’ intention to use the PSG, the actual use of the PSG, and their client-centred competences improve after training?</td></tr><tr><td> Intention to use the PSG</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td> Actual use of the PSG</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td></tr><tr><td> Client-centred competences</td><td>X</td><td>X</td><td></td><td></td><td></td><td></td></tr></table> |
163e5e3b8ccc4b70e7bbea526de98cf6f8bb6dcfdd710aaf23f76ea14e5feee3.png | simple | <table><tr><td>Food Group</td><td>Factors</td><td>B</td><td>β</td><td><i>P</i>-value</td></tr><tr><td>Grain</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Activity</td><td>0.334</td><td>0.235</td><td>0.018</td></tr><tr><td></td><td>Tobacco use</td><td>−0.866</td><td>−0.168</td><td>0.090</td></tr><tr><td>Vegetable</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Age</td><td>−0.038</td><td>−0.192</td><td>0.057</td></tr><tr><td></td><td>Diet related chronic disease</td><td>−0.353</td><td>0.164</td><td>0.033</td></tr><tr><td>Fruit</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Education level</td><td>0.164</td><td>0.177</td><td>0.079</td></tr><tr><td></td><td>Diet related chronic disease</td><td>−0.326</td><td>−0.173</td><td>0.085</td></tr><tr><td>Dairy</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Gender</td><td>0.410</td><td>0.262</td><td>0.006</td></tr><tr><td></td><td>Rural/urban</td><td>−0.257</td><td>−0.180</td><td>0.059</td></tr><tr><td>Meat/Beans</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>No statistically significant model</td><td></td><td></td><td></td></tr></table> |
cff551dd94ac0aa5930b023629be104a73f07ec9df218af55b6b5402b369938c.png | simple | <table><tr><td></td><td>amales</td><td>afemales</td><td>b</td><td>SD</td><td>r<sup>2</sup></td><td>p-value</td></tr><tr><td>LVEDV (ml)</td><td>77.5</td><td>67.8</td><td>1.380</td><td>0.0426</td><td>0.98</td><td><0.00005</td></tr><tr><td>LVESV (ml)</td><td>29.7</td><td>26.1</td><td>1.370</td><td>0.0647</td><td>0.95</td><td><0.005</td></tr><tr><td>LVSV (ml)</td><td>47.4</td><td>41.7</td><td>1.394</td><td>0.0500</td><td>0.97</td><td><0.0005</td></tr><tr><td>LVCO (ml/min)</td><td>3890</td><td>3622</td><td>1.062</td><td>0.0727</td><td>0.89</td><td>ns</td></tr><tr><td>LVM (g)</td><td>53</td><td>45.2</td><td>1.304</td><td>0.0475</td><td>0.97</td><td><0.00005</td></tr><tr><td>Papillary muscle (g)</td><td>1.9</td><td>1.6</td><td>1.451</td><td>0.0976</td><td>0.85</td><td><0.05</td></tr><tr><td>RVEDV (ml)</td><td>83.8</td><td>72.7</td><td>1.469</td><td>0.0499</td><td>0.97</td><td><0.0001</td></tr><tr><td>RVESV (ml)</td><td>35.3</td><td>30.2</td><td>1.559</td><td>0.0737</td><td>0.95</td><td><0.005</td></tr><tr><td>RVSV (ml)</td><td>48.2</td><td>42.1</td><td>1.407</td><td>0.0524</td><td>0.97</td><td><0.0005</td></tr><tr><td>RVCO (ml/min)</td><td>3947.3</td><td>3658.3</td><td>1.076</td><td>0.0783</td><td>0.88</td><td>ns</td></tr><tr><td>RVM (g)</td><td>16.7</td><td>14.9</td><td>1.331</td><td>0.0605</td><td>0.95</td><td><0.01</td></tr></table> |
59a8508d98f70da7b4f58c0421b131f091c4ae4e035d23e626ade433514cb629.png | complex | <table><tr><td></td><td></td><td colspan="2">95% Confidence Interval</td><td></td></tr><tr><td></td><td>Odds Ratio</td><td>Low</td><td>High</td><td>P value</td></tr><tr><td>Race/ethnicity</td><td></td><td></td><td></td><td></td></tr><tr><td> White</td><td>Reference</td><td></td><td></td><td></td></tr><tr><td> African American</td><td>1.34</td><td>0.88</td><td>2.05</td><td>.17</td></tr><tr><td> Hispanic</td><td>0.92</td><td>0.57</td><td>1.47</td><td>.73</td></tr><tr><td> Other</td><td>0.82</td><td>0.53</td><td>1.25</td><td>.35</td></tr><tr><td>Graduated college</td><td>1.09</td><td>0.92</td><td>1.31</td><td>.32</td></tr><tr><td>Employed</td><td>0.88</td><td>0.73</td><td>1.07</td><td>.21</td></tr><tr><td>Prescription coverage</td><td>1.49</td><td>1.22</td><td>1.82</td><td>< .001</td></tr><tr><td>Income ($25,000 unit)</td><td>1.08</td><td>1.01</td><td>1.15</td><td>.04</td></tr><tr><td>Out-of-pocket spending on prescriptions as a proportion of income</td><td>2.42</td><td>1.21</td><td>4.84</td><td>.01</td></tr><tr><td>Cost cutting actions</td><td>0.95</td><td>0.77</td><td>1.16</td><td>.60</td></tr><tr><td>Ask for generic</td><td>1.06</td><td>0.90</td><td>1.24</td><td>.48</td></tr><tr><td>Children in home</td><td>0.92</td><td>0.81</td><td>1.05</td><td>.21</td></tr><tr><td>Marital status</td><td></td><td></td><td></td><td></td></tr><tr><td> Married</td><td>reference</td><td>reference</td><td>reference</td><td></td></tr><tr><td> Single</td><td>1.49</td><td>1.02</td><td>2.20</td><td>.04</td></tr><tr><td> Divorced/separated</td><td>1.11</td><td>0.91</td><td>1.36</td><td>.31</td></tr><tr><td>Widowed</td><td>1.20</td><td>0.97</td><td>1.50</td><td>.10</td></tr></table> |
e1669bdc0b08bd024dfd2776566ba7091172476a4ca007084ffd41d22146b71a.png | simple | <table><tr><td>Treatment regimens</td><td>Main results</td><td>References no.</td></tr><tr><td>1. Heatstroke rats received intravenous or intracerebroventricular injection of HUCBCs</td><td>MSCs attenuate cerebral ischemic damage by reducing overproduction of TNF‐α, IL‐1β, and IL‐6, but stimulating production of IL‐10.</td><td>Chen et al. (2005) Chen et al. (2006) Liu et al. (2009)</td></tr><tr><td>2. Heatstroke rats received intravenous injection of HICBC‐derived CD34+ cells</td><td>MSCs reduce cerebral ischemic damage by reducing overproduction of both TNF‐α and ICAM‐1, but stimulating production of IL‐10.</td><td>Hwang et al. (2008) Chen et al. (2007) Tseng et al. (2014)</td></tr><tr><td>3. Heatstroke rats received subcutaneous injection of granulocyte‐colony stimulating factor</td><td>The factor attenuates cerebral ischemic damage by reducing overproduction of both TNF‐α and ICAM‐1, but stimulating production of IL‐10, EPSs, GDNF, and VEGF.</td><td>Yung et al. (2011)</td></tr><tr><td>4. Heatstroke mice received intravenous injection of human dental pulp‐derived stem cells or HUCBCs</td><td>MSCs attenuate cerebral ischemic damage by reducing overproduction of TNF‐α, intercellular adhesion molecule 1, and oxidative damage markers, but promoting both hypothalamo–pituitary–adrenocortical axis activity and IL‐10 production.</td><td>Tseng et al. (2014) Tseng et al. (2015)</td></tr></table> |
b60e58a4c646841fbbfa6fcb2ac5f80c461a70afaf0ddd1af239f3816540f4f8.png | simple | <table><tr><td>Polymer type</td><td>Applications</td><td>Reference</td></tr><tr><td>Bio-PE</td><td>Plastics bags, milk and water bottles, food packaging films, toys</td><td>Vona et al. 1965; Aamer et al. 2008</td></tr><tr><td>Bio-PE and blends</td><td>Agricultural mulch films</td><td>Kasirajan and Ngouajio 2012</td></tr></table> |
5c75ef5c1d096e0f8bd50680cf411f0d5724c957dba14616bc69173cd9e9e2a6.png | simple | <table><tr><td>EC name</td><td>definition</td><td>gene name</td><td>Microarray available</td><td>ORF</td></tr><tr><td>4.1.2.13</td><td>Fructose-bisphosphate aldolase</td><td>fbaI</td><td>x</td><td>Ot01g03020</td></tr><tr><td></td><td></td><td>fbaI</td><td>x</td><td>Ot03g00610</td></tr><tr><td></td><td></td><td>fbaII</td><td>x</td><td>Ot10g01490</td></tr><tr><td>3.1.3.11</td><td>Fructose-1,6-bisphosphatase</td><td></td><td>x</td><td>Ot03g00330</td></tr><tr><td></td><td></td><td></td><td>x</td><td>Ot14g01140</td></tr><tr><td>5.3.1.1</td><td>Triosephosphate isomerase</td><td></td><td>x</td><td>Ot09g00080</td></tr><tr><td>5.3.1.9</td><td>Glucose-6-phosphate isomerase</td><td></td><td>x</td><td>Ot11g02980</td></tr><tr><td>5.4.2.2</td><td>phosphoglucomutase</td><td></td><td>x</td><td>Ot15g02630</td></tr><tr><td>2.7.7.27</td><td>ADP-glucose pyrophosphorylase</td><td>AGPLU1</td><td></td><td>Ot07g03280</td></tr><tr><td></td><td></td><td>agpsu1</td><td>x</td><td>Ot07g02930</td></tr><tr><td></td><td></td><td>agplu2</td><td></td><td>Ot20g00490</td></tr><tr><td>2.4.1.21</td><td>Soluble Starch synthase</td><td>SSIII-C</td><td></td><td>Ot06g03410</td></tr><tr><td></td><td></td><td>SSIII-B</td><td>x</td><td>Ot13g01250</td></tr><tr><td></td><td></td><td>SSII</td><td>x</td><td>Ot16g02790</td></tr><tr><td></td><td></td><td>SSI</td><td>x</td><td>Ot13g01230</td></tr><tr><td></td><td></td><td>SSIII-A</td><td>x</td><td>Ot16g01560</td></tr><tr><td>2.4.1.242</td><td>Granul-bound starch synthase</td><td>gbssI</td><td>x</td><td>Ot06g03200</td></tr><tr><td>2.4.1.18</td><td>Starch branching enzyme</td><td>SBEII(?)</td><td>x</td><td>Ot03g00840</td></tr><tr><td></td><td></td><td>SBEI</td><td>x</td><td>Ot04g04110</td></tr><tr><td>2.4.1.1</td><td>starch phosphorylase</td><td></td><td></td><td>Ot11g00280</td></tr><tr><td></td><td></td><td></td><td>x</td><td>Ot04g02110</td></tr><tr><td></td><td></td><td>SPho1</td><td></td><td>Ot11g01020</td></tr><tr><td>2.4.1.25</td><td>disproportionating enzyme</td><td>DPE1</td><td>x</td><td>Ot02g05750</td></tr><tr><td></td><td></td><td></td><td></td><td>Ot11g02290</td></tr><tr><td></td><td></td><td></td><td></td><td>Ot11g02300</td></tr><tr><td>3.2.1.1</td><td>α-amylase</td><td>Aamy1</td><td>x</td><td>Ot16g00380</td></tr><tr><td></td><td></td><td></td><td>x</td><td>Ot02g05490</td></tr><tr><td></td><td></td><td>Aamy2</td><td>x</td><td>Ot10g00260</td></tr><tr><td></td><td></td><td>Aamy3</td><td>x</td><td>Ot07g02010</td></tr><tr><td>3.2.1.2</td><td>β-amylase</td><td></td><td>x</td><td>Ot02g06980</td></tr><tr><td></td><td></td><td>Bamy2</td><td>x</td><td>Ot03g03190</td></tr><tr><td></td><td></td><td>bamy1</td><td></td><td>Ot03g03170</td></tr><tr><td>3.2.1.68</td><td>Isoamylase (debranching enzyme)</td><td>dbe1 (Isa1)</td><td>x</td><td>Ot14g02550</td></tr><tr><td></td><td></td><td>Isa2</td><td></td><td>Ot02g07230</td></tr><tr><td></td><td></td><td>dbeII (Isa3)</td><td>x</td><td>Ot12g00310</td></tr><tr><td>3.2.1.142</td><td>Pullulanase</td><td>spu</td><td>x</td><td>Ot01g03030</td></tr><tr><td>2.7.9.4</td><td>α-glucan, water dikinase (GWD)</td><td>SR1-A</td><td>x</td><td>Ot13g01510</td></tr><tr><td></td><td></td><td>R1 C</td><td></td><td>Ot16g02370</td></tr><tr><td></td><td></td><td></td><td></td><td>Ot04g04170</td></tr><tr><td></td><td>Glucose transporter</td><td></td><td></td><td>Ot03g05590</td></tr><tr><td></td><td>Glucose transporter</td><td></td><td></td><td>Ot14g01870</td></tr><tr><td></td><td>Glucose transporter</td><td></td><td></td><td>Ot08g01260</td></tr><tr><td></td><td>Maltose transporter</td><td>MEX1</td><td>x</td><td>Ot09g03160</td></tr></table> |
c0aa36b3c8e601edf0ff58af2799883b22eed0e6c1e6f81cb09c990f1891ca7e.png | complex | <table><tr><td>Variable</td><td colspan="2">Males</td><td colspan="2">Females</td></tr><tr><td></td><td>F</td><td><i>p < 0.05</i></td><td>F</td><td><i>p < 0.05</i></td></tr><tr><td colspan="5"><i>Right hand</i></td></tr><tr><td>FRR1</td><td>0.349</td><td>0.706</td><td>0.658</td><td>0.519</td></tr><tr><td>FRR2</td><td>0.158</td><td>0.854</td><td>1.672</td><td>0.190</td></tr><tr><td>FRR3</td><td>1.928</td><td>0.148</td><td>1.413</td><td>0.245</td></tr><tr><td>FRR4</td><td>2.258</td><td>0.107</td><td>5.845</td><td>* 0.003</td></tr><tr><td>FRR5</td><td>5.926</td><td>* 0.003</td><td>5.103</td><td>* 0.007</td></tr><tr><td>a–b rc R</td><td>16.648</td><td>* 0.000</td><td>31.573</td><td>* 0.001</td></tr><tr><td>b–c rc R</td><td>1.032</td><td>0.358</td><td>2.327</td><td>0.096</td></tr><tr><td>c–d rc R</td><td>8.923</td><td>* 0.000</td><td>11.064</td><td>* 0.001</td></tr><tr><td>atd R</td><td>3.378</td><td>* 0.036</td><td>4.335</td><td>* 0.014</td></tr><tr><td colspan="5"><i>Left hand</i></td></tr><tr><td>FRL1</td><td>0.139</td><td>0.870</td><td>0.103</td><td>0.903</td></tr><tr><td>FRL2</td><td>1.336</td><td>0.265</td><td>0.143</td><td>0.867</td></tr><tr><td>FRL3</td><td>0.198</td><td>0.821</td><td>1.930</td><td>0.147</td></tr><tr><td>FRL4</td><td>2.547</td><td>0.080</td><td>3.522</td><td>* 0.031</td></tr><tr><td>FRL5</td><td>1.697</td><td>0.185</td><td>1.256</td><td>0.287</td></tr><tr><td>a–b rc L</td><td>21.277</td><td>* 0.000</td><td>26.045</td><td>* 0.001</td></tr><tr><td>b–c rc L</td><td>5.405</td><td>* 0.005</td><td>4.574</td><td>* 0.011</td></tr><tr><td>c–d rc L</td><td>7.666</td><td>* 0.001</td><td>7.460</td><td>* 0.001</td></tr><tr><td>atd L</td><td>7.914</td><td>* 0.000</td><td>8.487</td><td>* 0.001</td></tr></table> |
da4b127b02b0337547ffdd254def221c753e0673d34f1b058b06423cb7ae5974.png | complex | <table><tr><td> </td><td colspan="4">Perioperative morbidity (10 days)</td><td rowspan="3">Px2 test</td></tr><tr><td> </td><td colspan="2">No</td><td colspan="2">Yes</td></tr><tr><td> </td><td>N</td><td>%</td><td>N</td><td>%</td></tr><tr><td>Gender</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Male</td><td>36</td><td>59.0</td><td>25</td><td>41.0</td><td>0.752</td></tr><tr><td>Female</td><td>11</td><td>55.0</td><td>9</td><td>45.0</td><td> </td></tr><tr><td>Age (years) , mean (SD)</td><td colspan="2">79.3(4.0)</td><td colspan="2">78.9(3.2)</td><td>0.650**</td></tr><tr><td>Age (years)</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td><77</td><td>14</td><td>60.9</td><td>9</td><td>39.1</td><td>0.895</td></tr><tr><td>77-80</td><td>17</td><td>54.8</td><td>14</td><td>45.2</td><td> </td></tr><tr><td>>80</td><td>16</td><td>59.3</td><td>11</td><td>40.7</td><td> </td></tr><tr><td>BMI, mean (SD)</td><td colspan="2">25.6(2.9)</td><td colspan="2">25.5(3.7)</td><td>0.873**</td></tr><tr><td>Urinary diversion</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Ileal conduit</td><td>22</td><td>56.4</td><td>17</td><td>43.6</td><td>0.724*</td></tr><tr><td>S-pouch</td><td>4</td><td>80.0</td><td>1</td><td>20.0</td><td> </td></tr><tr><td>Cutaneous ureterostomy</td><td>21</td><td>56.8</td><td>16</td><td>43.2</td><td> </td></tr><tr><td>pT (TNM system)</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>pTis</td><td>3</td><td>25.0</td><td>9</td><td>75.0</td><td>0.070</td></tr><tr><td>pT1 to pT2b</td><td>17</td><td>60.7</td><td>11</td><td>39.3</td><td> </td></tr><tr><td>pT3a to pT3b</td><td>18</td><td>62.1</td><td>11</td><td>37.9</td><td> </td></tr><tr><td>pT4a to pT4b</td><td>9</td><td>75.0</td><td>3</td><td>25.0</td><td> </td></tr><tr><td>Nodes (TNM system)</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>0</td><td>34</td><td>56.7</td><td>26</td><td>43.3</td><td>0.675</td></tr><tr><td>1-2</td><td>13</td><td>61.9</td><td>8</td><td>38.1</td><td> </td></tr><tr><td>Hospital stay, mean (SD)</td><td colspan="2">13.7(8.4)</td><td colspan="2">12.1(5.4)</td><td>0.334**</td></tr><tr><td>Charlson score</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>≤6</td><td>39</td><td>56.5</td><td>30</td><td>43.5</td><td>0.511</td></tr><tr><td>>6</td><td>8</td><td>66.7</td><td>4</td><td>33.3</td><td> </td></tr></table> |
a8db3177732e8d4fb448b08330a852a1ba7ba349165cee7748e15e1a245e1b45.png | complex | <table><tr><td></td><td><i>n</i></td><td>%</td></tr><tr><td colspan="3">Disease stage</td></tr><tr><td> Indeterminate</td><td>32</td><td>64</td></tr><tr><td> Advanced (cardiomyopathy)</td><td>13</td><td>26</td></tr><tr><td> No data</td><td>5</td><td>10</td></tr><tr><td colspan="3">Treatment history*</td></tr><tr><td> Received etiological treatment</td><td>40</td><td>80</td></tr><tr><td>Benznidazole</td><td>19</td><td>47.5</td></tr><tr><td>Nifurtimox</td><td>17</td><td>42.5</td></tr><tr><td>Benznidazole and nifurtimox</td><td>4</td><td>10</td></tr><tr><td>Discontinued treatment (side effects)</td><td>6</td><td>15</td></tr><tr><td> Untreated</td><td>10</td><td>20</td></tr><tr><td>Due to advancement of the disease</td><td>5</td><td>50</td></tr><tr><td>Other (patient declined or unable)</td><td>5</td><td>50</td></tr></table> |
9db9bba453555777e1b3df0e08b1117ac0b2aff1008fd0fd63a6f741f7dd6c8b.png | complex | <table><tr><td></td><td></td><td colspan="4">Race/ethnicity comparisons</td></tr><tr><td>Treatment type</td><td>OverallN = 600% (SE)</td><td>WhiteN = 417% (SE)</td><td>BlackN = 135% (SE)</td><td>HispanicN = 108% (SE)</td><td>χ<sup>2 </sup>(p<sup>†</sup>)</td></tr><tr><td>Narcotics/cocaine/alcoholicsAnonymous or any 12 step meeting</td><td>62.64 (2.62)</td><td>60.86 (3.08)<sup>a</sup></td><td>79.67 (4.36)<sup>a</sup></td><td>54.19 (6.98)</td><td>11.34 (.005)</td></tr><tr><td>Private physician, psychiatrist, psychologist, social worker, or other professional</td><td>55.07 (2.45)</td><td>57.63 (2.95)<sup>a, b</sup></td><td>39.45 (4.93)<sup>a</sup></td><td>54.86 (6.19)<sup>b</sup></td><td>7.94 (.024)</td></tr><tr><td>Drug/alcohol rehabilitation program</td><td>51.45 (2.67)</td><td>49.93 (3.07)<sup>a</sup></td><td>65.85 (4.45)<sup>a</sup></td><td>44.59 (7.55)</td><td>8.45 (.019)</td></tr><tr><td>Drug/alcohol detoxification ward/clinic</td><td>39.18 (2.74)</td><td>38.33 (2.98)</td><td>48.03 (5.36)</td><td>34.37 (7.33)</td><td>3.56 (.177)</td></tr><tr><td>Outpatient clinic, including outreach and day/partial patient program</td><td>36.66 (2.47)</td><td>34.36 (2.87)<sup>a, b</sup></td><td>54.74 (5.36)<sup>a</sup></td><td>31.35 (5.36)<sup>b</sup></td><td>10.65 (.007)</td></tr><tr><td>Inpatient ward of psychiatric/general hospital or community mental health program</td><td>31.02 (2.10)</td><td>28.51 (2.41)</td><td>39.75 (5.16)</td><td>40.26 (7.27)</td><td>5.46 (.072)</td></tr><tr><td>Emergency room because of medicine/drug use</td><td>23.35 (1.86)</td><td>22.44 (2.14)</td><td>22.01 (4.41)</td><td>32.90 (8.26)</td><td>1.38 (.506)</td></tr><tr><td>Family services or other social service agency</td><td>21.69 (2.13)</td><td>20.29 (2.49)</td><td>27.07 (5.27)</td><td>26.20 (6.26)</td><td>2.03 (.368)</td></tr><tr><td>Clergyman, priest, or rabbi because of medicine/drug use</td><td>20.31 (1.89)</td><td>18.27 (2.25)</td><td>32.77 (4.80)</td><td>20.53 (5.54)</td><td>6.15 (.053)</td></tr><tr><td>Halfway house because of medicine/drug use</td><td>12.56 (1.71)</td><td>11.75 (1.92)</td><td>17.15 (4.60)</td><td>13.10 (4.05)</td><td>1.30 (.526)</td></tr><tr><td>Other agency or professional</td><td>11.75 (1.51)</td><td>10.06 (1.81)</td><td>20.03 (3.99)</td><td>14.68 (3.79)</td><td>5.16 (.084)</td></tr><tr><td>Employment assistance program (EAP)</td><td>9.49 (1.47)</td><td>9.45 (1.80)</td><td>13.95 (3.52)</td><td>3.73 (1.97)</td><td>6.14 (.053)</td></tr><tr><td>Crisis center because of medicine/drug use</td><td>6.37 (1.46)</td><td>5.82 (1.68)</td><td>11.07 (3.91)</td><td>4.54 (2.02)</td><td>2.05 (.364)</td></tr><tr><td>Methadone maintenance program</td><td>5.28 (1.10)</td><td>4.40 (1.20)</td><td>8.92 (2.65)</td><td>7.74 (3.46)</td><td>3.47 (.185)</td></tr></table> |
fe729a61abdd7084549c056deeca0461ba640b08d6878546afb6d35517ef8d17.png | simple | <table><tr><td>Variable</td><td>Men N = 52</td><td>Women N = 87</td></tr><tr><td> </td><td>Mean (SD)</td><td>Mean (SD)</td></tr><tr><td>Duration of arthritis<sup>*</sup> (years)</td><td>4.8 (2.9)</td><td>5.6 (2.8)</td></tr><tr><td> </td><td>Median (IQR)</td><td>Median (IQR)</td></tr><tr><td>Number of swollen joints</td><td>2.0 (1.0, 8.0)</td><td>5.0 (2.0, 11.0)</td></tr><tr><td>Number of tender joints</td><td>5.0 (2.0, 8.5)</td><td>6.0 (2.0, 15.0)</td></tr><tr><td>Number of both swollen and tender joints</td><td>1.0 (0.0, 3.5)</td><td>2.0 (0.0, 5.0)</td></tr><tr><td>Larsen score<sup>1</sup></td><td>27.5 (13.0,31.0)</td><td>11.0 (1.0, 21.0)</td></tr><tr><td>HAQ score (0–3)</td><td>0.5 (0.1, 1.1)</td><td>0.8 (0.4, 1.3)</td></tr><tr><td> </td><td>%</td><td>%</td></tr><tr><td>Rheumatoid factor + ve</td><td>39.1</td><td>33.8</td></tr><tr><td>Erosions<sup>1</sup></td><td>75.0</td><td>56.5</td></tr><tr><td>Satisfied ARA RA criteria (4/7 definition)</td><td>22.9</td><td>45.8</td></tr><tr><td>Satisfied ARA RA criteria (tree definition)</td><td>41.7</td><td>60.2</td></tr><tr><td>Steroid use for at least 3 months</td><td>5.8</td><td>17.2</td></tr></table> |
141cff1482d2e6d387c6c3d5a1058a327cd0d8c9266ca17f875b652c3ec8c9bd.png | complex | <table><tr><td></td><td>Small-voxel correct</td><td>Small-voxel not correct</td><td><i>p</i> value</td></tr><tr><td colspan="4">Malignant lymph nodes (<i>n</i> = 148)</td></tr><tr><td> Standard-voxel correct</td><td>112</td><td>1</td><td rowspan="2">< 0.001</td></tr><tr><td> Standard-voxel not correct</td><td>20</td><td>15</td></tr><tr><td colspan="4">Benign lymph nodes (<i>n</i> = 61)</td></tr><tr><td> Standard-voxel correct</td><td>42</td><td>12</td><td rowspan="2">0.04</td></tr><tr><td> Standard-voxel not correct</td><td>3</td><td>4</td></tr><tr><td colspan="4">All lymph nodes (<i>n</i> = 209)</td></tr><tr><td> Standard-voxel correct</td><td>154</td><td>13</td><td rowspan="2">0.13</td></tr><tr><td> Standard-voxel not correct</td><td>23</td><td>19</td></tr></table> |
6be34ad3b5e752750869b4c880c02955962c67b6f8ba5fc3e988897d866a4cb8.png | complex | <table><tr><td>Health Outcome</td><td>Total (<i>N</i> = 460)</td><td>Urban Parañaque (<i>N</i> = 250)</td><td>Rural Tagum (<i>N</i> = 210)</td><td><i>p</i>-value</td></tr><tr><td colspan="5">Ultrasound findings (%)</td></tr><tr><td> Normal scans</td><td>68.3</td><td>62.4</td><td>75.2</td><td>< 0.01</td></tr><tr><td> Abnormal scans</td><td>31.7</td><td>37.6</td><td>24.8</td><td></td></tr><tr><td colspan="5">Maternal deaths possibly averted<sup>a</sup> (%)</td></tr><tr><td> Normal</td><td>93.7</td><td>91.2</td><td>96.6</td><td>0.02</td></tr><tr><td colspan="5"> Abnormal placentation</td></tr><tr><td>Low lying</td><td>2.4</td><td>2.4</td><td>2.4</td><td></td></tr><tr><td>Placenta previa</td><td>1.3</td><td>2.0</td><td>0.5</td><td></td></tr><tr><td colspan="5"> Fetal malpresentation</td></tr><tr><td>Transverse</td><td>2.6</td><td>4.4</td><td>0.5</td><td></td></tr><tr><td colspan="5">Neonatal deaths possibly averted<sup>b</sup> (%)</td></tr><tr><td> Normal</td><td>74.6</td><td>71.2</td><td>78.6</td><td>0.02</td></tr><tr><td colspan="5"> Fetal malpresentation</td></tr><tr><td>Breech</td><td>24.1</td><td>26.8</td><td>20.9</td><td></td></tr><tr><td>Oligohydramnios</td><td>0.2</td><td>0.0</td><td>0.5</td><td></td></tr><tr><td>Polyhydramnios</td><td>0.4</td><td>0.8</td><td>0.0</td><td></td></tr><tr><td>Twins<sup>c</sup></td><td>1.3</td><td>2.4</td><td>0.0</td><td></td></tr></table> |
903f5e7228d4a0e9115e851d9ee8f909d1de41edd3e4cdace8190a6545469ee5.png | simple | <table><tr><td></td><td>ShamN = 8</td><td>MIN = 10</td><td>MI-VIN = 9</td><td>MI-VLN = 9</td></tr><tr><td>Heart rate (bpm)</td><td>346 ± 16</td><td>378 ± 7</td><td>350 ± 9</td><td>361 ± 12</td></tr><tr><td>LVESP (mmHg)</td><td>117 ± 4</td><td>109 ± 3</td><td>108 ± 3</td><td>109 ± 4</td></tr><tr><td>LVEDP (mmHg)</td><td>6.2 ± 0.8</td><td>9.6 ± 1.6*</td><td>9.8 ± 1.3*</td><td>7.4 ± 0.5</td></tr><tr><td>SBP (mmHg)</td><td>115 ± 3</td><td>111 ± 2</td><td>110 ± 3</td><td>113 ± 3</td></tr><tr><td>DBP (mmHg)</td><td>87 ± 2</td><td>86 ± 2</td><td>85 ± 2</td><td>84 ± 2</td></tr><tr><td>dPdtmax (mmHg/s)</td><td>8744 ± 435</td><td>7245 ± 436</td><td>6908 ± 396</td><td>7952 ± 484</td></tr><tr><td>dPdtmin (mmHg/s)</td><td>-9363 ± 268</td><td>-6419 ± 466*</td><td>-6592 ± 613*</td><td>-7077 ± 380*</td></tr></table> |
221bba14faccc9e746e18f84f5f1ae06c236ae182f2b610fcfe792604e1f2e7a.png | complex | <table><tr><td></td><td colspan="4">Cumulative no. with a newly detected HPV infection (cumulative%)</td><td></td></tr><tr><td></td><td>6 months</td><td>12 months</td><td>24 months</td><td>36 months</td><td><i>P </i>value for log-rank test</td></tr><tr><td>HIV-negative women</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Total sample:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Cryotherapy arm (n = 271)</td><td>15 (5.5)</td><td>21 (7.9)</td><td>25 (9.7)</td><td>28 (11.2)</td><td>0.0004</td></tr><tr><td> Control arm (n = 269)</td><td>17 (6.3)</td><td>30 (11.5)</td><td>45 (18.0)</td><td>59 (24.8)</td><td></td></tr><tr><td>Sexual activity reported during 1 month prior to enrolment or at 1 or 6 months after enrollment:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Cryotherapy arm (n = 238)<sup>a</sup></td><td>13 (5.5)</td><td>18 (7.7)</td><td>22 (9.7)</td><td>25 (11.3)</td><td>0.002</td></tr><tr><td> Control arm (n = 236)<sup>b</sup></td><td>16 (6.8)</td><td>27 (11.8)</td><td>42 (19.4)</td><td>56 (27.2)</td><td></td></tr><tr><td>No sexual activity reported during 1 month prior to enrollment and at 1 and 6 months after enrollment:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Cryotherapy arm (n = 31)<sup>a</sup></td><td>2 (6.5)</td><td>3 (10.4)</td><td>3 (10.4)</td><td>3 (10.4)</td><td>0.96</td></tr><tr><td> Control arm (n = 29)<sup>b</sup></td><td>1 (3.5)</td><td>3 (10.3)</td><td>3 (10.3)</td><td>3 (10.3)</td><td></td></tr><tr><td>HIV-positive women</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Total sample:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Cryotherapy arm (n = 38)</td><td>9 (23.7)</td><td>16 (42.1)</td><td>19 (50.8)</td><td>20 (53.7)</td><td>0.8</td></tr><tr><td> Control arm (n = 34)<sup>c</sup></td><td>7 (20.6)</td><td>14 (42.8)</td><td>15 (46.6)</td><td>16 (50.5)</td><td></td></tr><tr><td>Sexual activity reported during 1 month prior to enrollment or at 1 or 6 months after enrollment:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Cryotherapy arm (n = 33)</td><td>8 (24.2)</td><td>12 (36.4)</td><td>15 (46.4)</td><td>16 (49.8)</td><td>0.65</td></tr><tr><td> Control arm (n = 29)<sup>c</sup></td><td>7 (24.1)</td><td>14 (49.4)</td><td>15 (54.0)</td><td>15 (54.0)</td><td></td></tr><tr><td>No sexual activity reported during 1 month prior to enrollment and at 1 and 6 months after enrollment:</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Cryotherapy arm (n = 5)</td><td>1 (20.0)</td><td>4 (80.0)</td><td>4 (80.0)</td><td>4 (80.0)</td><td>0.08</td></tr><tr><td> Control arm (n = 3)</td><td>0</td><td>0</td><td>0</td><td>0</td><td></td></tr></table> |
784eb973af93f5c2f12b2f34e65aa498b6a5cd4ae5fdf7447a7f0db720faea9b.png | simple | <table><tr><td>Incentive</td><td>Study design (N)</td><td>Year(s) data collection</td><td>Relevant outcome measures</td><td>Healthcare quality</td></tr><tr><td>Western New York Physician Incentive Program (WNY-P4P) [16]</td><td>Pre-post testExperimental group: patients (n = 624) whose physicians (n = 21) participated in P4P schemeControl group: sample of diabetic patients from health plan</td><td>2002-2003</td><td>• Quality of care based on a composite score which was based on process and outcome measures.</td><td>• Average of physician's composite scores increased 48% (baseline to end of project).• 13 out of 21 physicians improved their average composite score enough to earn some level of financial reward.• Of the 8 physicians not receiving reward, 6 improved their composite score.</td></tr><tr><td>Integrated Healthcare Association Pay-for-performance Program (IHA-P4P) [30]</td><td>Cross-sectional analysis of linked 2006 clinical performance scores from IHA-P4P and survey data from the 2<sup>nd </sup>National Study of Physician Organizations among 108 California physician organizations.</td><td>2006</td><td>• Association between clinical performance and the use of chronic management processes• Association between clinical performance and electronic medical record capabilities• Association between clinical performance and participation in external quality improvement initiatives.</td><td>• Physician organizations investing more heavily in care management processes (e.g. patient registries, physician reminders and feedback, patient reminders and education) may achieve better performance scores.• Use of organized quality improvement efforts (e.g. participation in QI program) may be associated with increased delivery of recommended care processes, which in the context of the study translated into better performance on the clinical measures that were rewarded in the P4P scheme.</td></tr><tr><td>Practice Incentive Program Diabetes Incentive (PIP-DI) [38]</td><td>Retrospective study based on dataset from BEACH study (data from 100 consecutive encounters of 1000 GPs that are yearly randomly selected. Each encounter contains data on up to 4 problems treated, drugs prescribed, treatments conducted, referrals written and pathology).N = 12187: <underline>1. Treatment group 1</underline>: accredited practices that use IT for internet, prescribing and medical records; <underline>2. Treatment group 2</underline>: practices that are accredited and do not use IT for internet, prescribing and medical records; <underline>3. Control group</underline>: practices that are not accredited and do not use IT, for internet, prescribing and medical records.</td><td>April 2002-March 2007 from</td><td>• Percentage of patients that received a glycosylated haemoglobin blood test during GP consult</td><td>• PIP-DI increased probability of a HbA1c test being ordered by 20 percentage points.• For patients from Aboriginal and Torres Straight Islander background the increase was more than 35 percentage points.</td></tr><tr><td>Practice Incentive Program Diabetes Incentive (PIP-DI) [37]</td><td>Descriptive study based on semi structured face-to-face interviews (22 GP practices)</td><td>2003</td><td>• Implementation of components of diabetes cycle of care</td><td>• Financial incentives may promote better clinical management. GPs claiming incentives were more likely to comply with all requirements than GPs that did not claim incentives.</td></tr><tr><td>External incentives (including financial incentives). [39]</td><td>Cross-sectional study: telephone survey among 1104 physician organizations (PO) with 20 or more physicians</td><td>2000-2001</td><td>• Extent of use of organized CMPs on the basis of summary measure: PO care management index, external incentives (bonus from health plans, public recognition, better contracts with health plans) quality reporting to outside organization (HEDIS data, clinical outcome data, results of quality improvement projects, patient satisfaction data), IT use</td><td>• External incentives and clinical IT were most strongly associated with CMP use.• Use of the most strongly associated incentives (public recognition and better contracts for healthcare quality) was associated with use of 1.3 and 0.7 additional CMPs (significant).• Receiving a bonus for scoring well on quality of care measures was not significantly associated with CMP use.</td></tr></table> |
0142fca5a3b1ab720482e7050359ccb6f23c485babf3d88f2c4b1ce93acc022d.png | simple | <table><tr><td> </td><td>Resource</td><td>Mean frequency per patient</td><td>Price per item (in euro)</td></tr><tr><td> </td><td>10 Most frequent resource items</td><td> </td><td> </td></tr><tr><td>1</td><td>Tissue obtainment (microbiology and clinical chemistry)</td><td>18.1</td><td>13.73</td></tr><tr><td>2</td><td>Antibodies against any pathogen by using complement fixation test of haemagglutination inhibition essay</td><td>10.4</td><td>4.84</td></tr><tr><td>3</td><td>General ward nursing (one day)</td><td>9.4</td><td>375.00</td></tr><tr><td>4</td><td>Sodium</td><td>8.2</td><td>1.76</td></tr><tr><td>5</td><td>Potassium</td><td>8.2</td><td>1.76</td></tr><tr><td>6</td><td>Creatinine</td><td>6.6</td><td>1.76</td></tr><tr><td>7</td><td>Glucose</td><td>6.4</td><td>1.76</td></tr><tr><td>8</td><td>Leukocytes</td><td>6.1</td><td>1.76</td></tr><tr><td>9</td><td>C-reactive protein</td><td>6.0</td><td>4.84</td></tr><tr><td>10</td><td>Urea</td><td>5.9</td><td>1.76</td></tr><tr><td> </td><td>10 Most expensive resource items</td><td> </td><td> </td></tr><tr><td>1</td><td>Intensive care unit nursing (one day)</td><td>0.6</td><td>1,730.00</td></tr><tr><td>2</td><td>Surgical treatment of thorax empyema</td><td>0.2</td><td>1,084.75</td></tr><tr><td>3</td><td>Laryngoscopy</td><td>0.0</td><td>999.00</td></tr><tr><td>4</td><td>Microbiological determination on isolated DNA/RNA</td><td>0.0</td><td>867.61</td></tr><tr><td>5</td><td>General ward nursing (one day)</td><td>9.4</td><td>375.00</td></tr><tr><td>6</td><td>Flexible bronchoscopy</td><td>0.2</td><td>209.25</td></tr><tr><td>7</td><td>DNA/RNA amplification (qualitative)</td><td><0.1</td><td>208.60</td></tr><tr><td>8</td><td>Computer tomography of thorax</td><td>0.2</td><td>195.83</td></tr><tr><td>9</td><td>Immunopathologic research</td><td><0.1</td><td>109.57</td></tr><tr><td>10</td><td>Computer tomography airways</td><td><0.1</td><td>160.01</td></tr></table> |
0b438ab32a7682b1e6d92108735ba130be4e9926a55adc01033ac6ba56faaec4.png | simple | <table><tr><td>Model</td><td>Data</td><td>Description</td><td>Section with model details</td></tr><tr><td>M1</td><td>Aggregate data only</td><td>Aggregates the IPD and includes observational data through random effects on change from baseline 6MWD</td><td>2.1</td></tr><tr><td>M2</td><td>Aggregate and IPD</td><td>Extends M1 to combine aggregate data and IPD</td><td>2.2</td></tr><tr><td>M3</td><td>Aggregate and IPD</td><td>Extends M2 to include covariate adjustments on change from baseline 6MWD</td><td>2.3</td></tr><tr><td>M4</td><td>Aggregate and IPD</td><td>Extends M3 to include interactions between treatment effect and covariates</td><td>2.4</td></tr><tr><td>S1</td><td>Aggregate and IPD</td><td>Same as M4 but SE in observational studies are inflated by a factor of 10 to downweight their evidence</td><td>3.3</td></tr><tr><td>S2</td><td>Aggregate and IPD</td><td>Same as M4 but constructed a control arm for observational studies where all patients assumed to deteriorate by 25 m from baseline in 6MWD</td><td>3.4</td></tr></table> |
4ad69b8cc0523dae6573dd373e2a7475c9aad05d691d3d2e0abb65b2ed5fa9c0.png | simple | <table><tr><td></td><td>Vegetarian</td><td>Omnivorous</td><td><i>p</i> Value</td></tr><tr><td>Overall Energy intake (kJ/day)</td><td>4988 (3531–6387)</td><td>5528 (5021–6428)</td><td>0.15</td></tr><tr><td>Protein (g/day)</td><td>42.5 (32.7–59.2)</td><td>71.1 (61.3–77)</td><td>0.0003</td></tr><tr><td>Iron intake (g/day))</td><td>8.1</td><td>8.4</td><td>0.56</td></tr><tr><td>Carbohydrate (g/day)</td><td>129.1 (106.5–154.4)</td><td>144.6 (133.5–167)</td><td>0.21</td></tr><tr><td>Starch (g/day)</td><td>76.5 (47.5–95.1)</td><td>74.0 (54.1–88.0)</td><td>0.78</td></tr><tr><td>Sugars (g/day)</td><td>56.0 (44.2–72.1)</td><td>75.3 (64.2–92.3)</td><td>0.02</td></tr><tr><td>Dietary fibre (g/day)</td><td>20.9 (13.9–26.7)</td><td>16.5 (13.5–19.6)</td><td>0.13</td></tr><tr><td>Glycaemic Index</td><td>51.5 (49.0–52.1)</td><td>49.1 (46.7–52.6)</td><td>0.40</td></tr><tr><td>Saturated fatty acids (g/day)</td><td>13.9 (11.3–23.8)</td><td>21.5 (17.4–26.5)</td><td>0.04</td></tr><tr><td>Monounsaturated fatty acids (g/day)</td><td>18.0 (10.6–23.8)</td><td>18.9 (16.4–23.5)</td><td>0.53</td></tr><tr><td>Polyunsaturated fatty acids (g/day)</td><td>11.6 (9.1–15.8)</td><td>6.5 (5.0–8.6)</td><td>0.006</td></tr><tr><td>α-Linoleic acid (g/day)</td><td>0.97</td><td>0.63</td><td>0.16</td></tr><tr><td>Linoleic acid (g/day)</td><td>10.4</td><td>5.7</td><td>0.008</td></tr><tr><td>Arachidonic acid (g/day)</td><td>0.02</td><td>0.05</td><td>0.05</td></tr><tr><td>EPA (g/day)</td><td>0.003</td><td>0.078</td><td>0.002</td></tr><tr><td>DHA (g/day)</td><td>0.01</td><td>0.17</td><td>0.002</td></tr></table> |
624906b0d7fc6a6fad286ed03eae78d3e849fd337b84d0f611c4c9f747525d40.png | complex | <table><tr><td>Representation of compound</td><td><i>K</i></td><td colspan="2">Prediction accuracy for each class (%)</td></tr><tr><td></td><td></td><td>Networking triads (SN)</td><td>Non-networking triads (SP)</td></tr><tr><td>SMILES</td><td>3</td><td>92.67</td><td>92.03</td></tr><tr><td></td><td>5</td><td>89.79</td><td>92.92</td></tr><tr><td>Graph</td><td>3</td><td>95.34</td><td>99.48</td></tr><tr><td></td><td>5</td><td>94.18</td><td>99.48</td></tr></table> |
8632e39028cd9f6a4ec6e8e70b08c24ff8fc19b700009b0f3516e885aac09096.png | complex | <table><tr><td> </td><td>SA1</td><td>SA2</td><td>SA3</td><td>SA4</td></tr><tr><td><i>E</i><sub>rel</sub> (eV)</td><td>0.00</td><td>0.17</td><td>0.52</td><td>0.53</td></tr><tr><td><i>E</i><sub>ads</sub> (eV)</td><td>2.64</td><td>2.47</td><td>2.12</td><td>2.11</td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="5"><i>Step edge</i></td></tr><tr><td> Ṡ̇̇Au (Å)</td><td>3.12 (× 2)</td><td>2.54</td><td> </td><td> </td></tr><tr><td> –CṄ̇̇Au (Å)</td><td>2.18</td><td>2.56</td><td>2.31</td><td>2.34</td></tr><tr><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td colspan="5"><i>Terrace</i></td></tr><tr><td> Ṡ̇̇Au (Å)</td><td>3.34</td><td>3.33</td><td>3.61</td><td>3.69</td></tr><tr><td> –CṄ̇̇Au (Å)</td><td>3.17</td><td>2.36</td><td>2.68</td><td>3.14</td></tr></table> |
6667cda495b5fe3546a71abb373aa7948bd81c9bd66d37e513e708c12b16af73.png | simple | <table><tr><td><i>Parameters</i></td><td><i>Group A<sup>†</sup></i></td><td><i>Group B<sup>†</sup></i></td><td><i>Total<sup>†</sup></i></td></tr><tr><td><i>Ht</i></td><td>40.69 ± 0.80</td><td>41.27 ± 0.65</td><td>40.98 ± 0.51</td></tr><tr><td><i>WBC</i></td><td>8,821.00 ± 498.54</td><td>8,170.00 ± 400.25</td><td>8,501.02 ± 320.98</td></tr><tr><td><i>PLT</i></td><td>260,200 ± 15,850</td><td>302,414 ± 24,537</td><td>280,949 ± 14,643</td></tr><tr><td><i>PT</i></td><td>13.39 ± 0.41</td><td>12.57 ± 0.24</td><td>12.99 ± 0.25</td></tr><tr><td><i>PTT</i></td><td>33.8 ± 0.90</td><td>33.83 ± 1.25</td><td>33.6 ± 0.76</td></tr><tr><td><i>INR</i></td><td>1.06 ± 0.04</td><td>1.01 ± 0.02</td><td>1.04 ± 0.02</td></tr><tr><td><i>Fibrinogen</i></td><td>496.97 ± 24.63</td><td>471.28 ± 26.55</td><td>484.34 ± 18.01</td></tr><tr><td><i>D-dimers</i></td><td>0.84 ± 0.18</td><td>0.84 ± 0.21</td><td>0.84 ± 0.14</td></tr><tr><td><i>Urea</i></td><td>38.13 ± 2.15</td><td>37.76 ± 3.03</td><td>37.95 ± 1.83</td></tr><tr><td><i>Crea</i></td><td>0.94 ± 0.04</td><td>0.98 ± 0.05</td><td>0.96 ± 0.03</td></tr><tr><td><i>SGOT</i></td><td>21.13 ± 1.60</td><td>27.52 ± 3.05</td><td>24.27 ± 1.74</td></tr><tr><td><i>SGPT</i></td><td>29.33 ± 8.22</td><td>37.93 ± 6.84</td><td>33.56 ± 5.35</td></tr><tr><td><i>Total Protein</i></td><td>7.27 ± 0.10</td><td>7.36 ± 0.14</td><td>7.31 ± 0.08</td></tr><tr><td><i>Albumin</i></td><td>4.00 ± 0.10</td><td>4.16 ± 0.13</td><td>4.07 ± 0.8</td></tr><tr><td><i>Total Bil</i></td><td>0.61 ± 0.09</td><td>0.63 ± 0.06</td><td>0.62 ± 0.05</td></tr><tr><td><i>Direct Bil</i></td><td>0.11 ± 0.02</td><td>0.12 ± 0.01</td><td>0.11 ± 0.01</td></tr></table> |
78b411bb5bc876041ca4aedad856c7090bcdb81150028ba58bb338aabf14c360.png | complex | <table><tr><td>Category</td><td>Example</td><td>Concept</td><td>Global theme</td></tr><tr><td rowspan="8">Locus of control</td><td>Improve mental health</td><td><i>Additive</i></td><td rowspan="4"><i>Resilience</i></td></tr><tr><td>Removing negative friendships</td><td><i>Subtractive</i></td></tr><tr><td>Autonomy</td><td><i>Internal</i></td></tr><tr><td>Success of peers</td><td><i>External</i></td></tr><tr><td>Increase physical activity</td><td><i>Additive</i></td><td rowspan="4"><i>Self-management</i></td></tr><tr><td>Eating out less</td><td><i>Subtractive</i></td></tr><tr><td>Goal setting</td><td><i>Internal</i></td></tr><tr><td>Access to gym</td><td><i>External</i></td></tr></table> |
30e6bb41252bc44d1f8d6f340ccc9a52a71f5eb1e55b4372b5e4e2cceb5cda36.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">QLQ-C30</td><td colspan="2">QLQ-BR23</td></tr><tr><td>Then-test</td><td>Post-test</td><td>Then-test</td><td>Post-test</td></tr><tr><td>Baseline</td><td> </td><td>359 (94.2%)</td><td> </td><td>357 (93.7%)</td></tr><tr><td>After surgery</td><td>347 (91.1%)</td><td>347 (91.1%)</td><td>347 (91.1%)</td><td>346 (90.8%)</td></tr><tr><td>3 months</td><td>339 (90.0%)</td><td>342 (89.8%)</td><td>355 (87.9%)</td><td>340 (89.2%)</td></tr><tr><td>6 months</td><td>314 (82.4%)</td><td>322 (84.5%)</td><td>313 (82.1%)</td><td>322 (84.5%)</td></tr></table> |
e7d1ac5e0368b177b1797f1d5058e83b26dfecfaa158153c21b9582e8a14ba90.png | simple | <table><tr><td>Reactor Type</td><td>Anodic Supporting Materials</td><td>Cathode Materials</td><td>Power Density (mW m<sup>−2</sup>)</td><td>Comparision to Pt/C or Bare Materials</td><td>Ref.</td></tr><tr><td>250 mL double chambers</td><td>Graphite granule</td><td>Pt/C</td><td>1470 ± 10</td><td>-</td><td>[35]</td></tr><tr><td>250mL double chambers</td><td>Graphite granule</td><td>Co<sub>3</sub>O<sub>4</sub>/N doped graphene</td><td>1340 ± 10</td><td>Comparable to Pt/C</td><td>[35]</td></tr><tr><td>6 mL single chamber</td><td>Carbon paper</td><td>Co/Fe/N/CNTs</td><td>751</td><td>1.5 times > Pt/C</td><td>[36]</td></tr><tr><td>80 mL double chamber</td><td>Carbon fiber</td><td>N-doped CNTs on C cloth</td><td>1600 ± 50</td><td>12.8% > Pt/C</td><td>[37]</td></tr><tr><td>Single chamber</td><td>Carbon felts</td><td>Fe–N-functionalized graphene</td><td>1149.8</td><td>2.1 times > Pt/C</td><td>[38]</td></tr><tr><td>Single chamber</td><td>Carbon cloth</td><td>Graphene supported Pt–Co</td><td>1378</td><td>Comparable to Pt/C</td><td>[39]</td></tr><tr><td>Sediment MFCs</td><td>Graphite felt</td><td>Polyaniline-Graphene nanosheets</td><td>99</td><td>116 times > Graphite</td><td>[40]</td></tr><tr><td>Double chamber</td><td>-</td><td>N/S co-doped carbon nanosheets</td><td>1500</td><td>Comparable to Pt/C</td><td>[41]</td></tr><tr><td>15 mL sediment single chamber</td><td>MWNT coating Graphite</td><td>MWNT coating Graphite</td><td>214.7 ± 9.9</td><td>1.6 times higher than that of bare graphite</td><td>[42]</td></tr><tr><td>Single chamber</td><td>Carbon cloth</td><td>Graphene/poly(3,4-ethylenedioxythiophene)/Fe<sub>3</sub>O<sub>4</sub></td><td>3525</td><td>8.2 times > Carbon cloth</td><td>[43]</td></tr><tr><td>Double chamber</td><td>Carbon brush</td><td>N-doped Graphene/CoNi alloy encased within bamboo-like CNTs</td><td>2000</td><td>Comparable to Pt/C</td><td>[44]</td></tr><tr><td>210 mL double chamber</td><td>Carbon paper</td><td>CNTs/Polypyrrole</td><td>113.5</td><td>Comparable to Pt/C</td><td>[45]</td></tr><tr><td>Single chamber</td><td>Graphite fiber brush</td><td>Ag/Fe/N/C</td><td>1791</td><td>1.5 times > Pt/C</td><td>[46]</td></tr><tr><td>20 mL single chamber</td><td>N-Ni-carbon nanofibers</td><td>N-doped polymer-Ni–carbon nanofibers</td><td>1690 ± 30</td><td>-</td><td>[47]</td></tr><tr><td>1.5 L single chamber</td><td>Carbon fiber</td><td>Co-doped Carbon nanofibers</td><td>92</td><td>Stable more than 6000 h</td><td>[48]</td></tr></table> |
fbb93164bd458921e18376d24039640990d5c85e477f840578fdf453a4c97c5c.png | simple | <table><tr><td></td><td></td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td></tr><tr><td>Pumps</td><td><i>M</i></td><td>36.86</td><td>36.15</td><td>35.68</td><td>36.72</td><td>35.77</td><td>36.66</td><td>38.94</td><td>36.95</td></tr><tr><td></td><td><i>SD</i></td><td>14.95</td><td>8.80</td><td>5.59</td><td>6.36</td><td>5.37</td><td>4.22</td><td>7.25</td><td>3.28</td></tr><tr><td>Total of pumps</td><td><i>M</i></td><td>1105.88</td><td>1082.88</td><td>1070.25</td><td>1101.50</td><td>1073.13</td><td>1099.81</td><td>1168.31</td><td>1108.56</td></tr><tr><td></td><td><i>SD</i></td><td>448.60</td><td>266.08</td><td>167.83</td><td>190.78</td><td>161.24</td><td>126.74</td><td>217.46</td><td>98.30</td></tr><tr><td>Adjusted pumps</td><td><i>M</i></td><td>43.49</td><td>42.46</td><td>43.39</td><td>43.39</td><td>42.12</td><td>42.04</td><td>44.53</td><td>43.09</td></tr><tr><td></td><td><i>SD</i></td><td>21.29</td><td>13.96</td><td>10.14</td><td>8.23</td><td>8.61</td><td>4.04</td><td>7.06</td><td>5.65</td></tr><tr><td>Total of adjusted pumps</td><td><i>M</i></td><td>763.81</td><td>825.25</td><td>821.19</td><td>860.06</td><td>823.44</td><td>859.94</td><td>824.13</td><td>842.38</td></tr><tr><td></td><td><i>SD</i></td><td>183.96</td><td>121.06</td><td>100.71</td><td>138.70</td><td>94.21</td><td>106.56</td><td>199.06</td><td>101.34</td></tr><tr><td>Win trials</td><td><i>M</i></td><td>20.25</td><td>20.63</td><td>19.50</td><td>20.25</td><td>20.19</td><td>20.50</td><td>18.56</td><td>19.75</td></tr><tr><td></td><td><i>SD</i></td><td>5.98</td><td>4.27</td><td>2.99</td><td>3.79</td><td>3.73</td><td>2.07</td><td>3.92</td><td>2.65</td></tr><tr><td>Loss trials</td><td><i>M</i></td><td>9.75</td><td>9.38</td><td>10.50</td><td>9.75</td><td>9.81</td><td>9.50</td><td>11.44</td><td>10.25</td></tr><tr><td></td><td><i>SD</i></td><td>5.98</td><td>4.27</td><td>2.99</td><td>3.79</td><td>3.73</td><td>2.07</td><td>3.92</td><td>2.65</td></tr><tr><td>Total earning</td><td><i>M</i></td><td>20.60</td><td>27.71</td><td>28.16</td><td>30.40</td><td>28.17</td><td>30.45</td><td>23.64</td><td>28.33</td></tr><tr><td></td><td><i>SD</i></td><td>16.90</td><td>10.91</td><td>5.46</td><td>9.99</td><td>7.32</td><td>7.58</td><td>23.35</td><td>8.38</td></tr><tr><td>Adjusted pumps following a win</td><td><i>M</i></td><td>43.77</td><td>42.10</td><td>44.38</td><td>41.77</td><td>42.71</td><td>42.74</td><td>43.00</td><td>44.57</td></tr><tr><td></td><td><i>SD</i></td><td>22.59</td><td>12.67</td><td>10.60</td><td>7.77</td><td>8.22</td><td>3.93</td><td>13.62</td><td>7.13</td></tr><tr><td>Adjusted pumps following a loss</td><td><i>M</i></td><td>45.14</td><td>43.00</td><td>41.90</td><td>44.86</td><td>42.03</td><td>41.83</td><td>45.42</td><td>40.78</td></tr><tr><td></td><td><i>SD</i></td><td>20.48</td><td>14.81</td><td>12.03</td><td>10.18</td><td>12.02</td><td>7.51</td><td>11.51</td><td>7.00</td></tr><tr><td>Reaction time (ms)</td><td><i>M</i></td><td>287.57</td><td>218.84</td><td>205.47</td><td>185.03</td><td>197.53</td><td>156.00</td><td>177.29</td><td>182.28</td></tr><tr><td></td><td><i>SD</i></td><td>169.47</td><td>134.49</td><td>131.79</td><td>106.42</td><td>118.61</td><td>53.43</td><td>51.77</td><td>77.43</td></tr></table> |
2031c536cf4fa58ee612869911dbcc66871b4217c02042f0476c52b5dd5e6f6d.png | simple | <table><tr><td></td><td></td><td>NaCl (n = 12)</td><td>TCA (n = 9)</td><td>p</td></tr><tr><td>direct treatment response</td><td>no response</td><td>8</td><td>2</td><td></td></tr><tr><td></td><td>partial response, not satisfactory</td><td>1</td><td>0</td><td></td></tr><tr><td></td><td>partial response, satisfactory</td><td>2</td><td>1</td><td></td></tr><tr><td></td><td>complete resolution of symptoms</td><td>1</td><td>6</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td>0.015*</td></tr><tr><td>mean severity of pain in the past week (95% CI)</td><td></td><td>4.3 (2.3-6.3)</td><td>1.3 (0.3-2.9)</td><td></td></tr><tr><td></td><td>mean rank</td><td>13.1</td><td>7.4</td><td>0.031<sup>§</sup></td></tr><tr><td>mean Dutch AIMS-2-HFF (95% CI)</td><td></td><td>2.7 (1.9-3.6)</td><td>1.9 (0.7-3.2)</td><td></td></tr><tr><td></td><td>mean rank</td><td>12.4</td><td>8.2</td><td>0.112<sup>§</sup></td></tr><tr><td>patient perceived improvement</td><td>much worse</td><td>0</td><td>0</td><td></td></tr><tr><td></td><td>worse</td><td>2</td><td>0</td><td></td></tr><tr><td></td><td>not better not worse</td><td>6</td><td>2</td><td></td></tr><tr><td></td><td>better</td><td>1</td><td>1</td><td></td></tr><tr><td></td><td>much better</td><td>3</td><td>6</td><td></td></tr><tr><td></td><td></td><td></td><td></td><td>0.047*</td></tr></table> |
1265268ec4959599b9510c06cdb5e7ec92796ed337fddd65a1b3de569f2f9c73.png | simple | <table><tr><td>Feature combination</td><td>S1</td><td>S2</td><td>S3</td><td>S4</td><td>S5</td><td>S6</td><td>S7</td></tr><tr><td>Mean & slope</td><td>95.6</td><td>97.4</td><td>94.9</td><td>97.1</td><td>96.6</td><td>96.0</td><td>95.6</td></tr><tr><td>Mean & peak</td><td>96.9</td><td>98.5</td><td>98.1</td><td>98.7</td><td>97.9</td><td>98.4</td><td>98.4</td></tr><tr><td>Mean & variance</td><td>98.0</td><td>98.4</td><td>98.1</td><td>97.7</td><td>98.2</td><td>96.4</td><td>98.2</td></tr><tr><td>Slope & peak</td><td>95.4</td><td>92.3</td><td>95.9</td><td>96.1</td><td>95.5</td><td>90.2</td><td>92.7</td></tr><tr><td>Slope & variance</td><td>97.9</td><td>98.4</td><td>97.7</td><td>98.2</td><td>98.0</td><td>97.0</td><td>98.0</td></tr><tr><td>Peak & variance</td><td>98.1</td><td>97.9</td><td>97.4</td><td>97.2</td><td>98.0</td><td>97.4</td><td>98.4</td></tr><tr><td>Peak & skewness</td><td>92.8</td><td>89.0</td><td>84.2</td><td>94.1</td><td>91.6</td><td>88.5</td><td>84.7</td></tr><tr><td>Mean & skewness</td><td>92.0</td><td>94.0</td><td>90.6</td><td>92.8</td><td>89.8</td><td>88.7</td><td>92.7</td></tr><tr><td>Slope & skewness</td><td>90.8</td><td>88.0</td><td>88.2</td><td>90.7</td><td>90.0</td><td>91.6</td><td>90.6</td></tr><tr><td>Kurtosis & skewness</td><td>54.5</td><td>55.7</td><td>53.6</td><td>55.6</td><td>56.2</td><td>55.7</td><td>51.6</td></tr><tr><td>Variance & skewness</td><td>98.4</td><td>98.5</td><td>97.6</td><td>98.4</td><td>97.2</td><td>97.0</td><td>98.0</td></tr><tr><td>Peak & kurtosis</td><td>90.1</td><td>88.5</td><td>81.4</td><td>94.1</td><td>87.8</td><td>87.5</td><td>84.9</td></tr><tr><td>Mean & kurtosis</td><td>90.1</td><td>93.5</td><td>89.0</td><td>91.6</td><td>90.7</td><td>89.8</td><td>91.5</td></tr><tr><td>Slope & kurtosis</td><td>91.3</td><td>88.1</td><td>88.2</td><td>90.0</td><td>90.6</td><td>91.9</td><td>90.3</td></tr><tr><td>Variance & kurtosis</td><td>98.4</td><td>98.4</td><td>97.1</td><td>97.4</td><td>97.6</td><td>96.6</td><td>95.5</td></tr></table> |
e8e06ea36938fc1d5861d09596a3f5ec4d9080b2b2bfc42f65f41986705cca9e.png | complex | <table><tr><td></td><td>Total group <i>n</i> = 72</td><td>Controls <i>n</i> = 36</td><td>CVD patients <i>n</i> = 36</td><td><i>p</i> value</td></tr><tr><td colspan="5">Characteristics</td></tr><tr><td> Age (years)</td><td>60 ± 7</td><td>59 ± 7</td><td>61 ± 6</td><td>0.41</td></tr><tr><td> Body height (cm)</td><td>178 ± 7</td><td>180 ± 7</td><td>176 ± 6</td><td>0.011</td></tr><tr><td> Body mass (kg)</td><td>81 ± 11</td><td>81 ± 11</td><td>81 ± 12</td><td>0.98</td></tr><tr><td> Body Mass Index (kg/m<sup>2</sup>)<sup>a</sup></td><td>25.3 [23.6 to 27.0]</td><td>24.9 [23.3 to 26.9]</td><td>25.6 [24.2 to 27.9]</td><td>0.20</td></tr><tr><td> Mean arterial pressure (mmHg)<sup>a</sup></td><td>97 [91 to 105]</td><td>100 [93 to 106]</td><td>94 [90 to 100]</td><td>0.035</td></tr><tr><td> Diastolic blood pressure (mmHg)<sup>a</sup></td><td>79 [75 to 88]</td><td>83 [77 to 91]</td><td>77 [73 to 82]</td><td>0.011</td></tr><tr><td> Systolic blood pressure (mmHg)</td><td>131 [123 to 142]</td><td>136 [124 to 142]</td><td>128 [120 to 139]</td><td>0.19</td></tr><tr><td colspan="5">Cardiovascular medication use</td></tr><tr><td> Anticoagulant (n)</td><td></td><td>-</td><td>35 (97%)</td><td></td></tr><tr><td> Antihypertensive agents (n)</td><td></td><td>-</td><td>29 (81%)</td><td></td></tr><tr><td> Lipid lowering agents (n)</td><td></td><td>-</td><td>32 (89%)</td><td></td></tr><tr><td colspan="5">Vascular measurements</td></tr><tr><td> Radial strain (%)<sup>a</sup></td><td>4.2 [3.2 to 6.5]</td><td>4.2 [3.2 to 6.4]</td><td>4.8 [3.6 to 6.5]</td><td>0.50</td></tr><tr><td> Circumferential strain (%)<sup>a</sup></td><td>−10.0 [−13.6 to −6.5]</td><td>−10.2 [−14.9 to −7.0]</td><td>−8.8 [−13.2 to −6.2]</td><td>0.29</td></tr><tr><td> Distensibility<sup>a</sup></td><td>0.27 [0.19 to 0.37]</td><td>0.27 [0.20 to 0.35]</td><td>0.29 [0.18 to 0.40]</td><td>0.77</td></tr><tr><td> Central pulse wave velocity<sup>a</sup></td><td>8.0 [6.8 to 10.1]</td><td>7.8 [6.5 to 10.0]</td><td>8.0 [7.2 to 10.2]</td><td>0.22</td></tr><tr><td> Intima to media thickness (mm)<sup>a</sup></td><td>0.72 [0.61 to 0.78]</td><td>0.68 [0.58 to 0.76]</td><td>0.76 [0.68 to 0.80]</td><td>0.023</td></tr></table> |
60044eba6f590c8e2bceef500010b5b4a7c9aa250a6a0941527e4c43a0f5509c.png | complex | <table><tr><td colspan="6">After the Onset</td></tr><tr><td></td><td>Value</td><td>Std.Error</td><td><i>df</i></td><td><i>t</i>-value</td><td><i>p</i>-value</td></tr><tr><td>(Intercept)</td><td>22.00</td><td>3.37</td><td>4553</td><td>6.53</td><td><0.0001</td></tr><tr><td>AUT</td><td>16.58</td><td>4.90</td><td>26</td><td>3.39</td><td>0.0023</td></tr></table> |
ed8eb5e9c3d9a3650673ca13c96e196d6274b511ec741017fe7ee48eb8f124a7.png | complex | <table><tr><td>Dataset</td><td>Arrays (Drugs)</td><td>Unique Drugs</td><td colspan="2">Exp. Blockers (Unique)</td><td colspan="2">LQT Drugs (Unique)</td></tr><tr><td>CMap Build 02</td><td>7,056 (6,100)</td><td>1,309</td><td colspan="2">324 (61)</td><td colspan="2">284 (54)</td></tr><tr><td>HT-HG-U133A</td><td>6,029 (5,242)</td><td>1,219</td><td colspan="2">271 (60)</td><td colspan="2">234 (52)</td></tr><tr><td>Batch Correction</td><td>5,454 (4,754)</td><td>1,145</td><td colspan="2">253 (60)</td><td colspan="2">222 (52)</td></tr><tr><td>Non-Silent Drugs</td><td>2,119 (1,419)</td><td>673</td><td colspan="2">88 (37)</td><td colspan="2">76 (35)</td></tr><tr><td>Merge Replicates</td><td>-</td><td>673</td><td colspan="2">62 (37)</td><td colspan="2">57 (35)</td></tr></table> |
cb010d2c615af33078180721808fc5350e43af00e2b587cbca943470fe7f5597.png | simple | <table><tr><td>Variable</td><td>Aromatherapy group</td><td>Control group</td><td>p-value</td></tr><tr><td>Standard deviation and mean of mothers' age (year)</td><td>26.43±3.216</td><td>26.60±3.406</td><td>0.768</td></tr><tr><td>Educationhigh school and loweruniversity degree</td><td>79.4%20.6%</td><td>82.5%17.5%</td><td>0.967</td></tr><tr><td>ProfessionHousewifeWorking</td><td>79.4%20.6%</td><td>82.5%17.5%</td><td>0.650</td></tr><tr><td>Husband's Educationhigh school and loweruniversity degree</td><td>84.2%15.8%</td><td>87.3%12.7%</td><td>0.895</td></tr><tr><td>Husband's professionUnemployedFree workemploee</td><td>14.3%69.8%15.9%</td><td>12.7%69.8%17.5%</td><td>0.948</td></tr><tr><td>Standard deviation and mean of pregnancy age(week)</td><td>38.30±0.978</td><td>38.08±1.067</td><td>0.225</td></tr><tr><td>Wanted pregnancy</td><td>79.4%</td><td>82.5%</td><td>0.650</td></tr><tr><td>Receiving prenatal careYesNo</td><td>92.5%4.8%</td><td>96.8%3.2%</td><td>0.650</td></tr><tr><td>Type of childbirthNormal vaginal deliveryCesarian section</td><td>98.4%1.6%</td><td>96.8%3.2%</td><td>0.561</td></tr><tr><td>Standard deviation and mean ofcontraction length in 3-4 cm dilatation</td><td>44.08±0.703</td><td>43.94±0.759</td><td>0.275</td></tr><tr><td>Standard deviation and mean of contraction length in 5-7 cm dilatation</td><td>47.40±0.493</td><td>47.27±0.447</td><td>0.133</td></tr><tr><td>Standard deviation and mean of contraction length in8-10 cm dilatation</td><td>49.44±0.501</td><td>49.43±0.499</td><td>0.859</td></tr><tr><td>Standard deviation and mean of contraction frequency during 10 minutes in 3-4 cm dilatation</td><td>2.27±0.447</td><td>2.27±0.447</td><td>1.000</td></tr><tr><td>Standard deviation and mean of contraction frequency during 10 minutes in 5-7 cm dilatation</td><td>3.16±0.368</td><td>3.22±0.419</td><td>0.368</td></tr><tr><td>Standard deviation and mean of contraction frequency during 10 minutes in 8-10 cm dilatation</td><td>3.81±0.396</td><td>3.73±0.447</td><td>0.294</td></tr></table> |
a192477f624e543b151e9b3f32f3fc04e96ea20892285f72caa67ce9c178aee2.png | simple | <table><tr><td>Variables Separated by Category <sup>1</sup></td><td>Number of Responses/Number Total</td><td>Number Relative (%)</td></tr><tr><td>Lives near areas of vegetation</td><td></td><td></td></tr><tr><td>Yes</td><td>449/478</td><td>93.9 *</td></tr><tr><td>No</td><td>29/478</td><td>6.1</td></tr><tr><td>Destination of Household Waste</td><td></td><td></td></tr><tr><td>Garbage truck</td><td>288/478</td><td>60.3 *</td></tr><tr><td>Local dump site</td><td>6/478</td><td>1.3</td></tr><tr><td>Garbage truck and other destinations</td><td>184/478</td><td>38.5</td></tr><tr><td>Lives near open-air garbage dump</td><td></td><td></td></tr><tr><td>Yes</td><td>366/478</td><td>76.6 *</td></tr><tr><td>No</td><td>112/478</td><td>23.4</td></tr><tr><td>Disposal of domestic sewage</td><td></td><td></td></tr><tr><td>Mossoró River</td><td>213/478</td><td>44.6 *</td></tr><tr><td>Sanitation system</td><td>181/478</td><td>37.9</td></tr><tr><td>Sink</td><td>70/478</td><td>14.6</td></tr><tr><td>Sink and Mossoró River</td><td>8/478</td><td>1.7</td></tr><tr><td>Unknown</td><td>6/478</td><td>1.3</td></tr><tr><td>Vegetation around residence</td><td></td><td></td></tr><tr><td>Fruit trees</td><td>135/478</td><td>28.2</td></tr><tr><td>Other types of vegetation</td><td>166/478</td><td>34.7</td></tr><tr><td>Does not have vegetation</td><td>177/478</td><td>37.0</td></tr><tr><td>Presence of mosquitoes in house</td><td></td><td></td></tr><tr><td>Yes</td><td>412/478</td><td>86.2 *</td></tr><tr><td>No</td><td>66/478</td><td>13.8</td></tr><tr><td>Increase in mosquitoes in the rainy season</td><td></td><td></td></tr><tr><td>Yes</td><td>399/478</td><td>83.5 *</td></tr><tr><td>No</td><td>79/478</td><td>16.5</td></tr><tr><td>Repellent plants/insecticides used near home</td><td></td><td></td></tr><tr><td>Yes</td><td>15/478</td><td>3.1</td></tr><tr><td>No</td><td>463/478</td><td>96.9 *</td></tr></table> |
c89fc24f7bc7ddd4a9edb7c21795525aed59e48823027530de5b34311b499a63.png | simple | <table><tr><td>Inhibitor/control media</td><td>Isotonic RME (± S.E.)</td><td>Hypotonic RME (± S.E.)</td><td>Mean % of area change (± S.E.)</td><td>Translocation</td></tr><tr><td>Untreated control</td><td>28.77 (6.78)</td><td>78.84 (1.84)*</td><td>145.19 (1.11)*</td><td>Yes</td></tr><tr><td>Non-specific kinase inhibitor (hypericin)</td><td>21.85 (6.80)</td><td>38.22 (5.58)</td><td>103.50 (2.05)</td><td>No</td></tr><tr><td>PKC (Myr-PKCi)</td><td>27.27 (4.73)</td><td>55.28 (3.97)*</td><td>141.00 (2.05)*</td><td>Yes</td></tr><tr><td>PKA (Myr-PKAi)</td><td>25.62 (5.16)</td><td>33.66 (6.62)</td><td>102.97 (5.21)</td><td>No</td></tr><tr><td>Calcium-free media</td><td>26.69 (6.03)</td><td>32.16 (4.48)</td><td>111.60 (1.92)</td><td>No</td></tr><tr><td>Calmodulin inhibitor (trifluoperazine)</td><td>27.23 (7.11)</td><td>31.40 (5.91)</td><td>108.61 (5.47)</td><td>No</td></tr><tr><td>Calmodulin inhibitor (W7)</td><td>16.86 (8.43)</td><td>22.11 (8.14)</td><td>110.31 (14.21)</td><td>No</td></tr></table> |
8c97fb89508a4f42e59e4ce2add9de3da98cd48ec96673ccb412113d501798f8.png | simple | <table><tr><td>Group</td><td>IC<sub>50 </sub>(μmol/L)</td><td>RR</td></tr><tr><td><i>EST1</i> siRNA</td><td>34.63 ± 1.29*</td><td>2.35</td></tr><tr><td>Negative control siRNA</td><td>86.18 ± 5.29</td><td>0.94</td></tr><tr><td>Control untransfected</td><td>81.37 ± 6.34</td><td>1.00</td></tr></table> |
d4bbd61f34ca9f2c29980ce5eec01eba3227373b4b3950a8de8ca1971e13049a.png | complex | <table><tr><td rowspan="2"></td><td colspan="2">IBTR</td><td colspan="2">DFS</td><td colspan="3">OS</td></tr><tr><td>5-year</td><td>Adjusted<sup>a</sup> HR (95% CI)</td><td>5-year (%)</td><td>Adjusted<sup>a</sup> HR (95% CI)</td><td>5-year (%)</td><td>10-year (%)</td><td>Adjusted<sup>a</sup> HR (95% CI)</td></tr><tr><td>Negative margins and primary BCS only (<i>n</i> = 7820)<sup>b</sup></td><td>163 (2.3%)</td><td>0.76 (0.43–1.35)</td><td>89.2</td><td>0.81 (0.63–1.04)</td><td>93.1</td><td>82.9%</td><td>1.07 (0.85–1.34)</td></tr><tr><td colspan="8">Focally positive margins</td></tr><tr><td> Primary BCS only (<i>n</i> = 492)<sup>b</sup></td><td>13 (2.9%)</td><td>Reference</td><td>86.0</td><td>Reference</td><td>92.7</td><td>81.1</td><td>Reference</td></tr><tr><td> Primary BCS + re-excision (<i>n</i> = 586)<sup>c</sup></td><td>6 (1.1%)</td><td><i>0</i>.<i>30 (0</i>.<i>11</i>–<i>0</i>.<i>82)</i></td><td>87.1</td><td>0.83 (0.59–1.17)</td><td>92.1</td><td>82.1</td><td>1.17 (0.87–1.59)</td></tr><tr><td> By BCS (<i>n</i> = 268)<sup>b</sup></td><td>3 (1.3%)</td><td>0.39 (0.11–1.38)</td><td>90.7</td><td>0.66 (0.42–1.06)</td><td>94.8</td><td>86.0</td><td>1.01 (0.68–1.49)</td></tr><tr><td> By mastectomy (<i>n</i> = 318)<sup>d</sup></td><td>3 (1.0%)</td><td><i>0</i>.<i>23 (0</i>.<i>06</i>–<i>0</i>.<i>89)</i></td><td>84.0</td><td>0.98 (0.66–1.47)</td><td>89.9</td><td>78.7</td><td>1.34 (0.93–1.91)</td></tr><tr><td>Extensively positive margins and primary BCS + re-excision (<i>n</i> = 1535)<sup>e</sup></td><td>40 (2.9%)</td><td>0.75 (0.37–1.51)</td><td>84.7</td><td>0.97 (0.72–1.31)</td><td>91.8</td><td>81.1</td><td>1.22 (0.94–1.59)</td></tr></table> |
be5a7707d09244cd44ee508aba0ee75179096b58dcfde28f97a37c230427b496.png | simple | <table><tr><td>Strain</td><td>Growth rate</td><td>min Nar</td><td>max Nar</td><td>Distance to WT</td><td><i>p</i>-value</td><td><i>q</i>-value</td><td>Method</td></tr><tr><td></td><td>(<i>h</i><sup>−1</sup>)</td><td>(mmol/gDCW/h)</td><td>(mmol/gDCW/h)</td><td>(mmol/gDCW/h)</td><td></td><td></td><td></td></tr><tr><td>wild type</td><td>0.50</td><td>0</td><td>0</td><td></td><td></td><td></td><td></td></tr><tr><td><i>Δ</i><i>ackA</i><i>Δ</i><i>metY</i></td><td>0.32</td><td>0</td><td>0.50</td><td>400</td><td>0.0742</td><td>0.0779</td><td>OptKnock <sup>a</sup></td></tr><tr><td><i>Δ</i><i>pta</i><i>Δ</i><i>ilvA_ile</i></td><td>0.20</td><td>0</td><td>0.50</td><td>404</td><td>0.2432</td><td>0.1197</td><td></td></tr><tr><td><i>Δ</i><i>pta</i><i>Δ</i><i>metY</i></td><td>0.32</td><td>0</td><td>0.50</td><td>400</td><td>0.2342</td><td>0.1197</td><td></td></tr><tr><td><i>Δ</i><i>ackA</i><i>Δ</i><i>ilvA_ile</i></td><td>0.20</td><td>0</td><td>0.50</td><td>404</td><td>0.4139</td><td>0.1285</td><td></td></tr><tr><td><i>Δ</i><i>ackA</i><i>Δ</i><i>metY</i></td><td>0.32</td><td>0</td><td>0.50</td><td>400</td><td>0.3656</td><td>0.1285</td><td></td></tr><tr><td><i>Δ</i><i>sdhCAB</i><i>Δ</i><i>ddh</i></td><td>0.21</td><td>0</td><td>0.50</td><td>545</td><td>0.5443</td><td>0.1285</td><td>OptKnock</td></tr><tr><td><i>Δ</i><i>mdh</i><i>Δ</i><i>pyc</i></td><td>0.23</td><td>0</td><td>0.49</td><td>39</td><td>0.5377</td><td>0.1285</td><td>screening</td></tr><tr><td><i>Δ</i><i>pyc</i><i>Δ</i><i>zwf</i></td><td>0.13</td><td>0</td><td>0.50</td><td>565</td><td>0.8300</td><td>0.1285</td><td></td></tr><tr><td><i>Δ</i><i>pyc</i><i>Δ</i><i>opcA</i></td><td>0.13</td><td>0</td><td>0.50</td><td>565</td><td>0.8580</td><td>0.1285</td><td></td></tr><tr><td><i>Δ</i><i>pyc</i><i>Δ</i><i>gnd</i></td><td>0.13</td><td>0</td><td>0.50</td><td>565</td><td>0.8784</td><td>0.1285</td><td></td></tr><tr><td><i>Δ</i><i>pyc</i><i>Δ</i><i>rpe</i></td><td>0.16</td><td>0</td><td>0.50</td><td>441</td><td>0.7986</td><td>0.1285</td><td></td></tr><tr><td><i>Δ</i><i>pyc</i><i>Δ</i><i>tkt_1</i></td><td>0.15</td><td>0</td><td>0.50</td><td>532</td><td>0.8553</td><td>0.1285</td><td></td></tr><tr><td><i>Δ</i><i>pyc</i><i>Δ</i><i>tal</i></td><td>0.15</td><td>0</td><td>0.50</td><td>532</td><td>0.8940</td><td>0.1285</td><td></td></tr><tr><td><i>Δ</i><i>pyc</i><i>Δ</i><i>tkt_2</i></td><td>0.17</td><td>0</td><td>0.50</td><td>413</td><td>0.8340</td><td>0.1285</td><td></td></tr><tr><td><i>Δ</i><i>pyc</i><i>Δ</i><i>pmmB</i></td><td>0.19</td><td>0</td><td>0.17</td><td>47</td><td>0.7249</td><td>0.1285</td><td></td></tr></table> |
c54e407dfe05c46be317fbae6b75de31afc7c1d06fb8553a405f01c469790e89.png | complex | <table><tr><td>Predicted Variables (<i>Y</i>)</td><td>Variable Selection (Variables Left in the Model with <i>p</i> < 0.05)</td><td>Prediction Equations (Test Model: <i>Y</i> = <i>a</i> + <i>b</i><sub>1</sub><i>x</i><sub>1</sub> + <i>b</i><sub>2</sub><i>x</i><sub>2</sub>)</td><td>Model <i>R</i><sup>2</sup> Value</td><td>RSD <sup>a</sup></td><td><i>p</i> Value</td></tr><tr><td colspan="6">Carbohydrate fraction profiles</td></tr><tr><td>CA4 (% CHO)</td><td>Ratio of structural CHO to total CHO left in the model</td><td><i>Y</i> = −41.04 + 99.32 A_StCHO/A_CHO ratio</td><td>0.77</td><td>1.00</td><td>0.022</td></tr><tr><td>CB1 (% CHO)</td><td>H_1415 left in the model</td><td><i>Y</i> = −6.91 + 355.77 H_1415</td><td>0.70</td><td>0.97</td><td>0.038</td></tr><tr><td>CB3 (% CHO)</td><td>H_895 left in the model</td><td><i>Y</i> = 42.57 − 4338.00 H_895</td><td>0.91</td><td>0.64</td><td>0.004</td></tr><tr><td colspan="6">Total digestible nutrients</td></tr><tr><td>tdNDF (% DM)</td><td>A_non-STCHO left in the model</td><td><i>Y</i> = 21.84 − 83.78 A_non-STCHO</td><td>0.88</td><td>0.28</td><td>0.006</td></tr></table> |
4ea7150bdc912eb3e0ab56d8e187655ab7799adf26199dfe573605b9652d3ef3.png | simple | <table><tr><td></td><td>Overall (n = 93)</td><td>Dentist (n = 54)</td><td>Dental hygienist (n = 22)</td><td>Medical (n = 17)</td></tr><tr><td>Asking smoking status</td><td>66.9 (36.2)</td><td>68.5 (36.3)*</td><td>46.4 (32.3)</td><td>88.2 (27.2) **</td></tr><tr><td>Advise to quit</td><td>43.9 (36.5)</td><td>43.3 (36.4)</td><td>30.9 (25.6)</td><td>62.4 (42.8)*</td></tr><tr><td>Assess willingness to make a quit attempt</td><td>22.5 (28.3)</td><td>23.3 (28.9)</td><td>22.2 (23.1)</td><td>20.0 (33.5)</td></tr><tr><td>Assist in quit attempt</td><td>17.3 (25.2)</td><td>14.6 (21.0)</td><td>19.1 (21.6)</td><td>23.5 (39.0)</td></tr></table> |
522b7df68321ef4d4525cb1abdb710f35c2a82a5ce23ebb5db28f490d0c9f5e3.png | simple | <table><tr><td>Kinase</td><td>Activity %</td><td>Kinase</td><td>Activity %</td><td>Kinase</td><td>Activity %</td></tr><tr><td>CK2α<sub>2</sub>β<sub>2</sub></td><td>10</td><td>PKCa</td><td>95</td><td>TAK1</td><td>107</td></tr><tr><td>CK2α</td><td>42</td><td>IRAK4</td><td>95</td><td>CDK9-Cyclin T1</td><td>108</td></tr><tr><td>PIM3</td><td>62</td><td>HIPK3</td><td>96</td><td>RSK1</td><td>108</td></tr><tr><td>MLK3</td><td>63</td><td>JNK3</td><td>96</td><td>MPSK1</td><td>108</td></tr><tr><td>CK1<i>δ</i></td><td>72</td><td>IGF-1R</td><td>96</td><td>RSK2</td><td>108</td></tr><tr><td>BRK</td><td>72</td><td>VEG-FR</td><td>96</td><td>DDR2</td><td>109</td></tr><tr><td>PLK1</td><td>75</td><td>IRAK1</td><td>97</td><td>EPH-A2</td><td>110</td></tr><tr><td>MST2</td><td>77</td><td>MAPKAP-K2</td><td>97</td><td>MNK1</td><td>110</td></tr><tr><td>MST4</td><td>78</td><td>PAK5</td><td>97</td><td>PKC<i>γ</i></td><td>110</td></tr><tr><td>CHK2</td><td>80</td><td>IKKe</td><td>97</td><td>CHK1</td><td>111</td></tr><tr><td>MKK1</td><td>81</td><td>GSK3b</td><td>98</td><td>OSR1</td><td>111</td></tr><tr><td>TrkA</td><td>81</td><td>DYRK1A</td><td>98</td><td>JNK2</td><td>112</td></tr><tr><td>PKBb</td><td>81</td><td>MAPKAP-K3</td><td>98</td><td>STK33</td><td>112</td></tr><tr><td>CAMK1</td><td>82</td><td>MSK1</td><td>99</td><td>NEK6</td><td>112</td></tr><tr><td>MKK2</td><td>82</td><td>AMPK (hum)</td><td>99</td><td>IKKb</td><td>112</td></tr><tr><td>ABL</td><td>82</td><td>SYK</td><td>99</td><td>EIF2AK3</td><td>112</td></tr><tr><td>PDK1</td><td>83</td><td>PDGFRA</td><td>99</td><td>p38g MAPK</td><td>114</td></tr><tr><td>MAP4K3</td><td>84</td><td>LKB1</td><td>99</td><td>MKK6</td><td>114</td></tr><tr><td>MLK1</td><td>84</td><td>p38a MAPK</td><td>99</td><td>ZAP70</td><td>114</td></tr><tr><td>PIM1</td><td>85</td><td>HIPK2</td><td>99</td><td>p38b MAPK</td><td>114</td></tr><tr><td>FGF-R1</td><td>85</td><td>HER4</td><td>100</td><td>CSK</td><td>114</td></tr><tr><td>MAP4K5</td><td>86</td><td>MARK2</td><td>100</td><td>TTBK1</td><td>115</td></tr><tr><td>PAK6</td><td>87</td><td>TTBK2</td><td>100</td><td>Aurora A</td><td>115</td></tr><tr><td>TIE2</td><td>88</td><td>EPH-B2</td><td>101</td><td>TAO1</td><td>115</td></tr><tr><td>MNK2</td><td>88</td><td>TTK</td><td>101</td><td>MEKK1</td><td>115</td></tr><tr><td>SIK2</td><td>89</td><td>ULK2</td><td>101</td><td>MELK</td><td>116</td></tr><tr><td>MARK3</td><td>89</td><td>WNK1</td><td>101</td><td>SRPK1</td><td>117</td></tr><tr><td>YES1</td><td>89</td><td>ERK8</td><td>102</td><td>EPH-B3</td><td>117</td></tr><tr><td>GCK</td><td>90</td><td>PINK</td><td>102</td><td>PRK2</td><td>118</td></tr><tr><td>ERK1</td><td>90</td><td>PKCz</td><td>102</td><td>PIM2</td><td>120</td></tr><tr><td>TESK1</td><td>90</td><td>PAK4</td><td>102</td><td>IRR</td><td>120</td></tr><tr><td>PKBa</td><td>91</td><td>JAK2</td><td>102</td><td>ASK1</td><td>120</td></tr><tr><td>DYRK2</td><td>91</td><td>MARK4</td><td>103</td><td>p38d MAPK</td><td>120</td></tr><tr><td>SGK1</td><td>91</td><td>BRSK1</td><td>103</td><td>PKA</td><td>121</td></tr><tr><td>CK1<i>γ</i>2</td><td>91</td><td>PRAK</td><td>103</td><td>CDK2-Cyclin A</td><td>121</td></tr><tr><td>S6K1</td><td>91</td><td>RIPK2</td><td>103</td><td>Lck</td><td>122</td></tr><tr><td>CLK2</td><td>91</td><td>TBK1</td><td>103</td><td>HIPK1</td><td>123</td></tr><tr><td>SmMLCK</td><td>92</td><td>DYRK3</td><td>104</td><td>BTK</td><td>125</td></tr><tr><td>JNK1</td><td>92</td><td>NUAK1</td><td>104</td><td>EPH-A4</td><td>126</td></tr><tr><td>ULK1</td><td>92</td><td>NEK2a</td><td>105</td><td>TLK1</td><td>126</td></tr><tr><td>Aurora B</td><td>93</td><td>SIK3</td><td>105</td><td>MST3</td><td>126</td></tr><tr><td>DAPK1</td><td>93</td><td>ROCK 2</td><td>105</td><td>IR</td><td>128</td></tr><tr><td>ERK2</td><td>94</td><td>MINK1</td><td>105</td><td>TGFBR1</td><td>130</td></tr><tr><td>CAMKKb</td><td>94</td><td>ERK5</td><td>106</td><td>TSSK1</td><td>131</td></tr><tr><td>EF2K</td><td>94</td><td>EPH-B1</td><td>106</td><td>EPH-B4</td><td>132</td></tr><tr><td>BRSK2</td><td>95</td><td>PAK2</td><td>106</td><td> </td><td> </td></tr><tr><td>PKD1</td><td>95</td><td>MARK1</td><td>106</td><td> </td><td> </td></tr><tr><td>Src</td><td>95</td><td>PHK</td><td>107</td><td> </td><td> </td></tr></table> |
ba85805d3d40e8dfaec79134e075732a2db343e731f0579d5cd998847ebf5267.png | simple | <table><tr><td>Operator</td><td>Sagittal* (degrees)</td><td>Coronal** (degrees)</td><td>Horizontal*** (degrees)</td></tr><tr><td>A</td><td>24.8 (7.2)</td><td>0.9 (2.8)</td><td>-2.3 (4.4)</td></tr><tr><td>B</td><td>25.4 (8.0)</td><td>3.3 (2.2)</td><td>-1.2 (3.8)</td></tr><tr><td>C</td><td>26.8 (7.6)</td><td>1.2 (3.9)</td><td>-2.8 (4.1)</td></tr></table> |
cb64e6f789f23402821ee4bc0b84b2502e7f17051cc56a0bb023bd2e6fbd690a.png | simple | <table><tr><td>Grading</td><td>Description</td></tr><tr><td>0</td><td>No apparent EB extravasation </td></tr><tr><td>1</td><td>A small amount of EB extravasation within the cerebral cortex</td></tr><tr><td>2</td><td>Flake dispersion of EB at the lateral ventricle or hippocampal layer</td></tr><tr><td>3</td><td>Massive EB extravasation in the brain tissue </td></tr></table> |
144f7f4c3497c00e721196c07d96a70348f1bc387e29cf875f28d4a22d48aade.png | complex | <table><tr><td rowspan="3">LBI</td><td colspan="4">Peak method*</td></tr><tr><td colspan="2">≥ LLQ</td><td colspan="2">≥ LLD</td></tr><tr><td>Min</td><td>Max</td><td>Min</td><td>Max</td></tr><tr><td>Oxford qPCR</td><td>97,608**</td><td>1,396,941**</td><td>33,768</td><td>1,396,941</td></tr><tr><td>UW large volume qRT-PCR</td><td>37,800</td><td>1,855,630</td><td>37,800</td><td>1,855,630</td></tr></table> |
068d98e725b1a249f62a5e89d70f718c258332eac39297b0eb1209c39264d4e4.png | simple | <table><tr><td>Participant</td><td>Form of feedback</td><td>Total number</td></tr><tr><td>General practitioner</td><td>One-on-one interview</td><td>4</td></tr><tr><td>GP registrar</td><td>Focus group</td><td>1 group with 14 attendees</td></tr><tr><td>General practitioner</td><td>Focus group</td><td>3 groups (3 GPs, 4 GPs, 4 GPs)</td></tr><tr><td>Healthcare consumer representative</td><td>One-on-one interview</td><td>5</td></tr><tr><td>Representative bodies for chronic illness</td><td>One-on-one interview</td><td>2</td></tr><tr><td>Dietician</td><td>One-on-one interview</td><td>1</td></tr><tr><td>Psychologist</td><td>One-on-one interview</td><td>1</td></tr><tr><td></td><td></td><td>Total—38</td></tr></table> |
10887495664f67d94b906932a6ce7cd5413ccefa1abd0ed37e03d0f571004875.png | simple | <table><tr><td>Lead Author</td><td>Year</td><td>Journal</td><td>Detection Rate</td><td>Accuracy Rate</td><td>Sensitivity Rate</td><td>False Negative Rate</td><td>Negative Predictive Value</td><td>Upstaging Rate</td></tr><tr><td>Saha (a)[47]</td><td>2000</td><td>Ann Surg Oncol</td><td>99</td><td>96</td><td>91</td><td>9</td><td>Ns</td><td>18</td></tr><tr><td>Wiese (a)[48]</td><td>2000</td><td>Arch Pathol Lab Med</td><td>99</td><td>96</td><td>91</td><td>9</td><td>ns</td><td>ns</td></tr><tr><td>Waters (b)[49]</td><td>2000</td><td>Am Surg</td><td>91</td><td>100</td><td>100</td><td>0</td><td>100</td><td>6</td></tr><tr><td>Bilchik (c)[50]</td><td>2001</td><td>J Clin Oncol</td><td>100</td><td>100</td><td>100</td><td>0</td><td>100</td><td>50</td></tr><tr><td>Paramo (d)[51]</td><td>2001</td><td>Am J Surg</td><td>71</td><td>100</td><td>100</td><td>0</td><td>100</td><td>11</td></tr><tr><td>Wood (a)+(c)[52]</td><td>2001</td><td>Ann Surg Oncol</td><td>96</td><td>95</td><td>88</td><td>12</td><td>ns</td><td>25</td></tr><tr><td>Wood (c)[53]</td><td>2001</td><td>Surg Endosc</td><td>100</td><td>100</td><td>100</td><td>0</td><td>100</td><td>9</td></tr><tr><td>Saha (a)+(c)[54]</td><td>2001</td><td>Ann Surg Oncol</td><td>98</td><td>96</td><td>90</td><td>10</td><td>95</td><td>14</td></tr><tr><td>Esser [55]</td><td>2001</td><td>Dis Colon Rectum</td><td>58</td><td>94</td><td>67</td><td>33</td><td>94</td><td>7</td></tr><tr><td>Bendavid [56]</td><td>2002</td><td>J Surg Oncol</td><td>90</td><td>94</td><td>95</td><td>5</td><td>91</td><td>42</td></tr><tr><td>Paramo (d)[57]</td><td>2002</td><td>Ann Surg Oncol</td><td>82</td><td>98</td><td>93</td><td>7</td><td>97</td><td>11</td></tr><tr><td>Wood (c)[58]</td><td>2002</td><td>J GastroInt Surg</td><td>97</td><td>95</td><td>92</td><td>8</td><td>ns</td><td>24</td></tr><tr><td>Bilchik (c)[59]</td><td>2002</td><td>Eur J Cancer</td><td>97</td><td>95</td><td>91</td><td>5</td><td>ns</td><td>24</td></tr><tr><td>Kitagawa [60]</td><td>2002</td><td>Dis Colon Rectum</td><td>91</td><td>92</td><td>82</td><td>18</td><td>88</td><td>ns</td></tr><tr><td>Feig (e)[61]</td><td>2002</td><td>Am J Surg</td><td>98</td><td>79</td><td>38</td><td>62</td><td>76</td><td>8</td></tr><tr><td>Broderick-Villa [62]</td><td>2002</td><td>Cancer J</td><td>92</td><td>79</td><td>50</td><td>50</td><td>73</td><td>0</td></tr><tr><td>Tsioulias (c)[63]</td><td>2002</td><td>Am Surg</td><td>100</td><td>93</td><td>67</td><td>33</td><td>ns</td><td>15</td></tr><tr><td>Nastro [64]</td><td>2002</td><td>Tumori</td><td>75</td><td>100</td><td>100</td><td>0</td><td>100</td><td>ns</td></tr><tr><td>Bilchik (c)[65]</td><td>2003</td><td>Cancer Control</td><td>100</td><td>93</td><td>91</td><td>9</td><td>ns</td><td>14</td></tr><tr><td>Cox [66]</td><td>2003</td><td>Curr Surg</td><td>100</td><td>100</td><td>100</td><td>0</td><td>100</td><td>29</td></tr><tr><td>Bilchik (c)[67]</td><td>2003</td><td>J Clin Oncol</td><td>96</td><td>96</td><td>92</td><td>8</td><td>ns</td><td>29</td></tr><tr><td>Turner (c)[68]</td><td>2003</td><td>Archives Path</td><td>82</td><td>92</td><td>87</td><td>13</td><td>ns</td><td>29</td></tr><tr><td>Trocha (a)+(c)[69]</td><td>2003</td><td>J GastroInt Surg</td><td>98</td><td>95</td><td>84</td><td>16</td><td>93</td><td>21</td></tr><tr><td>Veihl [70]</td><td>2003</td><td>World J Surg</td><td>87</td><td>78</td><td>50</td><td>22</td><td>71</td><td>11</td></tr><tr><td>Levine (b)[71]</td><td>2003</td><td>J GastroInt Surg</td><td>92</td><td>ns</td><td>50</td><td>ns</td><td>86</td><td>ns</td></tr><tr><td>Saha (a)[72]</td><td>2004</td><td>Dis Colon Rectum</td><td>99</td><td>ns</td><td>88</td><td>12</td><td>ns</td><td>13</td></tr><tr><td>Dan (a)[73]</td><td>2004</td><td>Arch Surg</td><td>99</td><td>96</td><td>86</td><td>16</td><td>ns</td><td>5</td></tr><tr><td>Braat [21]</td><td>2004</td><td>Eur J Surg Oncol</td><td>94</td><td>97</td><td>80</td><td>20</td><td>92</td><td>3</td></tr><tr><td>Bertoglio [74]</td><td>2004</td><td>J Surg Oncol</td><td>95</td><td>92</td><td>78</td><td>22</td><td>88</td><td>ns</td></tr><tr><td>Read [75]</td><td>2004</td><td>Dis Colon Rectum</td><td>79</td><td>97</td><td>25</td><td>75</td><td>ns</td><td>3</td></tr><tr><td>Patten (e)[76]</td><td>2004</td><td>Cancer</td><td>98</td><td>89</td><td>83</td><td>17</td><td>76</td><td>20</td></tr><tr><td>Bertagnolli [77]</td><td>2004</td><td>Ann Surg</td><td>92</td><td>80</td><td>46</td><td>54</td><td>75</td><td>0</td></tr><tr><td>Saha (a)[78]</td><td>2004</td><td>Ann Surg Oncol</td><td>100</td><td>95</td><td>84</td><td>16</td><td>93</td><td>5</td></tr><tr><td>Saha (a)[79]</td><td>2004</td><td>Semin Oncol</td><td>100</td><td>96</td><td>92</td><td>8</td><td>ns</td><td>13</td></tr><tr><td>Bembenek (f)[80]</td><td>2005</td><td>World J Surg</td><td>85</td><td>ns</td><td>92</td><td>8</td><td>95</td><td>26</td></tr><tr><td>Codnignola [81]</td><td>2005</td><td>JJ Clin Oncol</td><td>100</td><td>ns</td><td>72</td><td>28</td><td>70</td><td>37</td></tr><tr><td>Dahl [82]</td><td>2005</td><td>Eur J Surg Oncol</td><td>100</td><td>92</td><td>83</td><td>17</td><td>91</td><td>ns</td></tr><tr><td>Bilchik (a)+(c)[83]</td><td>2006</td><td>Arch Surg</td><td>100</td><td>95</td><td>88</td><td>12</td><td>ns</td><td>23</td></tr><tr><td>Tuech [84]</td><td>2006</td><td>Eur J Surg Oncol</td><td>97</td><td>94</td><td>91</td><td>9</td><td>ns</td><td>ns</td></tr><tr><td>Saha (a)[85]</td><td>2006</td><td>Am J Surg</td><td>98</td><td>96</td><td>90</td><td>10</td><td>93</td><td>ns</td></tr><tr><td>Kelder (g)[86]</td><td>2006</td><td>Scand J Gastroenterol</td><td>97</td><td>93</td><td>86</td><td>14</td><td>89</td><td>33</td></tr><tr><td>Thomas (b)[87]</td><td>2006</td><td>Am Surg</td><td>93</td><td>20</td><td>46</td><td>54</td><td>73</td><td>5</td></tr><tr><td>Covarelli [88]</td><td>2006</td><td>Am Surg</td><td>95</td><td>95</td><td>86</td><td>14</td><td>ns</td><td>8</td></tr><tr><td>Kelder (g)[89]</td><td>2007</td><td>Int J Col Dis</td><td>97</td><td>96</td><td>89</td><td>11</td><td>93</td><td>ns</td></tr><tr><td>Bianchi [90]</td><td>2007</td><td>Surg End</td><td>100</td><td>95</td><td>83</td><td>17</td><td>94</td><td>9</td></tr><tr><td>Murawa [91]</td><td>2007</td><td>Acta Chir Belg</td><td>93</td><td>84</td><td>83</td><td>17</td><td>ns</td><td>8</td></tr><tr><td>Bembenek (f)[92]</td><td>2007</td><td>Ann Surg</td><td>85</td><td>86</td><td>54</td><td>46</td><td>80</td><td>21</td></tr><tr><td>Sandrucci [93]</td><td>2007</td><td>J Surg Oncol</td><td>100</td><td>91</td><td>92</td><td>9</td><td>ns</td><td>11</td></tr><tr><td>Tiffet [94]</td><td>2007</td><td>Dis Colon Rectum</td><td>92</td><td>81</td><td>80</td><td>20</td><td>74</td><td>ns</td></tr><tr><td>Lim (e)[95]</td><td>2008</td><td>Ann Surg Oncol</td><td>99</td><td>83</td><td>59</td><td>41</td><td>78</td><td>ns</td></tr><tr><td>Kusano [96]</td><td>2008</td><td>Digestive Surgery</td><td>88.5</td><td>82.6</td><td>33</td><td>67</td><td>81</td><td>ns</td></tr><tr><td>Quadros [97]</td><td>2008</td><td>J Surg Oncol</td><td>91</td><td>80</td><td>67</td><td>33</td><td>67</td><td>25</td></tr></table> |
a8eab840c326321df0da764ce9482583a2c0de286b6391eaf5ca7791de68920e.png | simple | <table><tr><td>Antibiotic</td><td>MBEC (−Streptokinase) (mg/L)</td><td>MBEC (+Streptokinase) (mg/L)</td></tr><tr><td>Daptomycin</td><td>1024</td><td>1024</td></tr><tr><td>Daptomycin + rifampicin</td><td>64</td><td><4</td></tr><tr><td>Vancomycin</td><td>128</td><td>64</td></tr><tr><td>Vancomycin + rifampicin</td><td>64</td><td>4</td></tr></table> |
80da2300399f66c0dc45070b1c3c00b9bed6756203944a39240b8726087ed10d.png | complex | <table><tr><td rowspan="2">Variable</td><td colspan="2">First assessment</td><td colspan="2">Second assessment</td><td rowspan="2"><i>p</i> value</td></tr><tr><td>Mean</td><td>95% CI</td><td>Mean</td><td>95% CI</td></tr><tr><td>Adjusted age</td><td>10.9</td><td>10.1–10.7</td><td>19.9</td><td>19.1–20.7</td><td><0.001</td></tr><tr><td>Cognitive</td><td>92.8</td><td>89.5–96.1</td><td>93.2</td><td>89.3–97.1</td><td>0.874</td></tr><tr><td>Language</td><td>103.0</td><td>99.7–106.2</td><td>94.6</td><td>91.7–97.5</td><td>0.001</td></tr><tr><td>Motor</td><td>95.2</td><td>92.2–98.3</td><td>100.1</td><td>97.9–102.4</td><td>0.004</td></tr></table> |
bab22920120a56ae917b3b9d859033dfb26fc777ba2453f45050f8b412188848.png | complex | <table><tr><td rowspan="2">Item</td><td colspan="2">Brucellosis</td><td colspan="2">Leptospirosis</td></tr><tr><td>Cases (%)</td><td>95% CI</td><td>Cases (%)</td><td>95% CI</td></tr><tr><td>Season</td><td></td><td></td><td></td><td></td></tr><tr><td>Spring</td><td>170 (26.1) **</td><td>22.2-29.5</td><td>32 (2.8)</td><td>1.9-3.8</td></tr><tr><td>Summer</td><td>207 (31.8) **</td><td>28.2-35.4</td><td>80 (6.9)</td><td>5.4-8.4</td></tr><tr><td>Autumn</td><td>156 (24.0)</td><td>20.7-27.3</td><td>940 (84.5) **</td><td>79.3-83.7</td></tr><tr><td>Winter</td><td>118 (18.1) **</td><td>15.1-21.1</td><td>101 (8.8)</td><td>7.2-10.4</td></tr><tr><td>Total</td><td>651</td><td></td><td>1,153</td><td></td></tr><tr><td>Region</td><td></td><td></td><td></td><td></td></tr><tr><td>Eastern</td><td>256 (39.3)</td><td>35.1-43.1</td><td>775 (67.2) **</td><td>64.5-69.9</td></tr><tr><td>Western</td><td>321 (49.3) **</td><td>45.5-53.1</td><td>325 (28.2)</td><td>25.6-30.8</td></tr><tr><td>Central</td><td>67 (10.3) **</td><td>8.0-12.6</td><td>51 (4.4)</td><td>3.2-5.6</td></tr><tr><td>Jeju-Island</td><td>7 (1.1)</td><td>0.3-1.9</td><td>2 (0.2)</td><td>-</td></tr><tr><td>Total</td><td>651</td><td></td><td>1,153</td><td></td></tr></table> |
339e4518874320a308f96558e62aec151a9e5e49e9538424976f716bbe9c1fce.png | complex | <table><tr><td>Operator\device</td><td>1</td><td>2</td></tr><tr><td rowspan="2">1</td><td><i>SEN</i> = 75%</td><td><i>SEN</i> = 68%</td></tr><tr><td><i>SPC</i> = 82%</td><td><i>SPC</i> = 61%</td></tr><tr><td rowspan="2">2</td><td><i>SEN</i> = 68%</td><td><i>SEN</i> = 58%</td></tr><tr><td><i>SPC</i> = 59%</td><td><i>SPC</i> = 70%</td></tr></table> |
bf580940a37e641b559027476d964bf479a153c86e127aebe889804d54d62b81.png | complex | <table><tr><td>Stimulation</td><td>Overexpressed in BCG-vaccinated infants</td><td>Median fold change</td><td>Under-expressed in BCG-vaccinated infants</td><td>Median fold change</td></tr><tr><td rowspan="4"><i>Mtb</i> lysate</td><td>IL-2, IFNγ, IL-13, IL-1α, IP-10, IL-6</td><td>>10</td><td rowspan="4"></td><td rowspan="4"></td></tr><tr><td>Flt-3L, IL-8, IL-1Rα, IL-12p40, IL-10, MCP-3</td><td>5–10</td></tr><tr><td>MIP-1α, IL-5, TNFα, VEGF, MIP-1β, GM-CSF, IL-7, IL-17, IFNα2, eotaxin</td><td>2–5</td></tr><tr><td>CD40L, TNFβ, fractalkine, FGF- 2, TGFα</td><td>1–2</td></tr><tr><td rowspan="3">Pam3Cys</td><td>IL-10, epidermal growth factor (EGF)</td><td>5–10</td><td rowspan="3"></td><td rowspan="3"></td></tr><tr><td>Platelet-derived growth factor (PDGF)-AB/BB, sCD40L, MIP-1α</td><td>2–5</td></tr><tr><td>IL-12p40, IL-6, MCP-3, IL-7, eotaxin</td><td>1–2</td></tr><tr><td><i>Candida albicans</i></td><td>EGF, IL-6, PDGF-AB/BB, MCP-3</td><td>2–5</td><td>IL-2, IL-13, IL-17, IP-10</td><td>0.2–0.5</td></tr><tr><td rowspan="2"><i>Staphylococcus aureus</i></td><td>EGF, IL-6</td><td>2–5</td><td></td><td></td></tr><tr><td>PDGF-AB/BB</td><td>1.7</td><td></td><td></td></tr><tr><td><i>Escherichia coli</i></td><td>EGF</td><td>2.8</td><td>GM-CSF, GRO</td><td>0.2–1.0</td></tr><tr><td>Lipopolysaccharide</td><td>IL-8</td><td>1.7</td><td>GM-CSF, GRO</td><td>0.2–1.0</td></tr></table> |
8fd36710bc69ebdaa23d76c407e306c00a95e81de01f8eb8128cfed9da2aa33a.png | simple | <table><tr><td>GI name</td><td>tRNA gene (gene_ID)</td><td>GI-left end</td><td>GI-right end</td><td>GI-length (bp)</td><td>GC%</td><td>duplication length (bp)</td><td>gene_ID of integrase</td></tr><tr><td>BJ6TGI01</td><td><i>trnR</i>-CCG (BJ6T08940)</td><td>911,924</td><td>937,940</td><td>26,017</td><td>55.7</td><td>50</td><td>BJ6T08690</td></tr><tr><td>BJ6TGI02</td><td><i>trnR</i>-ACG (BJ6T12260)</td><td>1,307,833</td><td>1,310,731</td><td>2,899</td><td>62.7</td><td>18</td><td>-</td></tr><tr><td>BJ6TGI03</td><td><i>trnE</i>-CTC (BJ6T19770)</td><td>2,046,607</td><td>2,146,757</td><td>100,151</td><td>59.7</td><td>48</td><td>BJ6T20830</td></tr><tr><td>BJ6TGI04</td><td><i>trnK</i>-CTT (BJ6T30200)</td><td>3,118,227</td><td>3,192,248</td><td>74,022</td><td>59.5</td><td>46</td><td>BJ6T31070</td></tr><tr><td>BJ6TGI05</td><td><i>trnK</i>-CTT (BJ6T30200)</td><td>3,192,295</td><td>3,236,376</td><td>44,082</td><td>60.9</td><td>46</td><td>BJ6T31620</td></tr><tr><td>BJ6TGI06</td><td><i>trnK</i>-CTT (BJ6T30200)</td><td>3,236,423</td><td>3,322,375</td><td>85,953</td><td>59.0</td><td>46</td><td>-</td></tr><tr><td>BJ6TGI07</td><td><i>trnK</i>-CTT (BJ6T30200)</td><td>3,322,421</td><td>3,326,439</td><td>4,019</td><td>58.6</td><td>45</td><td>BJ6T32590</td></tr><tr><td>BJ6TGI08</td><td><i>trnT</i>-TGT (BJ6T43300)</td><td>4,371,641</td><td>4,428,687</td><td>57,047</td><td>58.8</td><td>47</td><td>BJ6T42570</td></tr><tr><td>BJ6TGI09</td><td><i>trnS</i>-TGA (BJ6T51900)</td><td>5,251,688</td><td>5,269,566</td><td>17,879</td><td>58.4</td><td>14</td><td>BJ6T51650</td></tr><tr><td>BJ6TGI10</td><td><i>trnN</i>-GTT (BJ6T53120)</td><td>5,380,012</td><td>5,394,916</td><td>14,905</td><td>59.3</td><td>53</td><td>BJ6T52900</td></tr><tr><td>BJ6TGI11</td><td><i>trnQ</i>-TTG (BJ6T71420)</td><td>7,326,115</td><td>7,332,736</td><td>6,622</td><td>62.7</td><td>47</td><td>-</td></tr><tr><td>BJ6TGI12</td><td><i>trnQ</i>-TTG (BJ6T71420)</td><td>7,332,777</td><td>7,363,200</td><td>30,424</td><td>62.1</td><td>39</td><td>-</td></tr><tr><td>BJ6TGI13</td><td><i>trnI</i>-CAT (BJ6T75390)</td><td>7,790,844</td><td>7,797,321</td><td>6,478</td><td>61.1</td><td>48</td><td>-</td></tr><tr><td>BJ6TGI14</td><td><i>trnI</i>-CAT (BJ6T82220)</td><td>8,494,412</td><td>8,539,486</td><td>45,075</td><td>58.5</td><td>49</td><td>BJ6T82530</td></tr><tr><td>BJ6TGI15</td><td><i>trnI</i>-CAT (BJ6T82220)</td><td>8,539,534</td><td>8,591,258</td><td>51,725</td><td>59.5</td><td>47</td><td>BJ6T82650</td></tr></table> |
b5490660b1578350d1138c3d5af6cd979cfdb30a75be23c15fd02fd18ad387f0.png | complex | <table><tr><td>Fucans</td><td>Total sugar (%)</td><td>Sulfate (%)</td><td>Sulfate/Total sugar (%/%)</td><td>Proteins (%)</td><td colspan="6">Molar ratio</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>Fuc</td><td>Gal</td><td>Glc</td><td>Man</td><td>Xyl</td><td>Gluc A</td></tr><tr><td>F0.5v</td><td>89.1</td><td>14.1</td><td>0.16</td><td>0.1</td><td>1.0</td><td>2.0</td><td>0.3</td><td>0.5</td><td>0.7</td><td>0.9</td></tr><tr><td>F0.7v</td><td>70.0</td><td>17.8</td><td>0.25</td><td>0.3</td><td>1.0</td><td>3.0</td><td>0.4</td><td>0.6</td><td>1.5</td><td>2.2</td></tr><tr><td>F1.0v</td><td>65.0</td><td>19.0</td><td>0.29</td><td>0.5</td><td>1.0</td><td>1.9</td><td>0.2</td><td>0.5</td><td>0.8</td><td>1.5</td></tr><tr><td>F1.3v</td><td>68.2</td><td>14.5</td><td>0.21</td><td>0.1</td><td>1.0</td><td>2.4</td><td>0.3</td><td>0.2</td><td>0.6</td><td>0.5</td></tr><tr><td>F1.5v</td><td>61.3</td><td>15.4</td><td>0.25</td><td>0.1</td><td>1.0</td><td>1.6</td><td>0.2</td><td>0.4</td><td>1.3</td><td>1.9</td></tr><tr><td>F2.0v</td><td>64.3</td><td>16.0</td><td>0.25</td><td>0.7</td><td>1.0</td><td>1.8</td><td>0.2</td><td>0.4</td><td>1.6</td><td>2.2</td></tr></table> |
1b332e17d9324875d2532dd4aaf851644141526ce5bd45fb64b600ec06e08b99.png | complex | <table><tr><td rowspan="2">Genotype</td><td colspan="4">Overall colorectal cancer cases (<i>n</i> = 387) vs. controls (1,536)</td><td colspan="4">Colon cancer (<i>n</i> = 169) vs. controls (1,536)</td><td colspan="4">Rectum cancer (<i>n</i> = 218) vs. controls (1,536)</td></tr><tr><td>Crude OR (95% CI)</td><td><i>P</i></td><td>Adjusted OR<sup>a</sup> (95%CI)</td><td><i>P</i></td><td>Crude OR (95% CI)</td><td><i>P</i></td><td>Adjusted OR<sup>a</sup> (95% CI)</td><td><i>P</i></td><td>Crude OR (95% CI)</td><td><i>P</i></td><td>Adjusted OR<sup>a</sup> (95% CI)</td><td><i>P</i></td></tr><tr><td>Additive model</td><td>0.67 (0.43–1.04)</td><td>0.072</td><td>0.67 (0.43–1.04)</td><td>0.073</td><td>0.55 (0.27–1.09)</td><td>0.086</td><td>0.54 (0.27–1.08)</td><td>0.083</td><td>0.76 (0.45–1.31)</td><td>0.324</td><td>0.77 (0.45–1.32)</td><td>0.335</td></tr><tr><td>Homozygote model</td><td>0.77 (0.09–6.60)</td><td>0.810</td><td>0.77 (0.09–6.82)</td><td>0.814</td><td>1.75 (0.20–15.03)</td><td>0.612</td><td>1.80 (0.21–15.73)</td><td>0.596</td><td>–</td><td>–</td><td>–</td><td>–</td></tr><tr><td>Dominant model</td><td>0.68 (0.44–1.04)</td><td>0.077</td><td>0.68 (0.44–1.05)</td><td>0.078</td><td>0.59 (0.31–1.15)</td><td>0.120</td><td>0.59 (0.30–1.14)</td><td>0.117</td><td>0.76 (0.45–1.31)</td><td>0.324</td><td>0.77 (0.45–1.32)</td><td>0.335</td></tr><tr><td>Recessive model</td><td>0.80 (0.09–6.87)</td><td>0.839</td><td>0.80 (0.09–7.07)</td><td>0.838</td><td>1.84 (0.21–12.85)</td><td>0.579</td><td>1.89 (0.22–16.57)</td><td>0.566</td><td>–</td><td>–</td><td>–</td><td>–</td></tr></table> |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.